
<html lang="en"     class="pb-page"  data-request-id="212f3631-773f-4955-8f28-3fcaaf8af12c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm5000613;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Beatriz  López-Iglesias" /></meta><meta name="dc.Creator" content="Concepción  Pérez" /></meta><meta name="dc.Creator" content="José A.  Morales-García" /></meta><meta name="dc.Creator" content="Sandra  Alonso-Gil" /></meta><meta name="dc.Creator" content="Ana  Pérez-Castillo" /></meta><meta name="dc.Creator" content="Alejandro  Romero" /></meta><meta name="dc.Creator" content="Manuela G.  López" /></meta><meta name="dc.Creator" content="Mercedes  Villarroya" /></meta><meta name="dc.Creator" content="Santiago  Conde" /></meta><meta name="dc.Creator" content="María Isabel  Rodríguez-Franco" /></meta><meta name="dc.Description" content="Here, we describe a new family of melatonin–N,N-dibenzyl(N-methyl)amine hybrids that show a balanced multifunctional profile covering neurogenic, antioxidant, cholinergic, and neuroprotective prope..." /></meta><meta name="Description" content="Here, we describe a new family of melatonin–N,N-dibenzyl(N-methyl)amine hybrids that show a balanced multifunctional profile covering neurogenic, antioxidant, cholinergic, and neuroprotective prope..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 28, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5000613" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5000613" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5000613" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5000613" /></link>
        
    
    

<title>New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5000613" /></meta><meta property="og:title" content="New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0006.jpeg" /></meta><meta property="og:description" content="Here, we describe a new family of melatonin–N,N-dibenzyl(N-methyl)amine hybrids that show a balanced multifunctional profile covering neurogenic, antioxidant, cholinergic, and neuroprotective properties at low-micromolar concentrations. They promote maturation of neural stem cells into a neuronal phenotype and thus they could contribute to CNS repair. They also protect neural cells against mitochondrial oxidative stress, show antioxidant properties, and inhibit human acetylcholinesterase (AChE). Moreover, they displace propidium from the peripheral anionic site of AChE, preventing the β-amyloid aggregation promoted by AChE. In addition, they show low cell toxicity and can penetrate into the CNS. This multifunctional profile highlights these melatonin–N,N-dibenzyl(N-methyl)amine hybrids as useful prototypes in the research of innovative drugs for Alzheimer’s disease." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5000613"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5000613">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5000613&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5000613&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5000613&amp;href=/doi/10.1021/jm5000613" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3773-3785</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4019228" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500317a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">New Melatonin–<i>N</i>,<i>N</i>-Dibenzyl(<i>N</i>-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatriz++L%C3%B3pez-Iglesias">Beatriz López-Iglesias</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Concepci%C3%B3n++P%C3%A9rez">Concepción Pérez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+A.++Morales-Garc%C3%ADa">José A. Morales-García</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Alonso-Gil">Sandra Alonso-Gil</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana++P%C3%A9rez-Castillo">Ana Pérez-Castillo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alejandro++Romero">Alejandro Romero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuela+G.++L%C3%B3pez">Manuela G. López</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mercedes++Villarroya">Mercedes Villarroya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Santiago++Conde">Santiago Conde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Isabel++Rodr%C3%ADguez-Franco">María Isabel Rodríguez-Franco</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Instituto de Química Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Instituto de Investigaciones Biomédicas “Alberto Sols”, Consejo Superior de Investigaciones Científicas (IIB-CSIC), C/Arturo Duperier 4, 28029 Madrid, Spain </span></div><div class="aff-info" id="aff4"><span class="aff-symbol">§</span> <span class="aff-text">Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), C/ Valderrebollo 5, 28031 Madrid, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">Instituto Teófilo Hernando and Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain</span></div><div class="corresp-info"><strong>*</strong>Phone: 34-91-5622900. Fax: 34-91-5644853. E-mail: <a href="/cdn-cgi/l/email-protection#bcd5cfddded9d0cedbc9d9c6fcd5cdd192dfcfd5df92d9cf"><span class="__cf_email__" data-cfemail="325b415350575e4055475748725b435f1c51415b511c5741">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5000613&amp;href=/doi/10.1021%2Fjm5000613" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3773–3785</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 16, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 January 2014</li><li><span class="item_label"><b>Published</b> online</span>28 April 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 May 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5000613" title="DOI URL">https://doi.org/10.1021/jm5000613</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3773%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBeatriz%2BL%25C3%25B3pez-Iglesias%252C%2BConcepci%25C3%25B3n%2BP%25C3%25A9rez%252C%2BJos%25C3%25A9%2BA.%2BMorales-Garc%25C3%25ADa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D9%26contentID%3Djm5000613%26title%3DNew%2BMelatonin%25E2%2580%2593N%252CN-Dibenzyl%2528N-methyl%2529amine%2BHybrids%253A%2BPotent%2BNeurogenic%2BAgents%2Bwith%2BAntioxidant%252C%2BCholinergic%252C%2Band%2BNeuroprotective%2BProperties%2Bas%2BInnovative%2BDrugs%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3785%26publicationDate%3DMay%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5000613"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2191</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">63</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5000613" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Beatriz&quot;,&quot;last_name&quot;:&quot;López-Iglesias&quot;},{&quot;first_name&quot;:&quot;Concepción&quot;,&quot;last_name&quot;:&quot;Pérez&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;A. Morales-García&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Alonso-Gil&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Pérez-Castillo&quot;},{&quot;first_name&quot;:&quot;Alejandro&quot;,&quot;last_name&quot;:&quot;Romero&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;G. López&quot;},{&quot;first_name&quot;:&quot;Mercedes&quot;,&quot;last_name&quot;:&quot;Villarroya&quot;},{&quot;first_name&quot;:&quot;Santiago&quot;,&quot;last_name&quot;:&quot;Conde&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Isabel Rodríguez-Franco&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;3773-3785&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5000613&quot;},&quot;abstract&quot;:&quot;Here, we describe a new family of melatonin–N,N-dibenzyl(N-methyl)amine hybrids that show a balanced multifunctional profile covering neurogenic, antioxidant, cholinergic, and neuroprotective properties at low-micromolar concentrations. They promote maturation of neural stem cells into a neuronal phenotype and thus they could contribute to CNS repair. They also protect neural cells against mitochondrial oxidative stress, show antioxidant properties, and inhibit human acetylcholinesterase (AChE). Moreover, they displace propidium from the peripheral anionic site of AChE, preventing the β-amyloid aggregation promoted by AChE. In addition, they show low cell toxicity and can penetrate into the CNS. This multifunctional profile highlights these melatonin–N,N-dibenzyl(N-methyl)amine hybrids as useful prototypes in the research of innovative drugs for Alzheimer’s disease.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5000613&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5000613" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5000613&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5000613" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5000613&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5000613" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5000613&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5000613&amp;href=/doi/10.1021/jm5000613" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5000613" /></input><a href="/doi/pdf/10.1021/jm5000613" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5000613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5000613%26sid%3Dliteratum%253Aachs%26pmid%3D24738476%26genre%3Darticle%26aulast%3DL%25C3%25B3pez-Iglesias%26date%3D2014%26atitle%3DNew%2BMelatonin%25E2%2580%2593N%252CN-Dibenzyl%2528N-methyl%2529amine%2BHybrids%253A%2BPotent%2BNeurogenic%2BAgents%2Bwith%2BAntioxidant%252C%2BCholinergic%252C%2Band%2BNeuroprotective%2BProperties%2Bas%2BInnovative%2BDrugs%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D9%26spage%3D3773%26epage%3D3785%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290981" title="Oxygen radical absorbance capacity">Oxygen radical absorbance capacity</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jmcmar.2014.57.issue-9/production/jmcmar.2014.57.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Here, we describe a new family of melatonin–<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids that show a balanced multifunctional profile covering neurogenic, antioxidant, cholinergic, and neuroprotective properties at low-micromolar concentrations. They promote maturation of neural stem cells into a neuronal phenotype and thus they could contribute to CNS repair. They also protect neural cells against mitochondrial oxidative stress, show antioxidant properties, and inhibit human acetylcholinesterase (AChE). Moreover, they displace propidium from the peripheral anionic site of AChE, preventing the β-amyloid aggregation promoted by AChE. In addition, they show low cell toxicity and can penetrate into the CNS. This multifunctional profile highlights these melatonin–<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids as useful prototypes in the research of innovative drugs for Alzheimer’s disease.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a dreadful neurological illness and is the most frequent of the degenerative dementias. The slow but progressive impairment of the physical and neurological conditions of AD patients produces devastating effects on the patients themselves and on their caregivers as well as a very high economic burden for families and public health systems.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AD shows a highly complex network of interconnected pathological processes that result in the accumulation of abnormal deposits of β-amyloid peptide (Aβ) and hyperphosphorylated tau protein as well as massive cell death and the loss of synapses, especially in the cholinergic system.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Currently, the therapeutic options for the treatment of AD are limited to three acetylcholinesterase (AChE) inhibitors, namely, donepezil, rivastigmine, and galantamine,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and one <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonist, memantine.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">The main role of AChE is to hydrolyze the neurotransmitter acetylcholine (ACh) after the occurrence of a nerve impulse. Thus, inhibition of this enzyme has been largely used as a rational approach to palliate memory deficits by increasing ACh in the synaptic cleft. However, AChE also plays other noncholinergic functions, including an important role in Aβ processing. Several studies have indicated that AChE increases the formation of Aβ fibrils in vitro<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and Aβ plaques in the cerebral cortex of transgenic mouse models of AD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These effects seem to be mediated by interactions between Aβ and the peripheral anionic site (PAS) of the enzyme,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which is supported by the fact that propidium, a noncompetitive AChE inhibitor that binds purely to PAS, significantly decreases AChE-induced Aβ aggregation; however, edrophonium, a pure competitive inhibitor that binds the center active site (CAS), does not show any effect on AChE-induced Aβ fibrillogenesis.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These findings have led to the design and synthesis of inhibitors of both the CAS and PAS for use as promising disease-modifying AD drug candidates because they can simultaneously improve cognition and slow the rate of Aβ degeneration.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Recently, this hypothesis has been validated in murine models of AD that showed an improvement in cognition and a reduction of brain amyloid burden when mice were treated with dual-binding-site AChE inhibitors.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a></div><div class="NLM_p">Because of the progressive failure of the endogenous antioxidant systems, the oxidative damage in cellular structures is augmented during aging, and recent findings have shown the involvement of oxidative imbalance in different pathologies. For instance, a post-mortem study of the frontal cortex of AD patients demonstrated a significant disease-dependent increase in oxidative markers that correlated with mini-mental status examination scores.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Additionally, in a murine AD model, oxidative damage was found to be an event that precedes the appearance of other pathological hallmarks of AD.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> These findings pointed out the early involvement of mitochondrial oxidative stress in the pathogenesis and progression of this disease.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Thus, drugs that protect neurons from mitochondrial oxidative stress could be useful either for the prevention or treatment of AD.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Neurogenesis is a dynamic process occurring in the brain of adult vertebrates whereby new nervous cells are generated along the lifespan of an individual. Although it was thought for many years that the creation of nervous tissue was restricted to the first stages of embryonic development, this concept changed in 1962 when Altman demonstrated the formation of new neurons in the brain of adult rats.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In the following years, neurogenesis was also found in different species of vertebrates, including humans.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> The whole process comprises several stages, from the proliferation of progenitor cells to the integration of these new cells into cerebral circuits. Because renewal rates for neuronal cells decrease with aging, drugs capable of helping the replacement of damaged cells with healthy ones would represent an exciting new therapeutic treatment for AD and other neurodegenerative diseases.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Melatonin (<i>N</i>-acetyl-5-methoxytryptamine) is a ubiquitous molecule produced by a variety of organs and tissues. It is involved in many physiological processes, such as circadian rhythm, endogenous antioxidant regulation, and the immune system. The natural decline in melatonin levels with aging has been associated with insomnia and depression as well as the development of neurodegenerative disorders such as AD.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Among its extensive pharmacological profile, melatonin shows a potent antioxidant activity by the direct capture of free radicals,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> stimulates the synthesis of several endogenous antioxidant enzymes,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> improves mitochondrial energy metabolism,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> decreases neurofilament hyperphosphorylation, and plays a neuroprotective role against Aβ.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Moreover, melatonin potentiates the proliferation and differentiation of neural stem cells in the hippocampus of adult mice.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> Thus, melatonin-based compounds could show an interesting neurogenic profile of paramount importance in the search of new therapeutics for AD and other neurodegenerative diseases.</div><div class="NLM_p">Furthermore, the complexity of AD pathology has encouraged the design of molecules that are able to interact with two or more complementary targets, with the expectation that these multitarget ligands (MTL) may represent important advantages in the treatment of the disease.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> In recent years, many interesting MTLs have been developed, such as memoquin, ladostigil, and huprine X, among others. Memoquin is an AChE and β-secretase-1 (BACE-1) inhibitor with additional antioxidant and Aβ anti-aggregating properties, which has recently been proven to have in vivo efficacy using different mouse models of induced amnesia.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Ladostigil is an inhibitor of cholinesterases (ChEs) and is a brain-selective inhibitor of monoaminoxidases (MAO-A and -B), with little or no peripheral MAO inhibitory effects in in vivo experiments.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Huprine X is a subnanomolar AChE inhibitor that possesses additional effects, such as inhibition of BACE-1, activation of α-secretases, and stimulation of protein kinase C/mitogen-activated protein kinase pathway signaling, and was shown to improve learning and memory in a triple transgenic mouse model of AD.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> Our group has also reported several families of MTLs that combined neuroprotective, cholinergic, and antioxidant properties,<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> including melatonin-based hybrids that have proved their effectiveness in a murine model of AD.<a onclick="showRef(event, 'ref11 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref11 ref41 ref42">(11, 41, 42)</a></div><div class="NLM_p">Continuing with our interest in the design, synthesis, and biological evaluation of multifunctional molecules, our work is currently focused on taking advantage of the potential neurogenic profile of melatonin-based hybrids, which are endowed with additional anticholinergic properties. Thus, in this work, we have designed new melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids (<b>1</b>–<b>14</b>) by binding two fragments with interesting and complementary properties. The melatonin framework, in addition to its above-mentioned neurogenic profile, could demonstrate antioxidant and neuroprotective features and could also interact with the AChE-PAS because of its aromatic character, as we observed in the tacrine–melatonin series. <a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The second selected fragment was the protonable <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine, which is present in the well-known AChE inhibitor AP2238, because its interaction with the AChE-CAS has been probed<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). </div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of melatonin, AP2238, and new melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids (<b>1</b>–<b>14</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this article, we describe the synthesis of new melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids (<b>1</b>–<b>14</b>) and their biological evaluation, which comprises inhibition of human AChE and BuChE, displacement of propidium from AChE-PAS, in vitro CNS permeation, and oxygen radical absorbance capacity (ORAC). Using a human neuroblastoma cell line, we also studied the cell viability and the neuroprotective effects of these hybrids against death induced by mitochondrial oxidative stress. Lastly, we explored the neurogenic effects of a selection of these compounds using primary hippocampal neural stem cells from adult rats.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Melatonin–<i>N</i>, <i>N</i>-Dibenzyl(<i>N</i>-methyl)amine Hybrids </h3><div class="NLM_p">New melatonin–<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids <b>1</b>–<b>14</b> were obtained as depicted in Scheme  <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Reaction of commercially available 4-(bromomethyl)benzonitrile and differently substituted <i>N</i>-methylbenzylamines gave 4-{[benzyl(methyl)amino]methyl}benzonitriles <b>15</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a>–<b>19</b>  (77–93% yield), which were  hydrolyzed to corresponding acid derivatives <b>20</b>–<b>24</b> in good yields  (69–97%). Then, these intermediate acids were activated with benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and subsequently coupled with commercially available tryptamines in the presence of triethylamine in dimethylformamide solutions at room temperature overnight to afford the desired melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine derivatives (<b>1</b>–<b>14</b>) in moderate to good yields (30–82%). All new hybrids (<b>1</b>–<b>14</b>) were purified by chromatographic techniques and structurally characterized by their analytical (HPLC and combustion analysis) and spectroscopic data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, and MS).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Melatonin–<i>N</i>,<i>N</i>-Dibenzyl(<i>N</i>-methyl)amine Hybrids (<b>1</b>–<b>14</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Inhibition of Human Cholinesterases and Propidium Displacement from AChE</h3><div class="NLM_p">New melatonin–<i>N</i>, <i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids  <b>1</b>–<b>14</b> were assayed as inhibitors of human AChE (h-AChE) and BuChE (h-BuChE) by following the method of Ellman et al.,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> using tacrine as a reference (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). All tested compounds displayed inhibition of h-AChE with IC<sub>50</sub>’s in the low-micromolar range and showed little fluctuation after the introduction of different substituents in the benzene or indole ring. However, h-BuChE inhibition showed a higher dependency on the presence of substituents: only unsubstituted hybrid <b>1</b> displayed low-micromolar inhibition of h-BuChE (IC<sub>50</sub> = 3.7  μM), whereas the introduction of any substituent in <b>2</b>–<b>14</b> penalized the enzyme–hybrid interactions by   1 order of magnitude and showed IC<sub>50</sub>’s around 10 μM or higher.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Yield (%), Inhibition of h-AChE and h-BuChE [IC<sub>50</sub> (μM) or Percentage of Inhibition at 10 μM (%)], and Displacement of Propidium Iodide from the Peripheral Anionic Site of AChE (%) by New Melatonin–<i>N</i>,<i>N</i>-Dibenzyl(<i>N</i>-methyl)amine Hybrids <b>1</b>–<b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> or (inhibition % at 10 μM)</th><th class="rowsep1 colsep0" colspan="3" align="center">displacement of propidium iodide (%)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">yield (%)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">h-AChE</th><th class="colsep0 rowsep0" align="center">h-BuChE</th><th class="colsep0 rowsep0" align="center">0.3 μM</th><th class="colsep0 rowsep0" align="center">1.0 μM</th><th class="colsep0 rowsep0" align="center">3.0 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">37.6 ± 0.22</td><td class="colsep0 rowsep0" align="left">5.6 ± 0.11</td><td class="colsep0 rowsep0" align="left">51.4 ± 1.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-OH</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">4.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">9.5 ± 0.5</td><td class="colsep0 rowsep0" align="left">8.0 ± 0.54</td><td class="colsep0 rowsep0" align="left">22.4 ± 0.37</td><td class="colsep0 rowsep0" align="left">25.3 ± 0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">6.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">7.8 ± 0.5</td><td class="colsep0 rowsep0" align="left">45.2 ± 1.80</td><td class="colsep0 rowsep0" align="left">25.3 ± 0.96</td><td class="colsep0 rowsep0" align="left">67.3 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">4.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">50.0 ± 2.1</td><td class="colsep0 rowsep0" align="left">24.1 ± 1.01</td><td class="colsep0 rowsep0" align="left">24.9 ± 0.30</td><td class="colsep0 rowsep0" align="left">17.8 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">7.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">8.1 ± 0.87</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">34.5 ± 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">3.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">>10 (38%)</td><td class="colsep0 rowsep0" align="left">7.7 ± 0.08</td><td class="colsep0 rowsep0" align="left">25.8 ± 0.90</td><td class="colsep0 rowsep0" align="left">34.7 ± 0.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">>10 (37%)</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">5.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">>10 (38%)</td><td class="colsep0 rowsep0" align="left">10.9 ± 0.30</td><td class="colsep0 rowsep0" align="left">15.6 ± 0.32</td><td class="colsep0 rowsep0" align="left">29.9 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">5.6 ± 0.4</td><td class="colsep0 rowsep0" align="left">>10 (38%)</td><td class="colsep0 rowsep0" align="left">4.1 ± 0.70</td><td class="colsep0 rowsep0" align="left">11.3 ± 0.48</td><td class="colsep0 rowsep0" align="left">31.8 ± 0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">>10 (22%)</td><td class="colsep0 rowsep0" align="left">16.8 ± 0.06</td><td class="colsep0 rowsep0" align="left">11.4 ± 0.01</td><td class="colsep0 rowsep0" align="left">33.4 ± 0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">4.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">8.2 ± 0.4</td><td class="colsep0 rowsep0" align="left">11.5 ± 0.32</td><td class="colsep0 rowsep0" align="left">16.9 ± 1.21</td><td class="colsep0 rowsep0" align="left">37.9 ± 1.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">76</td><td class="colsep0 rowsep0" align="left">5.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">>10 (47%)</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">30.4 ± 0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">3.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">9.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">21.8 ± 0.56</td><td class="colsep0 rowsep0" align="left">21.4 ± 1.18</td><td class="colsep0 rowsep0" align="left">43.7 ± 1.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">6.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">>10 (45%)</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">tacrine</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.23 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.040 ± 0.002</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">BW284c51</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">16.0 ± 2.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Percentage of isolated product (%).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Results are the mean ± SEM (<i>n</i> = 3). n.d., not determined.</p></div></div></div><div class="NLM_p">As previously mentioned, the enzyme AChE interacts with Aβ oligomers and stimulates conformational changes that contribute to their aggregation and precipitation into amyloid plaques.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The enzymatic region that promotes these abnormal modifications is placed in the PAS of AChE<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> because the selective PAS ligand propidium inhibits AChE-induced Aβ aggregation, whereas the competitive CAS ligand edrophonium does not.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Therefore, the propidium displacement assay is a well-accepted method and is usually used as a first approach to study the inhibition of Aβ aggregation by PAS ligands.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">Propidium iodide undergoes a 10-fold increase in fluorescence when it is bound to AChE-PAS. In the presence of another inhibitor, the decay in the fluorescence signal is related to the displacement percentage of propidium from this enzymatic site and thus it is accepted as a measure of the affinity of such a compound for AChE-PAS.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Thus, the experimental affinity of new compounds <b>1</b>–<b>14</b> for AChE-PAS was studied by competitive enzymatic assays in the presence of propidium iodide as a first and indirect probe of the inhibition of Aβ aggregation.</div><div class="NLM_p">New hybrids <b>1</b>–<b>14</b> were evaluated at three concentrations, 0.3, 1.0, and 3.0 μM, and the results are gathered in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. All compounds displaced the propidium cation from the AChE-PAS better than 4,4′-(3-oxopentane-1,5-diyl)bis(<i>N</i>,<i>N</i>-dimethyl-<i>N</i>-prop-2-en-1-ylanilinium) dibromide (BW248c51), a PAS ligand used as a reference in this type of experiment.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> These results suggested that the new hybrids were able to bind to AChE-PAS and thus they could prevent Aβ aggregation stimulated by this enzyme. For the majority of compounds, a concentration–response relationship was obtained, yielding a maximum at 3.0 μM, which is a concentration that is very close to the IC<sub>50</sub> values observed for h-AChE inhibition (1.9–6.8 μM). However, some compounds (<b>1</b>, <b>3</b>, and <b>10</b>) displayed a U-shaped line in the concentration–response data, as observed in other MTLs in a previous work.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This could be explained by the fact that these multifunctional derivatives could interact with other points of the enzymatic gorge, depending on their concentration.</div><div class="NLM_p last">At 3.0 μM, hybrid <b>3</b>, which is derived from 5-methoxyindole and an unsubstituted dibenzylamine fragment, showed the best result with 67% propidium displacement. Other outstanding compounds were <b>1</b> (51%), <b>11</b> (38%), and <b>13</b> (44%).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> In Vitro Blood–Brain Barrier Permeation Assay</h3><div class="NLM_p">To explore whether new hybrids <b>1</b>–<b>14</b> could enter into the brain, we used a parallel artificial membrane permeation assay for the blood–brain barrier (PAMPA-BBB), described by Di et al.,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and then optimized these for molecules with limited water solubility.<a onclick="showRef(event, 'ref38 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref41">(38, 41)</a> The in vitro permeabilities (<i>P</i><sub>e</sub>) of new compounds <b>1</b>–<b>14</b> and 10 commercial drugs through a lipid extract of porcine brain were determined using a mixture of PBS/EtOH (70:30). Assay validation was performed by comparing the experimental permeability with the reported values of these commercial drugs, which gave a good linear correlation, <i>P</i><sub>e</sub> (exptl) = 0.57 <i>P</i><sub>e</sub> (bibl) + 2.36 (<i>r</i><sup>2</sup> = 0.919) (see the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). From this equation and taking into account the described limits for BBB permeation,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> we found that compounds with permeability values above 4.6 × 10<sup>–6</sup> cm s<sup>–1</sup> could penetrate into the CNS by passive diffusion. All melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids <b>1</b>–<b>14</b> showed permeability values over this limit, pointing out that these compounds could cross the BBB (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Permeability Values from the PAMPA-BBB Assay (<i>P</i><sub>e</sub>, 10<sup>–6</sup> cm s<sup>–1</sup>) and Oxygen Radical Absorbance Capacity by Fluorescence (ORAC-FL, Trolox Equiv) of Hybrids <b>1</b>–<b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">PAMPA-BBB assay</th><th class="rowsep1 colsep0" align="center">ORAC-FL</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center"><i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">(trolox equiv)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">3.2 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-OH</td><td class="colsep0 rowsep0" align="left">5.0 ± 0.5</td><td class="colsep0 rowsep0" align="left">4.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">6.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">5.9 ± 0.4</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">6-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">7.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.8 ± 0.3</td><td class="colsep0 rowsep0" align="left">2.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">9.9 ± 0.3</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">2.7 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">5-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">8.7 ± 0.4</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">melatonin</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">2.4 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Results are the mean ± SD (<i>n</i> = 3).</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Evaluation of the Oxygen Radical Absorbance Capacity</h3><div class="NLM_p">The oxygen radical absorbance capacity (ORAC) of new melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids <b>1</b>–<b>14</b> was determined as a measure of their antioxidant properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) following a well-established protocol.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Trolox, the aromatic part of vitamin E and the part that is responsible for radical capturing, was used as an internal standard to which the unit value is arbitrarily given, ORAC (trolox) = 1. Thus, results were expressed as trolox equivalents (micromoles of trolox/micromoles of tested compound) on a comparative scale that shows if the products are better (ORAC > 1) or worse than trolox (ORAC < 1). Melatonin was used as a positive standard for comparative purposes, giving an ORAC value of 2.4 that fully agreed with the value previously described by Sofic et al. (2.0 trolox   equiv). <a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Tested compounds showed potent peroxyl radical absorbance capacities ranging from 1.5- to 4.3-fold of the trolox value and thus they could be considered as potent antioxidant agents.</div><div class="NLM_p last">As expected, the ORAC of these compounds is mainly located in the melatonin-like fragment, where the presence of a phenolic group clearly yielded the best ORAC value (<b>2</b>, R′ = 5-OH, ORAC = 4.3 trolox equiv). However, the introduction of a halogen or a methoxy group in the indole and/or the <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine fragment penalized the ORAC ability to between 0.3 and 1.7 trolox equiv compared to unsubstituted hybrid <b>1</b> (ORAC = 3.2 trolox equiv). It is worth mentioning that 5-methoxyindole derivatives <b>3</b> and <b>9</b> showed better ORAC values (2.5 and 2.6 trolox equiv, respectively) than their 6-methoxy counterparts <b>4</b> and <b>10</b> (1.5 and 1.8 trolox equiv, respectively), suggesting the involvement of the indolic position 5 in the trapping mechanism of these hybrids.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cell Viability and Neuroprotection Studies</h3><div class="NLM_p">To explore the therapeutic potential of new melatonin–dibenzylamine hybrids <b>1</b>–<b>14</b>, cell viability and neuroprotective capacity against mitochondrial oxidative stress were evaluated using the human neuroblastoma cell line SH-SY5Y with a mixture of rotenone and oligomycin A as the toxic insult. The combination of such toxic agents induces mitochondrial ROS as a consequence of the blockade of complexes I and V of the mitochondrial electronic chain; thus, it is a good model of endogenous oxidative stress.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In these experiments, compounds were tested at 1.0 μM, a concentration close to their IC<sub>50</sub> in h-AChE inhibition. The percentage of cell death was determined by measuring the amount of lactic dehydrogenase (LDH), an enzyme that is released to the extracellular medium when neurons die.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_p">First, possible cytotoxic effects of <b>1</b>–<b>14</b> were studied by exposing cells to compounds at 1.0 μM for 24 h. In all cases, the LDH percentage was lower or equal to the basal value, suggesting that cell viability reached 100% (data not shown). Then, cells were incubated with hybrids <b>1</b>–<b>14</b> at 1.0 μM for 24 h before the addition of a mixture of rotenone (30 μM) and oligomycin A (10 μM) and then were maintained for another 24 h. Melatonin was used as a positive reference, and results are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> (and Table S3 in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). All new compounds displayed good levels of protection ranging from 12 to 36%. Among hybrids with an unsubstituted <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine fragment (<b>1</b>–<b>5</b>), the introduction of a 5- or a 6-substituent in the indole ring increased the protection percentage, especially in the case of the 5-methoxy group. In fact, hybrid <b>3</b>, derived from 5-methoxyindole and an unsubstituted dibenzylamine fragment, was the best neuroprotective agent, saving 36% of the cells from the damage induced by mitochondrial ROS.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of compounds <b>1</b>–<b>14</b> and melatonin on cell death induced by the combination of rotenone and oligomycin A. Human neuroblastoma SH-SY5Y cells were exposed for 24 h to compounds (1.0 μM) and then exposed for another 24 h to the combination of rotenone (30 μM) and oligomycin A (10 μM) in the presence of compounds. Cell viability was assessed by measuring LDH release. Data are expressed as the mean ± SEM of triplicates of seven different batches of cells. ***<i>p</i> < 0.001 with respect to toxic agents alone (ANOVA followed by Bonferroni post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Regarding 5-methoxyindole derivatives (R′ = 5-OCH<sub>3</sub>), the introduction of a chlorine atom in the <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine fragment had a detrimental effect on neuroprotection, reducing values from the highest value of 36% (<b>3</b>, R = H) to 27% (<b>7</b>, R = 2-Cl) and 12% (<b>9</b>, R = 3-Cl). However, the introduction of a second methoxy group in position 3 maintained an approximately equal degree of neuroprotection, 30% (<b>14</b>, R = 3-OCH<sub>3</sub>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Neurogenic Studies</h3><div class="NLM_p">To evaluate the potential ability of the new hybrids to repair brain damage, we performed in vitro neurogenesis studies. Considering the structure of the neurogenic melatonin, which is a 5-methoxyindole derivative, hybrids bearing one or two methoxy groups in different positions were selected for these experiments, namely, <b>3</b> (R = H, R′ = 5-OCH<sub>3</sub>), <b>11</b> (R = 2-OCH<sub>3</sub>, R′ = H), and <b>14</b> (R = 3-OCH<sub>3</sub>, R′ = 5-OCH<sub>3</sub>) (see Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> for R and R′ definitions). Primary neural stem cells were obtained from the subgranular zone of the dentate gyrus of the hippocampus of adult Wistar rats, which were induced to proliferate following described protocols.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56-58)</a> Then, we analyzed whether addition of different compounds could promote early stages of neurogenesis and neuronal maturation by staining the cells for β-tubulin (antibody clone TuJ1) and MAP-2 (microtubule-associated protein 2), respectively. All tested compounds, including references, were used at a concentration of 10 μM, which was determined on the basis of our experience with neurosphere-based neurogenic experiments.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a></div><div class="NLM_p">Moreover, we performed additional viability studies with compounds <b>3</b>, <b>11</b>, and <b>14</b> at 10 μM using the human neuroblastoma cell line. None of tested compounds caused a significant reduction of cell viability (measured as MTT reduction) or cell death (measured as LDH release) after exposing the SH-SY5Y cells for 48 h to compounds at 10 μM (see Figure S1 and Table S4 in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). These results indicated that compounds <b>3</b>, <b>11</b>, and <b>14</b> were not toxic at the concentration used in the neurogenic studies.</div><div class="NLM_p">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> show the neurogenic effects of compounds <b>3</b>, <b>11</b>, and <b>14</b> at 10 μM on neural stem cell cultures, which are compared with the effect of vehicle (basal), melatonin (endogenous substrate of melatonin receptors), and luzindole (antagonist of melatonin receptors). In each bar chart, quantifications of TuJ<sup>+</sup> or MAP-2<sup>+</sup> cells are shown using five neurospheres per condition (Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). As expected, melatonin induced both early neurogenesis and cell maturation, whereas luzindole was not able to promote either of these processes. All tested melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids, <b>3</b>, <b>11</b>, and <b>14</b>, were able to stimulate early neurogenesis and cell maturation into a neuronal phenotype and were more effective than melatonin itself. By using TuJ1 fluorescence immunodetection, compound <b>11</b> was found to be the most effective hybrid for early neurogenesis, being twice as potent as melatonin (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). However, in the cell maturation experiments, the most efficient agent was hybrid  <b>3</b>, derived from 5-methoxyindole and an unsubstituted  <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine, which was almost twice as efficient as melatonin. Moreover, hybrid  <b>3</b> showed a dense crown of both β-tubulin- and MAP-2-positive cells around the neurosphere core and additional positive cells outside of it, suggesting a migration out of the neurosphere (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Neural stem cell cultures (neurospheres), derived from the subgranular zone of the dentate gyrus of the hippocampus of adult Wistar rats, treated with vehicle (basal), melatonin, luzindole (MT antagonist), <b>3</b>, <b>11</b>, and <b>14</b> at 10 μM for 48 h. Neuronal cells were detected using an anti-β-tubulin antibody (TuJ1 clone, green) as an early neurogenesis marker. DAPI (blue) was used for nuclear staining. Scale bar, 200 μm. Quantification of TuJ<sup>+</sup> cells in neurospheres is shown. Values are the mean ± SD from five neurospheres per condition. *** <i>p</i> ≤ 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Neural stem cell cultures (neurospheres), derived from the subgranular zone of the dentate gyrus of the hippocampus of adult Wistar rats, treated with vehicle (basal), melatonin, luzindole (MT antagonist), <b>3</b>, <b>11</b>, and <b>14</b> at 10 μM for 48 h. MAP-2 (red) was used as a marker that is associated with neuronal maturation, and DAPI (blue) was used for nuclear staining. Scale bar, 200 μm. Quantification of MAP-2<sup>+</sup> cells in neurospheres is shown. Values are the mean ± SD from five neurospheres per condition. *** <i>p</i> ≤ 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The results presented here clearly show that the new melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids display a balanced biological profile. At low-micromolar concentrations, they stimulate early stages of neurogenesis from neural stem cells and neuronal maturation into a neuronal phenotype, inhibit h-AChE, displace propidium from AChE-PAS, and protect a human neuroblastoma cell line against damage caused by mitochondrial free radicals. In addition, they are CNS-permeable compounds with low cell toxicity that show good antioxidant properties.</div><div class="NLM_p last">Thus, it is expected that these new melatonin–<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids could promote autorepair processes from neural stem cells in the CNS, protect neurons from mitochondrial oxidative stress, increase patient memory, and reduce the formation of amyloid plaques. These biological properties, along with their ability to penetrate into the CNS, highlight these new hybrids as exciting new multifunctional prototypes in the search for new regenerative drugs for the treatment of AD and other neurodegenerative pathologies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Methods</h3><div class="NLM_p">Reagents and solvents were purchased from common commercial suppliers and were used without further purification. Chromatographic separations were performed on silica gel (Kielgel 60 Merck of 230–400 mesh), and compounds were detected with UV light (λ = 254 nm). HPLC analyses were used to confirm the purity of all compounds (>95%) and were performed on Waters 6000 equipment at a flow rate of 1.0 mL/min with a UV detector (λ = 214–274 nm) and using a Delta Pak C<sub>18</sub> 5 μm, 300 Å column.</div><div class="NLM_p last">Melting points (uncorrected) were determined with a Reichert-Jung Thermovar apparatus. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded in CDCl<sub>3</sub> or CD<sub>3</sub>OD solutions using a Varian XL-300 spectrometer. Chemical shifts are reported in δ (ppm) relative to internal Me<sub>4</sub>Si. <i>J</i> values are given in hertz, and spin multiplicities are expressed as s (singlet), d (doublet), t (triplet), q (quartet), or m (multiplet). Mass spectra (MS) were obtained by electron spray ionization (ESI) in positive mode using a Hewlett-Packard MSD 1100 spectrometer. Elemental analyses were carried out in a PerkinElmer 240C in the Centro de Química Orgánica “Manuel Lora-Tamayo” (CSIC), and the results are within ±0.4% of the theoretical values.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for the Synthesis of 4-{[Benzyl(methyl)amino]methyl}benzonitriles (<b>15</b>–<b>19</b>)</h3><div class="NLM_p last">A mixture of 4-(bromomethyl)benzonitrile (5 mmol) and the corresponding amine (15 mmol) in ethyl ether (50 mL) was refluxed for 10 h. After cooling to room temperature, a white solid was removed by filtration, and the solvent was evaporated to dryness under reduced pressure. The residue was purified on a silica gel column using mixtures of hexane/EtOAc as eluent, obtaining the corresponding 4-{[benzyl(methyl)amino]methyl}benzonitrile as a pure solid. Analytical and spectroscopic data of <b>15</b> were consistent with those previously described.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-{[(2-Chlorobenzyl)(methyl)amino]methyl}benzonitrile (<b>16</b>)</h3><div class="NLM_p last">Reagents used were 4-(bromomethyl)benzonitrile (941 mg, 4.8 mmol) and 1-(2-chlorophenyl)-<i>N</i>-methylmethanamine (2.23 g, 14.3 mmol). Purification involved the use of hexane/EtOAc (15:1) as eluent. <b>16</b>: colorless syrup (1.15 g, 88%). ESI-MS <i>m</i>/<i>z</i> 271 [MH]<sup>+</sup>, 273 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.60 (d, 2H, <i>J</i> = 8.4 Hz), 7.51 (dd, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.5 Hz), 7.49 (d, 2H, <i>J</i> = 8.4 Hz), 7.36 (dd, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.2 Hz) 7.26 (td, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.2 Hz), 7.20 (td, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.5 Hz), 3.67 (s, 2H), 3.63 (s, 2H), 2.22 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 145.1 (C), 136.3 (C), 134.3 (C), 132.1 (2CH), 130.6 (CH), 129.6 (CH), 129.3 (2CH), 128.3 (2CH), 126.6 (CH), 119.0 (C), 110.7 (C), 61.5 (CH<sub>2</sub>), 58.7 (CH<sub>2</sub>), 42.3 (CH<sub>3</sub>). Purity: 100% (by HPLC). Anal. (C<sub>16</sub>H<sub>15</sub>ClN<sub>2</sub>) C, H, N.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 4-{[(3-Chlorobenzyl)(methyl)amino]methyl}benzonitrile (<b>17</b>)</h3><div class="NLM_p last">Reagents used were 4-(bromomethyl)benzonitrile (941 mg, 4.8 mmol) and 1-(3-chlorophenyl)-<i>N</i>-methylmethanamine (2.23 g, 14.3 mmol). Purification involved the use of hexane/EtOAc (15:1) as eluent. <b>17</b>: colorless syrup (1.29 g, 83%). ESI-MS <i>m</i>/<i>z</i> 271 [MH]<sup>+</sup>, 273 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.60 (d, 2H, <i>J</i> = 8.4 Hz), 7.47 (d, 2H, <i>J</i> = 8.4 Hz), 7.36 (s, 1H), 7.26 (m, 3H), 3.55 (s, 2H), 3.50 (s, 2H), 2.17 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 145.2(C), 141.3 (C), 134.5 (C), 132.4 (2CH), 129.9 (CH), 129.5 (2CH), 129.0 (CH), 127.6 (CH), 127.1 (CH), 119.2 (C), 111.1 (C), 61.7 (CH<sub>2</sub>), 61.6 (CH<sub>2</sub>), 42.6 (CH<sub>3</sub>). Purity: 100% (by HPLC). Anal. (C<sub>16</sub>H<sub>15</sub>ClN<sub>2</sub>) C, H, N.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 4-{[(2-Methoxybenzyl)(methyl)amino]methyl}benzonitrile (<b>18</b>)</h3><div class="NLM_p last">Reagents used were 4-(bromomethyl)benzonitrile (941 mg, 4.8 mmol) and 1-(2-methoxyphenyl)-<i>N</i>-methylmethanamine (1.96 g, 14.3 mmol). Purification involved the use of hexane/EtOAc (12:1) as eluent. <b>18</b>: colorless syrup (1.58 g, 93%). ESI-MS <i>m</i>/<i>z</i> 267 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.60 (d, 2H, <i>J</i> = 8.2 Hz), 7.50 (d, 2H, <i>J</i> = 8.2 Hz), 7.40 (dd, 1H, <i>J</i> = 7.9 Hz, <i>J</i> = 1.6 Hz), 7.25 (td, 1H, <i>J</i> = 7.9 Hz, <i>J</i> = 1.6 Hz), 6.96 (td, 1H, <i>J</i> = 7.9 Hz, <i>J</i> = 0.7 Hz), 6.87 (dd, 1H, <i>J</i> = 7.9 Hz, <i>J</i> = 0.7 Hz), 3.81 (s, 3H), 3.60 (s, 2H), 3.57 (s, 2H), 2.24 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 158.0 (C), 145.8 (C), 132.3 (2CH), 130.5 (CH), 129.6 (2CH), 128.4 (CH), 126.9 (C), 120.6 (CH), 119.4 (C), 110.8 (C), 110.6 (CH), 61.9 (CH<sub>2</sub>), 55.6 (CH<sub>3</sub>), 55.5 (CH<sub>2</sub>), 42.8 (CH<sub>3</sub>). Purity: 100% (by HPLC). Anal. (C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-{[(3-Methoxybenzyl)(methyl)amino]methyl}benzonitrile (<b>19</b>)</h3><div class="NLM_p last">Reagents used were 4-(bromomethyl)benzonitrile (941 mg, 4.8 mmol) and 1-(3-methoxyphenyl)-<i>N</i>-methylmethanamine (1.96 g, 14.3 mmol). Purification involved the use of hexane/EtOAc (12:1) as eluent. <b>19</b>: colorless syrup (1.33 g, 77%). ESI-MS <i>m</i>/<i>z</i> 267 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.52 (d, 2H, <i>J</i> = 8.4 Hz), 7.41 (d, 2H, <i>J</i> = 8.4 Hz), 7.18 (t, 1H, <i>J</i> = 8.1 Hz), 6.88 (s, 1H), 6.87 (dd, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.7 Hz), 6.74 (dd, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.7 Hz), 3.74 (s, 3H), 3.47 (s, 2H), 3.45 (s, 2H), 2.12 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 159.5 (C), 145.2 (C), 140.4 (C), 131.9 (2CH), 129.2 (CH), 129.1 (2CH), 120.9 (CH), 118.9 (C), 114.2 (CH), 112.2 (CH), 110.5 (C), 61.8 (CH<sub>2</sub>), 61.0 (CH<sub>2</sub>), 55.1 (CH<sub>2</sub>), 42.3 (CH<sub>3</sub>). Purity: 100% (by HPLC). Anal. (C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O) C, H, N.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Synthesis of 4-{[Benzyl(methyl)amino]methyl}benzoic Acids (<b>20</b>–<b>24</b>)</h3><div class="NLM_p last">To a solution of the corresponding nitrile (3.8 mmol) in dioxane (6 mL) was added a solution of NaOH (2 M aq., 29 mL), and the mixture was refluxed for 4 h. After cooling to room temperature, the solution was made acidic with HCl (2 M aqueous), and the resulting acid was isolated by filtration.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-Benzyl-1-(4-carboxyphenyl)-<i>N</i>-methylmethanaminium Chloride (<b>20</b>)</h3><div class="NLM_p last">From 4-{[benzyl(methyl)amino]methyl}benzonitrile (<b>15</b>) (898 mg, 3.8 mmol), 727 mg (75%) of <b>20</b> was obtained as a pure white solid. mp 230–231 °C. ESI-MS <i>m</i>/<i>z</i> 256 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.00 (d, 2H, <i>J</i> = 8.2 Hz), 7.49 (d, 2H, <i>J</i> = 8.2 Hz), 7.39 (m, 5H), 3.98 (s, 2H), 3.95 (s, 2H), 2.43 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 172.0 (CO), 139.2 (C), 135.7 (C), 135.4 (C), 131.3 (2CH), 131.0 (2CH), 130.9 (2CH), 129.8 (2CH), 129.7 (CH), 61.8 (CH<sub>2</sub>), 61.3 (CH<sub>2</sub>), 41.0 (CH<sub>3</sub>). Purity: 99% (by HPLC). Anal. (C<sub>16</sub>H<sub>18</sub>ClNO<sub>2</sub>) C, H, N.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(4-Carboxybenzyl)-1-(2-chlorophenyl)-<i>N</i>-methylmethanaminium Chloride (<b>21</b>)</h3><div class="NLM_p last">From 4-{[(2-chlorobenzyl)(methyl)amino]methyl}benzonitrile (<b>16</b>) (1.03 g, 3.8 mmol), 967 mg (88%) of <b>21</b> was obtained as a white solid. mp 144–146 °C. ESI-MS <i>m</i>/<i>z</i> 290 [MH]<sup>+</sup>, 292 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.00 (d, 2H, <i>J</i> = 8.4 Hz), 7.57 (dd, 1H, <i>J</i> = 7.0 Hz, <i>J</i> = 2.4 Hz) 7.51 (d, 2H, <i>J</i> = 8.4 Hz), 7.41 (dd, 1H, <i>J</i> = 7.3 Hz, <i>J</i> = 2.0 Hz), 7.33 (dd, 1H, <i>J</i> = 7.3 Hz, <i>J</i> = 2.0 Hz), 7.30 (dd, 1H, <i>J</i> = 7.3 Hz, <i>J</i> = 2.4 Hz), 3.91 (s, 4H,), 2.38 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 170.3 (C), 142.2 (C), 135.8 (C), 135.0 (C), 133.0 (CH), 132.8 (CH), 130.9 (2CH), 130.8 (2CH), 130.7 (2CH), 128.3 (CH), 62.2 (CH<sub>2</sub>), 58.9 (CH<sub>2</sub>), 41.9 (CH<sub>3</sub>). Purity: 99% (by HPLC). Anal. (C<sub>16</sub>H<sub>17</sub>Cl<sub>2</sub>NO<sub>2</sub>) C, H, N.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(4-Carboxybenzyl)-1-(3-chlorophenyl)-<i>N</i>-methylmethanaminium Chloride (<b>22</b>)</h3><div class="NLM_p last">From 4-{[(3-chlorobenzyl)(methyl)amino]methyl}benzonitrile (<b>17</b>) (1.03 g, 3.8 mmol), 1.07 g (97%) of <b>22</b> was obtained as a white solid. mp 140–142 °C. ESI-MS <i>m</i>/<i>z</i> 290 [MH]<sup>+</sup>, 292 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.13 (d, 2H, <i>J</i> = 8.4 Hz), 7.64 (d, 2H, <i>J</i> = 8.4 Hz), 7.61 (s, 1H), 7.51 (m, 3H), 4.48 (s, 2H), 4.42 (s, 2H), 2.73 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 167.5 (C), 135.0 (C), 134.1 (C), 132.6 (C), 131.6 (C), 131.3 (2CH), 131.1 (CH), 130.8 (CH), 130.4 (2CH), 130.3 (CH), 129.6 (CH), 59.3 (CH<sub>2</sub>), 59.1 (CH<sub>2</sub>), 38.6 (CH<sub>3</sub>). Purity: 100% (by HPLC). Anal. (C<sub>16</sub>H<sub>17</sub>Cl<sub>2</sub>NO<sub>2</sub>) C, H, N.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(4-Carboxybenzyl)-1-(2-methoxyphenyl)-<i>N</i>-methylmethanaminium Chloride (<b>23</b>)</h3><div class="NLM_p last">From 4-{[(2-methoxybenzyl)(methyl)amino]methyl}benzonitrile (<b>18</b>) (1.01 g, 3.8 mmol), 1.05 g (97%) of <b>23</b> was obtained as a white solid. mp 164–166 °C. ESI-MS <i>m</i>/<i>z</i> 286 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD)  δ 8.11 (d, 2H, <i>J</i> = 8.4 Hz), 7.69 (d, 2H, <i>J</i> = 8.4 Hz), 7.45 (td, 1H, <i>J</i> = 7.7 Hz, <i>J</i> = 1.7 Hz), 7.40 (dd, 1H, <i>J</i> = 7.7 Hz, <i>J</i> = 1.7 Hz), 7.05 (dd, 1H, <i>J</i> = 7.7 Hz, <i>J</i> = 0.9 Hz), 7.00 (td, 1H, <i>J</i> = 7.7, <i>J</i> = 0.9 Hz), 3.80 (s, 3H), 3.29 (s, 2H), 3.23 (s, 2H), 2.81 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 168.8 (C), 159.4 (C), 135.8 (C), 133.6 (C), 133.5 (CH), 132.4 (2CH), 131.4 (2CH), 129.5 (CH), 122.1 (CH), 118.9 (C) 62.2 (CH<sub>2</sub>), 60.7 (CH<sub>3</sub>), 56.1 (CH<sub>2</sub>), 55.9 (CH<sub>2</sub>) 41.2 (CH<sub>3</sub>). Purity: 99% (by HPLC). Anal. (C<sub>17</sub>H<sub>20</sub>ClNO<sub>3</sub>) C, H, N.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(4-Carboxybenzyl)-1-(3-methoxyphenyl)-<i>N</i>-methylmethanaminium Chloride (<b>24</b>)</h3><div class="NLM_p last">From 4-{[(3-methoxybenzyl)(methyl)amino]methyl}benzonitrile (<b>19</b>) (1.01 g, 3.8 mmol), 748 mg (69%) of <b>24</b> was obtained as a white solid. mp 100–102 °C. ESI-MS <i>m</i>/<i>z</i> 286 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD)  δ 8.00 (d, 2H, <i>J</i> = 8.3 Hz), 7.47 (d, 2H, <i>J</i> = 8.3 Hz), 7.31 (t, 1H, <i>J</i> = 7.9 Hz), 7.00 (s, 1H), 6.95 (m, 2H), 3.92 (s, 2H), 3.87 (s, 2H), 3.80 (s, 3H), 2.41 (s, 3H).  <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 161.5 (CO), 139.8 (C), 137.3 (C), 135.4 (C), 130.9 (2CH), 130.8 (2CH), 130.7 (CH), 123.2 (CH), 122.9 (C), 116.5 (CH), 115.0 (CH), 62.0 (CH<sub>2</sub>), 61.5 (CH<sub>2</sub>), 55.7 (CH<sub>3</sub>), 41.3 (CH<sub>3</sub>). Purity: 99% (by HPLC). Anal. (C<sub>17</sub>H<sub>20</sub>ClNO<sub>3</sub>) C, H, N.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for the Synthesis of Melatonin– <i>N</i>,<i>N</i>-Dibenzyl(<i>N</i>-methyl)amino Hybrids (<b>1</b>–<b>14</b>)</h3><div class="NLM_p last">To a solution of the corresponding 4-{[benzyl(methyl)amino]methyl}benzoic acid <b>20</b>–<b>24</b> (0.5 mmol), triethylamine (1.2 mmol), and PyBOP (0.6 mmol) in DMF (8 mL) was added the appropriated 2-(1<i>H</i>-indol-3-yl)ethanamine (0.5 mmol). The reaction mixture was stirred at room temperature overnight, and DMF was then evaporated to dryness under reduced pressure. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and consecutively washed with a 10% aqueous NaHCO<sub>3</sub> solution (3 × 10 mL) and H<sub>2</sub>O (10 mL). The organic phase was dried over sodium sulfate and evaporated to dryness under reduced pressure. The residue was purified on a silica gel column using mixtures of hexane/EtOAc as eluent, obtaining the corresponding dibenzylamino–melatonin derivative as a pure solid.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-[2-(1<i>H</i>-Indol-3-yl)ethyl]-4-{[benzyl(methyl)amino]methyl}benzamide (<b>1</b>)</h3><div class="NLM_p last">Reagents used were 4-{[benzyl(methyl)amino]methyl}benzoic acid (<b>20</b>) (127.6 mg, 0.5 mmol), 2-(1<i>H</i>-indol-3-yl)ethanamine (80.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:3) as eluent. Hybrid <b>1</b>: white solid. mp 94–96 °C (91.4 mg, 46%). ESI-MS <i>m</i>/<i>z</i> 398 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.20 (s, NH), 7.65 (s, 1H), 7.62 (d, 2H, <i>J</i> = 8.2 Hz), 7.37 (d, 2H, <i>J</i> = 8.2 Hz), 7.33 (m, 5H), 7.25 (m, 1H), 7.21 (td, 1H, <i>J</i> = 7.1 Hz, <i>J</i> = 1.0 Hz), 7.12 (td, 1H, <i>J</i> = 7.9 Hz, <i>J</i> = 1.0 Hz), 7.05 (m, 1H), 6.22 (t, NH, <i>J</i> = 5.4 Hz), 3.79 (q, 2H, <i>J</i> = 6.6 Hz), 3.53 (s, 2H), 3.51 (s, 2H), 3.09 (t, 2H, <i>J</i> = 6.6 Hz), 2.16 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.4 (CONH), 142.9 (C), 138.8 (C), 136.4 (C), 133.4 (C), 128.9 (2CH), 128.9 (2CH), 128.3 (2CH), 127.3 (C), 127.1 (CH), 126.8 (2CH), 122.2 (CH), 122.1 (CH), 119.5 (CH), 118.7 (CH), 113.0 (C), 111.3 (CH), 61.8 (CH<sub>2</sub>), 61.3 (CH<sub>2</sub>), 42.2 (CH<sub>3</sub>), 40.2 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). Purity: 99% (by HPLC). Anal. (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-{[Benzyl(methyl)amino]methyl}-<i>N</i>-[2-(5-hydroxy-<i>1H</i>-indol-3-yl)ethyl]benzamide (<b>2</b>)</h3><div class="NLM_p last">Reagents used were 4-{[benzyl(methyl)amino]methyl}benzoic acid (<b>20</b>) (127.6 mg, 0.5 mmol), 3-(2-aminoethyl)-1<i>H</i>-indol-5-ol (88.0 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (2:1) as eluent. Compound <b>2</b>: white solid. mp 75–77 °C (62.0 mg, 30%). ESI-MS <i>m</i>/<i>z</i> 414 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.74 (d, 2H, <i>J</i> = 8.2 Hz), 7.41 (d, 2H, <i>J</i> = 8.2 Hz), 7.32 (m, 4H), 7.24 (t, 1H, <i>J</i> = 7.1 Hz), 7.15 (d, 1H, <i>J</i> = 8.5 Hz), 7.03 (s, 1H), 6.99 (d, 1H, <i>J</i> = 2.2 Hz), 6.66 (dd, 1H, <i>J</i> = 8.5 Hz, <i>J</i> = 2.2 Hz), 3.63 (d, 2H, <i>J</i> = 7.4 Hz), 3.54 (s, 2H), 3.51 (s, 2H), 2.98 (t, 2H, <i>J</i> = 7.4 Hz), 2.16 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 170.6 (CONH), 151.7 (C), 144.2 (C), 140.1 (C), 135.3 (C), 133.6 (C), 130.8 (2CH), 130.7 (2CH), 130.0 (C), 129.8 (2CH), 128.8 (CH), 128.7 (2CH), 124.7 (CH), 113.2 (CH), 113.1 (C), 112.9 (CH), 104.1 (CH), 63.3 (CH<sub>2</sub>), 62.7 (CH<sub>2</sub>), 42.9 (CH<sub>3</sub>), 42.5 (CH<sub>2</sub>), 26.8 (CH<sub>2</sub>). Purity: 99% (by HPLC). Anal. (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-{[Benzyl(methyl)amino]methyl}-<i>N</i>-[2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl]benzamide (<b>3</b>)</h3><div class="NLM_p last">Reagents used were 4-{[benzyl(methyl)amino]methyl}benzoic acid (<b>20</b>) (127.6 mg, 0.5 mmol), 2-(5-methoxy-1<i>H</i>-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:1) as eluent. Hybrid <b>3</b>: yellow solid. mp 102–103 °C (154 mg, 72%). ESI-MS <i>m</i>/<i>z</i> 428 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.68 (s, NH), 7.66 (d, 2H, <i>J</i> = 8.2 Hz), 7.36 (d, 2H, <i>J</i> = 8.2 Hz), 7.32 (m, 4H), 7.20 (d, 1H, <i>J</i> = 8.8 Hz), 7.04 (d, 1H, <i>J</i> = 2.3 Hz), 6.95 (d, 1H, <i>J</i> = 2.3 Hz), 6.84 (dd, 1H, <i>J</i> = 8.8 Hz, <i>J</i> = 2.3 Hz), 6.52 (t, NH, <i>J</i> = 5.5 Hz), 3.75 (q, 2H, <i>J</i> = 6.7 Hz), 3.74 (s, 3H), 3.51 (s, 4H), 3.03 (t, 2H, <i>J</i> = 6.7 Hz), 2.16 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.4 (CONH), 153.8 (C), 143.0 (C), 138.8 (C), 133.1 (C), 131.5 (C), 128.8 (2CH), 128.8 (2CH), 128.2 (2CH), 127.6 (C), 127.0 (CH), 126.8 (2CH), 123.0 (CH), 112.3 (C), 112.2 (CH), 112.1 (CH), 100.2 (CH), 61.7 (CH<sub>2</sub>), 61.1 (CH<sub>2</sub>), 55.6 (CH<sub>3</sub>), 42.1 (CH<sub>3</sub>), 40.4 (CH<sub>2</sub>), 25.2 (CH<sub>2</sub>). Purity: 98% (by HPLC). Anal. (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-{[Benzyl(methyl)amino]methyl}-<i>N</i>-[2-(6-methoxy-1<i>H</i>-indol-3-yl)ethyl]benzamide (<b>4</b>)</h3><div class="NLM_p last">Reagents used were 4-{[benzyl(methyl)amino]methyl}benzoic acid (<b>20</b>) (127.6 mg, 0.5 mmol), 2-(6-methoxy-1<i>H</i>-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:1) as eluent. Derivative <b>4</b>: yellow solid. mp 119–121 °C (139 mg, 65%). ESI-MS <i>m</i>/<i>z</i> 428 [MH]<sup>+</sup>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) δ 7.87 (d, 2H, <i>J</i> = 8.2 Hz), 7.49 (d, 1H, <i>J</i> = 8.6 Hz), 7.44 (d, 2H, <i>J</i> = 8.2 Hz), 7.37 (m, 2H), 7.31 (m, 2H), 7.23 (m, 1H), 7.05 (s, 1H), 6.90 (d, 1H, <i>J</i> = 2.2 Hz), 6.68 (dd, 1H, <i>J</i> = 8.6 Hz, <i>J</i> = 2.2 Hz), 3.76 (s, 3H), 3.69 (t, 2H, <i>J</i> = 7.4 Hz), 3.54 (s, 2H), 3.51 (s, 2H), 3.02 (t, 2H, <i>J</i> = 7.4 Hz), 2.12 (s, 3H). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>) δ 167.2 (CONH), 157.2 (C), 143.7 (C), 140.2 (C), 138.2 (C), 134.7 (C), 129.5 (2CH), 129.3 (2CH), 129.0 (2CH), 127.9 (2CH), 127.7 (CH), 122.9 (C), 121.7 (CH), 119.9 (CH), 113.4 (C), 109.6 (CH), 95.2 (CH), 62.3 (CH<sub>2</sub>), 61.9 (CH<sub>2</sub>), 55.6 (CH<sub>3</sub>), 42.3 (CH<sub>3</sub>), 41.2 (CH<sub>2</sub>), 26.3 (CH<sub>2</sub>). Purity: 99% (by HPLC). Anal. (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-{[Benzyl(methyl)amino]methyl}-<i>N</i>-[2-(6-fluoro-1<i>H</i>-indol-3-yl)ethyl]benzamide (<b>5</b>)</h3><div class="NLM_p last">Reagents used were 4-{[benzyl(methyl)amino]methyl}benzoic acid (<b>20</b>) (127.63 mg, 0.5 mmol), 2-(6-fluoro-1<i>H</i>-indol-3-yl)ethanamine (89.0 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (2:3) as eluent. Hybrid <b>5</b>: yellow solid. mp 83–85 °C (135 mg, 65%). ESI-MS <i>m</i>/<i>z</i> 416 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.63 (s, NH), 7.63 (d, 2H, <i>J</i> = 8.2 Hz), 7.49 (dd, 1H, <i>J</i> = 9.0 Hz, <i>J</i> = 5.2 Hz), 7.36 (d, 2H, <i>J</i> = 8.2 Hz), 7.32 (m, 4H), 7.24 (m, 1H), 6.99 (dd, 1H, <i>J</i> = 9.7 Hz, <i>J</i> = 2.3 Hz), 6.96 (d, 1H, <i>J</i> = 2.3 Hz), 6.84 (td, 1H, <i>J</i> = 9.0 Hz, <i>J</i> = 2.3 Hz), 6.40 (t, 1H, <i>J</i> = 5.7 Hz), 3.74 (q, 2H, <i>J</i> = 6.7 Hz), 3.24 (s, 2H), 3.51 (s, 2H), 3.02 (t, 2H, <i>J</i> = 6.7 Hz), 2.16 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.5 (CONH), 161.1 (C), 158.8 (C), 143.0 (C), 138.7 (C), 136.3 (C, J=12.2), 128.9 (2CH), 128.8 (2CH), 128.3 (2CH), 127.1 (CH), 126.8 (2CH), 123.9 (C), 122.4 (CH), 122.3 (CH), 119.4 (C), 119.3 (CH), 112.8 (CH), 108.0 (CH, <i>J</i><sub>C,F</sub> = 24.4 Hz), 97.6 (CH, <i>J</i><sub>C,F</sub> = 25.9 Hz), 61.8 (CH<sub>2</sub>), 61.2 (CH<sub>2</sub>), 42.1 (CH<sub>3</sub>), 40.2 (CH<sub>3</sub>), 25.2 (CH<sub>2</sub>). Purity: 98% (by HPLC). Anal. (C<sub>26</sub>H<sub>26</sub>FN<sub>3</sub>O) C, H, N.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[2-(1<i>H</i>-Indol-3-yl)ethyl]-4-{[(2-chlorobenzyl)(methyl)amino]methyl} benzamide (<b>6</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(2-chlorobenzyl)(methyl)amino]methyl}benzoic acid (<b>21</b>) (135.4 mg, 0.5 mmol), 2-(1<i>H</i>-indol-3-yl)ethanamine (80.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:1) as eluent. Compound <b>6</b>: white solid. mp 97–99 °C (106 mg, 49%). ESI-MS <i>m</i>/<i>z</i> 432 [MH]<sup>+</sup>, 434 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.20 (s, NH), 7.65 (d, 1H, <i>J</i> = 8.1 Hz), 7.62 (d, 2H, <i>J</i> = 8.3 Hz), 7.52 (dd, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.2 Hz), 7.38 (d, 2H, <i>J</i> = 8.3 Hz), 7.37 (d, 1H, <i>J</i> = 8.1 Hz), 7.34 (dd, 1H, <i>J</i> = 7.8 Hz, <i>J</i> = 1.0 Hz).7.21 (m, 4H), 7.13 (t, 1H, <i>J</i> = 7.2 Hz), 7.06 (d, <i>J</i> = 2.0 Hz), 6.23 (t, NH, <i>J</i> = 5.4 Hz), 3.80 (q, 2H, <i>J</i> = 6.6 Hz), 3.63 (s, 2H), 3.60 (s, 2H), 3.09 (t, 2H, <i>J</i> = 6.6 Hz), 2.19 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.3 (CONH), 143.0 (C), 136.5 (C), 136.4 (C), 134.2 (C), 133.4 (C), 130.6 (CH), 129.4 (CH), 128.9 (2CH), 128.1 (CH), 127.2 (CH), 126.8 (2CH), 126.6 (CH), 122.2 (CH), 122.1 (CH), 119.5 (CH), 118.7 (CH), 113.0 (C), 111.3 (CH), 61.7 (CH<sub>2</sub>), 58.5 (CH<sub>2</sub>), 42.2 (CH<sub>3</sub>), 40.2 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>26</sub>H<sub>26</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-{[(2-Chlorobenzyl)(methyl)amino]methyl}-<i>N</i>-[2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl]benzamide (<b>7</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(2-chlorobenzyl)(methyl)amino]methyl}benzoic acid (<b>21</b>) (135.4 mg, 0.5 mmol), 2-(5-methoxy-1<i>H</i>-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:1) as eluent. Hybrid <b>7</b>: white solid. mp 120–122 °C (132 mg, 57%). ESI-MS <i>m</i>/<i>z</i> 462 [MH]<sup>+</sup>, 464 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.73 (d, 2H, <i>J</i> = 8.3 Hz), 7.54 (d, 1H, <i>J</i> = 8.3 Hz), 7.46 (d, 1H, <i>J</i> = 8.3 Hz), 7.44 (d, 2H, <i>J</i> = 8.6 Hz), 7.32 (d, 1H, <i>J</i> = 8.3 Hz), 7.36 (m, 1H), 7.21 (d, 1H, <i>J</i> = 8.8 Hz), 6.72 (dd, 1H, <i>J</i> = 8.8 Hz, <i>J</i> = 2.4 Hz), 3.72 (s, 3H), 3.66 (s, 2H), 3.63 (s, 2H), 3.34 (t, 2H, <i>J</i> = 7.3 Hz), 3.03 (t, 2H, <i>J</i> = 7.3 Hz), 2.20 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 170.1 (CONH), 154.9 (C), 137.5 (C), 135.5 (C), 134.8 (C), 133.3 (C), 132.3 (C), 132.3 (CH), 130.5 (CH), 130.4 (CH), 130.3 (C), 130.2 (2CH), 129.7 (CH), 129.2 (C), 128.3 (2CH), 113.3 (C), 112.9 (CH), 112.7 (CH), 101.2 (CH), 62.6 (CH<sub>2</sub>), 59.4 (CH<sub>2</sub>), 56.1 (CH<sub>3</sub>), 42.5 (CH<sub>2</sub>), 42.3 (CH<sub>3</sub>), 26.3 (CH<sub>2</sub>). Purity: 99% (by HPLC). Anal. (C<sub>27</sub>H<sub>28</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-[2-(1<i>H</i>-Indol-3-yl)ethyl]-4-{[(3-chlorobenzyl)(methyl)amino]methyl}benzamide (<b>8</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(3-chlorobenzyl)(methyl)amino]methyl}benzoic acid (<b>22</b>) (135.4 mg, 0.5 mmol), 2-(1<i>H</i>-indol-3-yl)ethanamine (80.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (2:1) as eluent. Derivative <b>8</b>: white solid. mp 110–112 °C (119 mg, 55%). ESI-MS <i>m</i>/<i>z</i> 432 [MH]<sup>+</sup>, 434 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.21(s, NH), 7.64 (d, 2H, <i>J</i> = 8.3 Hz), 7.64 (m, 1H), 7.37 (d, 2H, <i>J</i> = 8.3 Hz), 7.37 (m, 2H), 7.23 (m, 4H), 7.13 (td, 1H, <i>J</i> = 7.5 Hz, <i>J</i> = 1.0 Hz), 7.06 (d, 1H, <i>J</i> = 2.5 Hz), 6.23 (t, NH, <i>J</i> = 5.5 Hz), 3.80 (q, 2H, <i>J</i> = 6.7 Hz), 3.52 (s, 2H), 3.46 (s, 2H), 3.09 (t, 2H, <i>J</i> = 6.7 Hz), 2.16 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.4 (CONH), 142.8 (C), 141.3 (C), 136.4 (C), 134.2 (C), 133.5 (C), 129.5 (CH), 128.8 (2CH), 128.7 (2CH), 127.3 (C), 127.2 (CH), 126.9 (2CH), 122.2 (CH), 122.1 (CH), 119.5 (CH), 118.7 (CH), 113.0 (C), 111.3 (CH), 61.4 (CH<sub>2</sub>), 61.2 (CH<sub>2</sub>), 42.3 (CH<sub>3</sub>), 40.2 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>26</sub>H<sub>26</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-{[(3-Chlorobenzyl)(methyl)amino]methyl}-<i>N</i>-[2-(5-methoxy-1<i>H</i>-indol-3-yl)ethyl]benzamide (<b>9</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(3-chlorobenzyl)(methyl)amino]methyl}benzoic acid (<b>22</b>) (135.4 mg, 0.5 mmol), 2-(5-methoxy-1<i>H</i>-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (2:1) as eluent. Hybrid <b>9</b>: yellow solid. mp 108–110 °C (119 mg, 55%). ESI-MS <i>m</i>/<i>z</i> 462 [MH]<sup>+</sup>, 464 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.15 (s, NH), 7.62 (d, 2H, <i>J</i> = 8.3 Hz), 7.35 (d, 2H, <i>J</i> = 8.3 Hz), 7.34 (s, 2H), 7.25 (d, 1H, <i>J</i> = 8.6 Hz), 7.22 (m, 3H), 7.03 (s. 2H), 6.85 (dd, 1H, <i>J</i> = 8.6 Hz, <i>J</i> = 2.3 Hz), 6.27 (t, NH, <i>J</i> = 5.6 Hz), 3.77 (q, 2H, <i>J</i> = 6.5 Hz), 3.86 (s, 3H), 3.51 (s, 2H) 3.45 (s, 2H), 3.04 (t, 2H, <i>J</i> = 6.5 Hz), 2.14 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.6 (CONH), 154.3 (C), 143.1 (C), 141.5 (C), 134.4 (C), 133.6 (C), 131.7 (C), 129.8 (CH), 129.1 (2CH), 129.0 (2CH), 127.9 (C), 127.5 (CH), 127.2 (2CH), 123.2 (CH), 113.0 (C), 112.8 (CH), 112.3 (CH), 100.5 (CH), 61.7 (CH<sub>2</sub>), 61.4 (CH<sub>2</sub>), 56.0 (CH<sub>3</sub>), 42.5 (CH<sub>3</sub>), 40.5 (CH<sub>2</sub>), 25.5 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>27</sub>H<sub>28</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-{[(3-Chlorobenzyl)(methyl)amino]methyl}-<i>N</i>-[2-(6-methoxy-1<i>H</i>-indol-3-yl)ethyl]benzamide (<b>10</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(3-chlorobenzyl)(methyl)amino]methyl}benzoic acid (<b>22</b>) (135.4 mg, 0.5 mmol), 2-(6-methoxy-1<i>H</i>-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:1) as eluent. Hybrid <b>10</b>: yellow solid. mp 58–60 °C (189 mg, 82%). ESI-MS <i>m</i>/<i>z</i> 462 [MH]<sup>+</sup>, 464 [MH + 2]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.31 (s, NH), 7.65 (d, 2H, <i>J</i> = 8.4 Hz), 7.48 (d, 1H, <i>J</i> = 8.6 Hz), 7.36 (d, 2H, <i>J</i> = 8.4 Hz), 7.35 (s, 1H), 7.23 (m, 3H), 6.91 (d, 1H, <i>J</i> = 2.2 Hz), 6.84 (d, 1H, <i>J</i> = 2.2 Hz), 6.78 (dd, 1H, <i>J</i> = 8.6 Hz, <i>J</i> = 2.2 Hz), 6.35 (t, NH, <i>J</i> = 5.6 Hz), 3.81 (s, 3H), 3.75 (q, 2H, <i>J</i> = 6.6 Hz), 3.52 (s, 2H) 3.46 (s, 2H), 3.03 (t, 2H, <i>J</i> = 6.6 Hz), 2.15 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.4 (CONH), 156.5 (C), 142.7 (C), 141.2 (C), 137.2 (C), 134.1 (C), 133.4 (C), 129.85 (CH), 128.8 (2CH), 128.7 (2CH), 127.2 (CH), 126.9 (2CH), 121.6 (C), 120.9 (CH), 119.3 (C), 112.7 (C), 109.4 (CH), 94.7 (CH), 61.4 (CH<sub>2</sub>), 61.2 (CH<sub>2</sub>), 55.6 (CH<sub>3</sub>), 42.2 (CH<sub>3</sub>), 40.2 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>27</sub>H<sub>28</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-[2-(1<i>H</i>-Indol-3-yl)ethyl]-4-{[(2-methoxybenzyl)(methyl)amino]methyl}benzamide (<b>11</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(2-methoxybenzyl)(methyl)amino]methyl}benzoic acid (<b>23</b>) (142.7 mg, 0.5 mmol), 2-(1<i>H</i>-indol-3-yl)ethanamine (80.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (1:1) as eluent. Compound <b>11</b>: white solid. mp 80–82 °C (130 mg, 61%). ESI-MS <i>m</i>/<i>z</i> 428 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.74 (d, 2H, <i>J</i> = 8.3 Hz), 7.60 (d, 1H, <i>J</i> = 8.1 Hz), 7.42 (d, 2H, <i>J</i> = 8.3 Hz), 7.31 (m, 2H), 7.24 (td, 1H, <i>J</i> = 7.8 Hz, <i>J</i> = 1.7 Hz), 7.09 (s, 1H), 7.06 (m, 1H), 6.97 (td, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.0 Hz), 6.93 (m, 1H), 6.91 (td, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.0 Hz), 3.78 (s, 3H), 3.66 (t, 2H, <i>J</i> = 7.4 Hz), 3.54 (s, 2H) 3.34 (s, 2H), 3.06 (t, 2H, <i>J</i> = 7.4 Hz), 2.18 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 170.1 (CONH), 159.4 (C), 143.7 (C), 138.1 (C), 134.7 (C), 132.1 (CH), 130.4 (2CH), 129.7 (CH), 128.8 (C), 128.2 (2CH), 127.0 (C), 123.4 (CH), 122.3 (CH), 121.2 (CH), 119.6 (CH), 119.4 (CH), 113.4 (C), 112.2 (CH), 111.6 (CH), 62.5 (CH<sub>2</sub>), 56.0 (CH<sub>3</sub>), 55.7 (CH<sub>2</sub>), 42.6 (CH<sub>3</sub>), 42.2 (CH<sub>2</sub>), 26.3 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl]-4-{[(2-methoxybenzyl)(methyl)amino]methyl}benzamide (<b>12</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(2-methoxybenzyl)(methyl)amino]methyl}benzoic acid (<b>23</b>) (142.7 mg, 0.5 mmol), 2-(5-methoxy-1H-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of EtOAc as eluent. Hybrid <b>12</b>: yellow solid. mp 58–60 °C (174 mg, 76%). ESI-MS <i>m</i>/<i>z</i> 458 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.18 (s, NH), 7.62 (d, 2H, <i>J</i> = 8.6 Hz), 7.40 (m, 1H), 7.39 (d, 2H, <i>J</i> = 8.6 Hz), 7.25 (d, 1H, <i>J</i> = 9.0 Hz), 7.22 (td, 1H, <i>J</i> = 7.7 Hz, <i>J</i> = 2.0 Hz), 7.03 (m, 2H), 6.94 (td, 1H, <i>J</i> = 7.7 Hz, <i>J</i> = 1.0 Hz), 6.85 (m, 2H), 6.27 (t, NH, <i>J</i> = 5.6 Hz), 3.79 (s, 3H), 3.77 (s, 3H), 3.75 (q, 2H, <i>J</i> = 6.6 Hz), 3.58 (s, 2H) 3.55 (s, 2H), 3.05 (t, 2H, <i>J</i> = 6.6 Hz), 2.20 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 167.4 (CONH), 157.7 (C), 154.0 (C), 143.3 (C), 133.2 (C), 131.5 (C), 130.3 (CH), 128.9 (2CH), 128.0 (CH), 127.7 (C), 126.8 (C), 126.7 (2CH), 122.9 (CH), 120.3 (CH), 112.8 (C), 112.5 (CH), 112.0 (CH), 110.3 (CH), 100.3 (CH), 61.7 (CH<sub>2</sub>), 55.8 (CH<sub>2</sub>), 55.3 (CH<sub>3</sub>), 55.2 (CH<sub>3</sub>), 42.4 (CH<sub>3</sub>), 40.3 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>28</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-[2-(1<i>H</i>-Indol-3-yl)ethyl]-4-{[(3-methoxybenzyl)(methyl)amino]methyl}benzamide (<b>13</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(3-methoxybenzyl)(methyl)amino]methyl}benzoic acid (<b>24</b>) (142.7 mg, 0.5 mmol), 2-(1<i>H</i>-indol-3-yl)ethanamine (80.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of EtOAc as eluent. Compound <b>13</b>: yellow solid. mp 81–83 °C (166 mg, 78%). ESI-MS <i>m</i>/<i>z</i> 428 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.74 (d, 2H, <i>J</i> = 8.4 Hz), 7.60 (dd, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.0 Hz), 7.42 (d, 2H, <i>J</i> = 8.4 Hz), 7.32 (dd, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.0 Hz), 7.22 (t, 1H, <i>J</i> = 8.1 Hz), 7.09 (s, IH), 7.06 (td, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.0 Hz), 6.98 (td, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 1.0 Hz), 6.93 (d, 1H, <i>J</i> = 2.0 Hz), 6.91 (d, 1H, <i>J</i> = 8.1 Hz), 6.80 (dd, 1H, <i>J</i> = 8.1 Hz, <i>J</i> = 2.0 Hz), 3.77 (s, 3H), 3.66 (t, 2H, <i>J</i> = 7.4 Hz), 3.53 (s, 2H) 3.48 (s, 2H), 3.05 (t, 2H, <i>J</i> = 7.4 Hz), 2.16 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 170.1 (CONH), 161.2 (C), 143.8 (C), 141.3 (C), 138.1 (C), 134.8 (C), 130.3 (CH), 130.3 (2CH), 128.8 (C), 128.3 (2CH), 123.4 (CH), 122.5 (CH), 122.3 (CH), 119.6 (CH), 119.4 (CH), 115.7 (CH), 113.7 (CH), 113.4 (C), 112.2(CH), 62.7 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 55.6 (CH<sub>3</sub>), 42.5 (CH<sub>3</sub>), 42.2 (CH<sub>2</sub>), 26.3 (CH<sub>2</sub>). Purity: 99% (by HPLC). Anal. (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-[2-(5-Methoxy-1<i>H</i>-indol-3-yl)ethyl]-4-{[(3-methoxybenzyl)(methyl)amino]methyl}benzamide (<b>14</b>)</h3><div class="NLM_p last">Reagents used were 4-{[(3-methoxybenzyl)(methyl)amino]methyl}benzoic acid (<b>24</b>) (142.7 mg, 0.5 mmol), 2-(5-methoxy-1H-indol-3-yl)ethanamine (95.1 mg, 0.5 mmol), PyBOP (312.2 mg, 0.6 mmol), and Et<sub>3</sub>N (156 μL, 1.2 mmol). Purification involved the use of hexane/EtOAc (2:1) as eluent. Hybrid <b>14</b>: white solid. mp 82–84 °C (144 mg, 63%). ESI-MS <i>m</i>/<i>z</i> 458 [MH]<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.71 (d, 2H, <i>J</i> = 8.3 Hz), 7.38 (d, 2H, <i>J</i> = 8.3 Hz), 7.21 (d, 1H, <i>J</i> = 8.7 Hz), 7.20 (t, 1H, <i>J</i> = 7.6 Hz), 7.06 (d, 1H, <i>J</i> = 2.4 Hz), 7.05 (s, 1H), 6.90 (d, 1H, <i>J</i> = 1.2 Hz), 6.88 (d, 1H, <i>J</i> = 7.6 Hz), 6.78 (dd, 1H, <i>J</i> = 7.6 Hz, <i>J</i> = 1.2 Hz), 6.72 (dd, 1H, <i>J</i> = 8.7 Hz, <i>J</i> = 2.4 Hz), 3.75 (s, 3H), 3.70 (s, 3H), 3.63 (t, 2H, <i>J</i> = 7.3 Hz), 3.49 (s, 2H) 3.44 (s, 2H), 3.02 (t, 2H, <i>J</i> = 7.3 Hz), 2.13 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 170.0 (CONH), 161.2 (C), 154.9 (C), 143.8 (C), 141.3 (C), 134.7 (C), 133.3 (C), 130.3 (CH), 130.2 (2CH), 129.2 (C), 128.3 (2CH), 124.2 (CH), 122.5 (CH), 115.6 (CH), 113.7 (CH), 113.3 (C), 112.9 (CH), 112.7 (CH), 101.2 (CH), 62.7 (CH<sub>2</sub>), 62.1 (CH<sub>2</sub>), 56.1 (CH<sub>3</sub>), 55.6 (CH<sub>3</sub>), 42.5 (CH<sub>2</sub>), 42.3 (CH<sub>3</sub>), 26.3 (CH<sub>2</sub>). Purity: 100% (by HPLC). Anal. (C<sub>28</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Biochemical Studies</h3></div><div id="sec4_28_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Inhibition of Human AChE and BuChE</h3><div class="NLM_p last">The method of Ellman et al. was followed.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The assay solution consisted of 0.1 M phosphate buffer, pH 8.0, 400 μM 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB, Ellman’s reagent), 0.05 U mL<sup>–1</sup> h-AChE (human recombinant acetylcholinesterase, Sigma Chemical Co.) or 0.024 U mL<sup>–1</sup> h-BuChE (butyrylcholinesterase from human serum, Sigma Chemical Co.), and 800 μM acetylthiocholine iodide or 500 μM butyrylthiocholine as the substrate of the enzymatic reaction, respectively. The compounds tested were added to the assay solution and preincubated with the enzyme for 5 min at 30 °C. After that period, the substrate was added. The absorbance changes at 412 nm were recorded for 5 min with a UV/vis microplate spectrophotometer (Multiskan Spectrum, Thermo Electron Co.). The reaction rates were compared, and the inhibition percentage resulting from the presence of test compound was calculated. The IC<sub>50</sub> is defined as the concentration of each compound that reduces 50% of the enzymatic activity without any inhibitor.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Measurement of Propidium Iodide Displacement from the Peripheral Anionic Site (PAS) of AChE</h3><div class="NLM_p last">A soltion of AChE from bovine erythrocytes at a concentration of 5 μM in 0.1 mM Tris buffer, pH 8.0, was used. Aliquots of compounds were added to obtain final concentrations of 0.3, 1.0, and 3.0 μM, and the solutions were kept at room temperature for at least 6 h. Afterward, the samples were incubated for 15 min with propidium iodide at a final concentration of 20 μM, and the fluorescence was measured in a fluorescence microplate reader (Fluostar Optima, BMG, Germany). Wavelengths of excitation and emission were 485 and 620 nm, respectively.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> In Vitro Blood–Brain Barrier Permeation Assay (PAMPA-BBB)</h3><div class="NLM_p last">Prediction of the brain penetration was evaluated using a parallel artificial membrane permeation assay (PAMPA-BBB) in a similar manner as previously described.<a onclick="showRef(event, 'ref38 ref41 ref51'); return false;" href="javascript:void(0);" class="ref ref38 ref41 ref51">(38, 41, 51)</a> Pipetting was performed with a semi-automatic robot (CyBi-SELMA), and UV absorbance was read with a microplate spectrophotometer (Multiskan Spectrum, Thermo Electron Co.). Commercial drugs, phosphate buffered saline solution at pH 7.4 (PBS), and dodecane were purchased from Sigma, Aldrich, Acros, and Fluka. Millex filter units (PVDF membrane, diameter 25 mm, pore size 0.45 μm) were acquired from Millipore. The porcine brain lipid (PBL) was obtained from Avanti Polar Lipids. The donor microplate was a 96-well filter plate (PVDF membrane, pore size 0.45 μm), and the acceptor microplate was an indented 96-well plate, both from Millipore. The acceptor 96-well microplate was filled with 200 μL of PBS/ethanol (70:30), and the filter surface of the donor microplate was impregnated with 4 μL of PBL in dodecane (20 mg mL<sup>–1</sup>). Compounds were dissolved in PBS/ethanol (70:30) at 100 μg mL<sup>–1</sup>, filtered through a Millex filter, and then added to the donor wells (200 μL). The donor filter plate was carefully placed on the acceptor plate to form a sandwich, which was left undisturbed for 240 min at 25 °C. After incubation, the donor plate was carefully removed, and the concentration of compounds in the acceptor wells was determined by UV/vis spectroscopy. Every sample was analyzed at five wavelengths in four wells and in at least three independent runs, and the results are given as the mean ± standard deviation. In each experiment, 11 quality control standards of known BBB permeability were included to validate the analysis set.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Oxygen Radical Absorbance Capacity Assay</h3><div class="NLM_p last">The ORAC method was followed<a onclick="showRef(event, 'ref52 ref59'); return false;" href="javascript:void(0);" class="ref ref52 ref59">(52, 59)</a> using a Polarstar Galaxy plate reader (BMG Labtechnologies GmbH, Offenburg, Germany) with 485-P excitation and 520-P emission filters. The equipment was controlled by Fluorostar Galaxy software (version 4.11-0) for fluorescence measurement. 2,2′-Azobis(amidinopropane) dihydrochloride (AAPH), (±)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (trolox), and fluorescein (FL) were purchased from Sigma-Aldrich. The reaction was carried out in 75 mM phosphate buffer (pH 7.4), and the final reaction mixture was 200 μL. Antioxidant (20 μL) and FL (120 μL; 70 mM, final concentration) solutions were placed in a black 96-well microplate (96F untreat, Nunc). The mixture was preincubated for 15 min at 37 °C, and AAPH solution (60 μL, 12 mM, final concentration) was then added rapidly using a multichannel pipet. The microplate was immediately placed in the reader, and the fluorescence was recorded every minute for 80 min. The microplate was automatically shaken prior each reading. Samples were measured at eight different concentrations (0.1–1 μM). A blank (FL + AAPH in phosphate buffer), instead of the sample solution, and eight calibration solutions using trolox (1–8 μM) were also carried out in each assay. All reaction mixtures were prepared in duplicate, and at least three independent assays were performed for each sample. Raw data were exported from Fluostar Galaxy Software to an Excel sheet for further calculations. Antioxidant curves (fluorescence vs time) were first normalized to the curve of the blank corresponding to the same assay, and the area under the fluorescence decay curve (AUC) was calculated. The net AUC corresponding to a sample was calculated by subtracting the AUC corresponding to the blank. Regression equations between net AUC and antioxidant concentration were calculated for all samples. ORAC-FL values were expressed as trolox equivalents by using the standard curve calculated for each assay, where the ORAC-FL value of trolox was taken to be 1.0.</div></div><div id="sec4_32_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Studies of Cell Viability and Neuroprotection</h3></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Culture of SH-SY5Y Cells</h3><div class="NLM_p last">SH-SY5Y cells, at passages between 3 and 16 after defreezing, were maintained in a Dulbecco’s modified Eagle’s medium (DMEM) containing 15 nonessential amino acids and supplemented with 10% fetal calf serum (FCS), 1 mM glutamine, 50 units mL<sup>–1</sup> penicillin, and 50 μg mL<sup>–1</sup> streptomycin (reagents from GIBCO, Madrid, Spain). Cultures were seeded into flasks containing supplemented medium and were maintained at 37 °C in 5% CO<sub>2</sub>/humidified air. Stock cultures were passaged 1:4 twice weekly. For assays, SH-SY5Y cells were subcultured in 48-well plates at a seeding density of 10<sup>5</sup> cells per well. For the cytotoxicity experiments, cells were treated with drugs before they reached confluence in DMEM free of serum.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Cell Viability Experiments</h3><div class="NLM_p last">To study the cytotoxic effects of compounds alone, cells were plated at a density of 10<sup>5</sup> cells per well at least 48 h before the toxicity measurements. Cells were exposed for 24 h to the compound at 1 μM, and the quantitative assessment of cell death was made by measurement of the percent of the intracellular enzyme lactate dehydrogenase (LDH) released to the extracellular medium (cytotoxicity detection kit, Roche). The quantity of LDH was evaluated in a microplate reader (Anthos 2010 or Labsystems iMES Reader MS) at 492 nm (λ excitation) and 620 nm (λ emission).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Neuroprotection Studies</h3><div class="NLM_p last">To study the cytoprotective action of the compounds against cell death induced by the mixture of rotenone (30 μM) and oligomycin A (10 μM), drugs were given at time zero and maintained for 24 h. Then, the media were replaced by fresh media that still contained the drug plus the cytotoxic insult, which was left for an additional 24 h period. Thereafter, cell survival was assessed by measuring LDH activity.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Measurement of Lactic Dehydrogenase (LDH) Activity</h3><div class="NLM_p last">Extracellular and intracellular LDH activity was measured by UV/vis using a cytotoxicity cell death kit (Roche-Boehringer Mannheim, Germany) according to the manufacturer’s indications. Total LDH activity was defined as the sum of intracellular and extracellular LDH activity, and released LDH was defined as the percentage of extracellular compared with total LDH activity. Data were expressed as the mean (±SEM) of at least three different cultures in quadruplicate. LDH released was calculated for each individual experiment relative to 100% of the extracellular LDH released by the vehicle with respect to the total. To determine percent protection, LDH release was normalized as follows: in each individual triplicate experiment, LDH release obtained in nontreated cells (basal) was subtracted from the LDH released upon the toxic treatment and normalized to 100%, and that value was subtracted from 100.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Measurement of Cell Viability by MTT Assay</h3><div class="NLM_p last">Cell viability was also measured by quantitative colorimetric assay with 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) (Sigma-Aldrich), as described previously.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Briefly, 50 μL of the MTT labeling reagent, at a final concentration of 0.5 mg mL<sup>–1</sup>, was added to each well at the end of the incubation period, and the plate was placed in a humidified incubator at 37 °C with 5% CO<sub>2</sub> and 95% air (v/v) for an additional 2 h. Then, the insoluble formazan was dissolved with dimethyl sulfoxide; colorimetric determination of MTT reduction was measured at 540 nm. Control cells treated with 0.1% DMSO were taken as 100% viability.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Neurogenesis Assays</h3></div><div id="sec4_37_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Animals</h3><div class="NLM_p last">Adult (8–12 weeks old) male Wistar rats (<i>n</i> = 6 per group), housed in a 12 h light–dark cycle animal facility, were used in this study. All procedures with animals were specifically approved by the Ethics Committee for Animal Experimentation of the CSIC and carried out in accordance with National (normative 1201/2005) and International recommendations (Directive 2010/63 from the European Communities Council). Special care was taken to minimize animal suffering.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Neurosphere Cultures</h3><div class="NLM_p last">Neurospheres (NS) were derived from the subgranular zone of the dentate gyrus of the hippocampus of adult Wistar rats, which were induced to proliferate using established passaging methods to achieve optimal cellular expansion according to published protocols.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Rats were decapitated, and brains were dissected, obtaining the hippocampus as described.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Briefly, cells were seeded into 12-well dishes and cultured in DMEM/F12 (1:1, Invitrogen) containing 10 ng mL<sup>–1</sup> epidermal growth factor (EGF, Peprotech, London, UK), 10 ng mL<sup>–1</sup> fibroblast growth factor (FGF, Peprotech), and B27 medium (Gibco). After 3 days in culture, primary NS cultures were treated with different compounds. To determine the ability of compounds to induce differentiation, NS from 10 day old cultures were plated onto 100 μg mL<sup>–1</sup> poly-<span class="smallcaps smallerCapital">l</span>-lysine-coated coverslips and treated for 48 h in the presence of serum but in the absence of exogenous growth factors.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Immunocytochemistry</h3><div class="NLM_p last">After treatment, cells were processed for immunocytochemistry with two types of neurogenesis-associated neuronal markers: anti-β-tubulin antibody (clone TuJ1), associated with early stages of neurogenesis, and MAP-2 (microtubule-associated protein 2), a marker of neuronal maturation. DAPI staining (4′,6-diamidino-2-phenylindole) was used as a nuclear marker. Basal values were obtained under the same conditions but in the absence of any product. Melatonin (endogenous ligand of the melatoninergic receptors) and luzindole (melatoninergic antagonist) were used as controls. The images were obtained using a Nikon fluorescence microscope 90i that was coupled to a digital camera Qi. The microscope configuration was adjusted to produce the optimum signal-to-noise ratio. For quantifying the number of cells producing a given marker in any experiment, the number of positive cells in the neurosphere was counted as previously described.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Cell numbers were estimated from a total of five neurospheres per condition over three independent experiments.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Statistical Determinations</h3><div class="NLM_p last">One-way ANOVA analysis for comparisons between different treatments on neurospheres was performed using the SPSS statistical software package (version 20.0) for Windows (Chicago, IL) followed by Student’s <i>t</i> post hoc test. A <i>p</i> value ≤ 0.05 was considered to be statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58"><a href="/doi/suppl/10.1021/jm5000613">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analyses of new melatonin–<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids <b>1</b>–<b>14</b> and intermediates <b>16</b>–<b>24</b>; permeability in the PAMPA-BBB assay of 10 commercial drugs; neuroprotection of the human neuroblastoma cell line SH-SY5Y against the combination of rotenone and oligomycin by hybrids <b>1</b>–<b>14</b>; percentages of MTT reduction and LDH release in SH-SY5Y cells exposed to compounds <b>3</b>, <b>11</b>, and <b>14</b>; and molecular modelling overlay of AP2238 and <b>3</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5000613/suppl_file/jm5000613_si_001.pdf">jm5000613_si_001.pdf (368.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5000613" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Isabel Rodríguez-Franco</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, Consejo Superior de Investigaciones
Científicas (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d5bca6b4b7b0b9a7b2a0b0af95bca4b8fbb6a6bcb6fbb0a6"><span class="__cf_email__" data-cfemail="49203a282b2c253b2e3c2c3309203824672a3a202a672c3a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatriz López-Iglesias</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, Consejo Superior de Investigaciones
Científicas (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Concepción Pérez</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, Consejo Superior de Investigaciones
Científicas (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José A. Morales-García</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Investigaciones Biomédicas “Alberto Sols”,
Consejo Superior de Investigaciones Científicas (IIB-CSIC), C/Arturo Duperier 4, 28029 Madrid, Spain </span>; 
    <span class="hlFld-Affiliation affiliation">Centro
de Investigación Biomédica en Red sobre Enfermedades
Neurodegenerativas (CIBERNED), C/ Valderrebollo 5, 28031 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Alonso-Gil</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Investigaciones Biomédicas “Alberto Sols”,
Consejo Superior de Investigaciones Científicas (IIB-CSIC), C/Arturo Duperier 4, 28029 Madrid, Spain </span>; 
    <span class="hlFld-Affiliation affiliation">Centro
de Investigación Biomédica en Red sobre Enfermedades
Neurodegenerativas (CIBERNED), C/ Valderrebollo 5, 28031 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Pérez-Castillo</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Investigaciones Biomédicas “Alberto Sols”,
Consejo Superior de Investigaciones Científicas (IIB-CSIC), C/Arturo Duperier 4, 28029 Madrid, Spain </span>; 
    <span class="hlFld-Affiliation affiliation">Centro
de Investigación Biomédica en Red sobre Enfermedades
Neurodegenerativas (CIBERNED), C/ Valderrebollo 5, 28031 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alejandro Romero</span> - <span class="hlFld-Affiliation affiliation">Instituto
Teófilo Hernando and Departamento de Farmacología y
Terapéutica, Facultad de Medicina, Universidad Autónoma
de Madrid, C/Arzobispo
Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela G. López</span> - <span class="hlFld-Affiliation affiliation">Instituto
Teófilo Hernando and Departamento de Farmacología y
Terapéutica, Facultad de Medicina, Universidad Autónoma
de Madrid, C/Arzobispo
Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercedes Villarroya</span> - <span class="hlFld-Affiliation affiliation">Instituto
Teófilo Hernando and Departamento de Farmacología y
Terapéutica, Facultad de Medicina, Universidad Autónoma
de Madrid, C/Arzobispo
Morcillo 4, 28029 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santiago Conde</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, Consejo Superior de Investigaciones
Científicas (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2224e4823-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge the financial support of the Spanish Ministry of Economy and Competitiveness (projects SAF2012-31035, SAF2009-13015-C02-01, and SAF2012-32223), the Fundación de Investigación Médica Mutua Madrileña Automovilística (AP103952012), and the CSIC (PIE-201280E074). B.L.-I. thanks the CSIC for an I3P Training Contract.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid peptide</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">BACE-1 </td><td class="NLM_def"><p class="first last">β-secretase-1</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic active site</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">hAChE</td><td class="NLM_def"><p class="first last">human AChE</p></td></tr><tr><td class="NLM_term">hBuChE</td><td class="NLM_def"><p class="first last">human BuChE</p></td></tr><tr><td class="NLM_term">MTL</td><td class="NLM_def"><p class="first last">multitarget ligand</p></td></tr><tr><td class="NLM_term">ORAC-FL</td><td class="NLM_def"><p class="first last">oxygen radical absorbance capacity by fluorescence</p></td></tr><tr><td class="NLM_term">PAMPA-BBB</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay for blood–brain barrier permeation</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic site</p></td></tr><tr><td class="NLM_term">PyBOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sloane, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchindran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boustani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudha, S.</span><span> </span><span class="NLM_article-title">The public health impact of Alzheimer’s disease, 2000–2050: Potential implication of treatment advances</span> <span class="citation_source-journal">Annu. Rev. Public Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1146%2Fannurev.publhealth.23.100901.140525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=11910061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADC%252BD387ns1OrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=213-231&author=P.+D.+Sloaneauthor=S.+Zimmermanauthor=C.+Suchindranauthor=P.+Reedauthor=L.+Wangauthor=M.+Boustaniauthor=S.+Sudha&title=The+public+health+impact+of+Alzheimer%E2%80%99s+disease%2C+2000%E2%80%932050%3A+Potential+implication+of+treatment+advances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances</span></div><div class="casAuthors">Sloane Philip D; Zimmerman Sheryl; Suchindran Chirayath; Reed Peter; Wang Lily; Boustani Malaz; Sudha S</div><div class="citationInfo"><span class="NLM_cas:title">Annual review of public health</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213-31</span>
        ISSN:<span class="NLM_cas:issn">0163-7525</span>.
    </div><div class="casAbstract">Recent developments in basic research suggest that therapeutic breakthroughs may occur in Alzheimer's disease treatment over the coming decades.  To model the potential magnitude and nature of the effect of these advances, historical data from congestive heart failure and Parkinson's disease were used.  Projections indicate that therapies which delay disease onset will markedly reduce overall disease prevalence, whereas therapies to treat existing disease will alter the proportion of cases that are mild as opposed to moderate/severe.  The public health impact of such changes would likely involve both the amount and type of health services needed.  Particularly likely to arise are new forms of outpatient services, such as disease-specific clinics and centers.  None of our models predicts less than a threefold rise in the total number of persons with Alzheimer's disease between 2000 and 2050.  Therefore, Alzheimer's care is likely to remain a major public health problem during the coming decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRD3ruq-t6fkLjnyZkbE8yXfW6udTcc2eZjbeX1grcPi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ns1OrsA%253D%253D&md5=457b171729773d62e360bd5c210530c0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.publhealth.23.100901.140525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.publhealth.23.100901.140525%26sid%3Dliteratum%253Aachs%26aulast%3DSloane%26aufirst%3DP.%2BD.%26aulast%3DZimmerman%26aufirst%3DS.%26aulast%3DSuchindran%26aufirst%3DC.%26aulast%3DReed%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBoustani%26aufirst%3DM.%26aulast%3DSudha%26aufirst%3DS.%26atitle%3DThe%2520public%2520health%2520impact%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%25202000%25E2%2580%25932050%253A%2520Potential%2520implication%2520of%2520treatment%2520advances%26jtitle%3DAnnu.%2520Rev.%2520Public%2520Health%26date%3D2002%26volume%3D23%26spage%3D213%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lgNfK0b1s6WSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miners, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thokala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wailoo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffreys, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, C.</span><span> </span><span class="NLM_article-title">The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of technology appraisal no. 111): A systematic review and economic model</span> <span class="citation_source-journal">Health Technol. Assess.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22541366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADC%252BC38roslKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1-470&author=M.+Bondauthor=G.+Rogersauthor=J.+Petersauthor=R.+Andersonauthor=M.+Hoyleauthor=A.+Minersauthor=T.+Moxhamauthor=S.+Davisauthor=P.+Thokalaauthor=A.+Wailooauthor=M.+Jeffreysauthor=C.+Hyde&title=The+effectiveness+and+cost-effectiveness+of+donepezil%2C+galantamine%2C+rivastigmine+and+memantine+for+the+treatment+of+Alzheimer%E2%80%99s+disease+%28review+of+technology+appraisal+no.+111%29%3A+A+systematic+review+and+economic+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model</span></div><div class="casAuthors">Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C</div><div class="citationInfo"><span class="NLM_cas:title">Health technology assessment (Winchester, England)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1-470</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Alzheimer's disease (AD) is the most commonly occurring form of dementia.  It is predominantly a disease of later life, affecting 5% of those over 65 in the UK.  OBJECTIVES:  Review and update guidance to the NHS in England and Wales on the clinical effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine [acetylcholinesterase inhibitors (AChEIs)] and memantine within their licensed indications for the treatment of AD, which was issued in November 2006 (amended September 2007 and August 2009).  DATA SOURCES:  Electronic databases were searched for systematic reviews and/or metaanalyses, randomised controlled trials (RCTs) and ongoing research in November 2009 and updated in March 2010; this updated search revealed no new includable studies.  The databases searched included The Cochrane Library (2009 Issue 4, Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials), MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, PsycINFO, EconLit, ISI Web of Science Databases--Science Citation Index, Conference Proceedings Citation Index, and BIOSIS; the Centre for Reviews and Dissemination (CRD) databases--NHS Economic Evaluation Database, Health Technology Assessment, and Database of Abstracts of Reviews of Effects.  REVIEW METHODS:  The clinical effectiveness systematic review was undertaken following the principles published by the NHS CRD.  We included RCTs whose population was people with AD.  The intervention and comparators depended on disease severity, measured by the Mini Mental State Examination (MMSE).  Interventions: mild AD (MMSE 21-26)--donepezil, galantamine and rivastigmine; moderate AD (MMSE 10-20)--donepezil, galantamine, rivastigmine and memantine; severe AD (MMSE < 10)--memantine.  Comparators: mild AD (MMSE 21-26)--placebo or best supportive care (BSC); moderate AD (MMSE 10-20)--donepezil, galantamine, rivastigmine, memantine, placebo or BSC; severe AD (MMSE < 10)--placebo or BSC.  The outcomes were clinical, global, functional, behavioural, quality of life, adverse events, costs and cost-effectiveness.  Where appropriate, data were pooled using pair-wise meta-analysis, multiple outcome measures, metaregression and mixedtreatment comparisons.  The decision model was based broadly on the structure of the three-state Markov model described in the previous technology assessment report, based upon time to institutionalisation, parameterised with updated estimates of effectiveness, costs and utilities.  RESULTS:  Notwithstanding the uncertainty of our results, we found in the base case that the AChEIs are probably cost saving at a willingness-to-pay (WTP) of £'30,000 per qualityadjusted life-year (QALY) for people with mild-to-moderate AD.  For this class of drugs, there is a > 99% probability that the AChEIs are more cost-effective than BSC.  These analyses assume that the AChEIs have no effect on survival.  For the AChEIs, in people with mild to moderate AD, the probabilistic sensitivity analyses suggested that donepezil is the most cost-effective, with a 28% probability of being the most cost-effective option at a WTP of £'30,000 per QALY (27% at a WTP of £'20,000 per QALY).  In the deterministic results, donepezil dominates the other drugs and BSC, which, along with rivastigmine patches, are associated with greater costs and fewer QALYs.  Thus, although galantamine has a slightly cheaper total cost than donepezil (£'69,592 vs £'69,624), the slightly greater QALY gains from donepezil (1.616 vs 1.617) are enough for donepezil to dominate galantamine.The probability that memantine is cost-effective in a moderate to severe cohort compared with BSC at a WTP of £'30,000 per QALY is 38% (and 28% at a WTP of £'20,000 per QALY).  The deterministic ICER for memantine is £'32,100 per/QALY and the probabilistic ICER is £'36,700 per/QALY.  LIMITATIONS:  Trials were of 6 months maximum follow-up, lacked reporting of key outcomes, provided no subgroup analyses and used insensitive measures.  Searches were limited to English language, The model does not include behavioural symptoms and there is uncertainty about the model structure and parameters.  CONCLUSIONS:  The additional clinical effectiveness evidence identified continues to suggest clinical benefit from the AChEIs in alleviating AD symptoms, although there is debate about the magnitude of the effect.  Although there is also new evidence on the effectiveness of memantine, it remains less supportive of this drug's use than the evidence for AChEIs.  The conclusions concerning cost-effectiveness are quite different from the previous assessment.  This is because both the changes in effectiveness and costs between drug use and non-drug use underlying the ICERs are very small.  This leads to highly uncertain results, which are very sensitive to change.  RESEARCH PRIORITIES: RCTs to include mortality, time to institutionalisation and quality of life, powered for subgroup analysis.  FUNDING:  The National Institute for Health Research Health Technology Assessment programme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqn3zHwwrT-Bcr74wzj5o5fW6udTcc2eZjbeX1grcPi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38roslKqsg%253D%253D&md5=28160bcdfa6f9cc71ce3efb90ea57266</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBond%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DR.%26aulast%3DHoyle%26aufirst%3DM.%26aulast%3DMiners%26aufirst%3DA.%26aulast%3DMoxham%26aufirst%3DT.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DThokala%26aufirst%3DP.%26aulast%3DWailoo%26aufirst%3DA.%26aulast%3DJeffreys%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DC.%26atitle%3DThe%2520effectiveness%2520and%2520cost-effectiveness%2520of%2520donepezil%252C%2520galantamine%252C%2520rivastigmine%2520and%2520memantine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520%2528review%2520of%2520technology%2520appraisal%2520no.%2520111%2529%253A%2520A%2520systematic%2520review%2520and%2520economic%2520model%26jtitle%3DHealth%2520Technol.%2520Assess.%26date%3D2012%26volume%3D16%26spage%3D1%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wilkinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebel, C.</span><span> </span><span class="NLM_article-title">Memantine in patients with moderate to severe Alzheimer’s disease: Meta-analyses using realistic definitions of response</span> <span class="citation_source-journal">Dementia Geriatr. Cognit. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1159%2F000353801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=24107324" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2013&pages=71-85&author=D.+Wilkinsonauthor=Y.+Wirthauthor=C.+Goebel&title=Memantine+in+patients+with+moderate+to+severe+Alzheimer%E2%80%99s+disease%3A+Meta-analyses+using+realistic+definitions+of+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1159%2F000353801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000353801%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DWirth%26aufirst%3DY.%26aulast%3DGoebel%26aufirst%3DC.%26atitle%3DMemantine%2520in%2520patients%2520with%2520moderate%2520to%2520severe%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Meta-analyses%2520using%2520realistic%2520definitions%2520of%2520response%26jtitle%3DDementia%2520Geriatr.%2520Cognit.%2520Disord.%26date%3D2013%26volume%3D37%26spage%3D71%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinamarca, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span> </span><span class="NLM_article-title">Amyloid–cholinesterase interactions. Implications for Alzheimer’s disease</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=625-632&author=N.+C.+Inestrosaauthor=M.+C.+Dinamarcaauthor=A.+Alvarez&title=Amyloid%E2%80%93cholinesterase+interactions.+Implications+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DDinamarca%26aufirst%3DM.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26atitle%3DAmyloid%25E2%2580%2593cholinesterase%2520interactions.%2520Implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D625%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rees, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soreq, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brimijoin, S.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0197-4580%2802%2900230-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=12927760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVeisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=777-787&author=T.+Reesauthor=P.+I.+Hammondauthor=H.+Soreqauthor=S.+Younkinauthor=S.+Brimijoin&title=Acetylcholinesterase+promotes+beta-amyloid+plaques+in+cerebral+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex</span></div><div class="casAuthors">Rees, T.; Hammond, P. I.; Soreq, H.; Younkin, S.; Brimijoin, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">777-787</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Studies in vitro have suggested that acetylcholinesterase (AChE) may interact with beta-amyloid to promote deposition of amyloid plaques in the brain of patients with Alzheimer's disease.  To test that hypothesis in vivo, the authors crossed Tg2576 mice, which express human amyloid precursor protein and develop plaques at 9 mo, with transgenic mice expressing human AChE.  The resulting F1 hybrids (FVB/N×[C57B6×SJL/J]) expressed both transgenes in brain.  By 6 mo of age, their cerebral cortex showed authentic plaques that stained both by thioflavin S and by beta-amyloid 1-40 and 1-42 immunohistochem.  The plaques also stained pos. for other components including Cd11b, GFAP, and AChE.  Plaque onset in the hybrids occurred 30-50% sooner than in the parental lines.  Plaque nos. increased with age and plaques remained more numerous in the doubly transgenic animals at 9 and 12 mo.  Quant. immunoassay via ELISA also showed an increase of total amyloid content in brain at 9-12 mo.  These histol. and biochem. results support the conclusion that AChE may play a role in pathogenesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5qyVg2WZCmbVg90H21EOLACvtfcHk0lifMfLzPyxnTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVeisrg%253D&md5=68451e268783be8af8f6e53671b8c4d7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2802%2900230-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252802%252900230-0%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DT.%26aulast%3DHammond%26aufirst%3DP.%2BI.%26aulast%3DSoreq%26aufirst%3DH.%26aulast%3DYounkin%26aufirst%3DS.%26aulast%3DBrimijoin%26aufirst%3DS.%26atitle%3DAcetylcholinesterase%2520promotes%2520beta-amyloid%2520plaques%2520in%2520cerebral%2520cortex%26jtitle%3DNeurobiol.%2520Aging%26date%3D2003%26volume%3D24%26spage%3D777%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Ferrari, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10447</span><span class="NLM_x">–</span> <span class="NLM_lpage">10457</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0101392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10447-10457&author=G.+V.+De+Ferrariauthor=M.+A.+Canalesauthor=I.+Shinauthor=L.+M.+Weinerauthor=I.+Silmanauthor=N.+C.+Inestrosa&title=A+structural+motif+of+acetylcholinesterase+that+promotes+amyloid+beta-peptide+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi0101392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0101392%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFerrari%26aufirst%3DG.%2BV.%26aulast%3DCanales%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DI.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DA%2520structural%2520motif%2520of%2520acetylcholinesterase%2520that%2520promotes%2520amyloid%2520beta-peptide%2520fibril%2520formation%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10447%26epage%3D10457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cavriniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0lifMfLzPyxnTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Dual inhibitors of beta-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F15680266113139990139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=23931440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1820-1842&author=E.+Viaynaauthor=R.+Sabateauthor=D.+Mu%C3%B1oz-Torrero&title=Dual+inhibitors+of+beta-amyloid+aggregation+and+acetylcholinesterase+as+multi-target+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Sabate, Raimon; Muaoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1820-1842</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Notwithstanding the functional role that the aggregates of some amyloidogenic proteins can play in different organisms, protein aggregation plays a pivotal role in the pathogenesis of a large no. of human diseases.  One of such diseases is Alzheimer's disease (AD), where the overprodn. and aggregation of the β-amyloid peptide (A β) are regarded as early crit. factors.  Another protein that seems to occupy a prominent position within the complex pathol. network of AD is the enzyme acetylcholinesterase (AChE), with classical and non-classical activities involved at the late (cholinergic deficit) and early (A β aggregation) phases of the disease.  Dual inhibitors of A aggregation and AChE are thus emerging as promising multi-target agents with potential to efficiently modify the natural course of AD.  In the initial phases of the drug discovery process of such compds., in vitro evaluation of the inhibition of Aβ β aggregation is rather troublesome, as it is very sensitive to exptl. assay conditions, and requires expensive synthetic Aβ peptides, which makes cost-prohibitive the screening of large compd. libraries.  Herein, we review recently developed multitarget anti-Alzheimer compds. that exhibit both Aβ aggregation and AChE inhibitory activities, and, in some cases also addnl. valuable activities such as BACE-1 inhibition or antioxidant properties.  We also discuss the development of simplified in vivo methods for the rapid, simple, reliable, unexpensive, and high-throughput amenable screening of Aβ aggregation inhibitors that rely on the overexpression of Aβ42 alone or fused with reporter proteins in Escherichia coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyUwDaYut4bVg90H21EOLACvtfcHk0ljyU0D4yG8ttA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M&md5=5df3642ce69af587b82d1dac92014f0d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990139%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DDual%2520inhibitors%2520of%2520beta-amyloid%2520aggregation%2520and%2520acetylcholinesterase%2520as%2520multi-target%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1820%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Potent beta-amyloid modulators</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1159%2F000113688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=18322376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=153-156&author=E.+Garc%C3%ADa-Palomeroauthor=P.+Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=P.+Garc%C3%ADaauthor=E.+Delgadoauthor=C.+De+Austriaauthor=R.+Valenzuelaauthor=L.+Rubioauthor=M.+Medinaauthor=A.+Martinez&title=Potent+beta-amyloid+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Potent β-Amyloid Modulators</span></div><div class="casAuthors">Garcia-Palomero, E.; Munoz, P.; Usan, P.; Garcia, P.; Delgado, E.; De Austria, C.; Valenzuela, R.; Rubio, L.; Medina, M.; Martinez, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">153-156</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Currently, the potential to interfere with the pathol. of β-amyloid targeting a well-known drugable enzyme, the acetylcholinesterase (AChE), is opened.  Peripheral or dual binding site inhibitors of AChE may simultaneously alleviate the cognitive and behavioral deficits in Alzheimer's disease (AD) patients and, more importantly, act as disease-modifying agents delaying amyloid plaque formation.  As part of a rational drug design program directed to find dual binding site AChE inhibitors, several families of compds. have been synthesized as potent AChE inhibitors.  From these series, several drug candidates were selected based on their potent and selective inhibition of AChE (subnanomolar activity) and their interference with the β-amyloid aggregation in vitro (IC50 in the low micromolar range).  First in vivo data confirm our initial hypothesis.  Oral treatment with NP-61 for 3 mo is able to reverse the cognitive impairment (Morris water maze test) and to reduce plaque load in the brains of human amyloid precursor protein transgenic mice (Swedish mutation).  These results suggest that NP-61, a potent β-amyloid modulator, is able to reverse the AD-like neurodegenerative phenotype in transgenic mice, indicating a promising disease-modifying agent for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzLEGLsdWOyrVg90H21EOLACvtfcHk0ljyU0D4yG8ttA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7w%253D&md5=5d4e5f59b1ac00d6ee78e38705d95fda</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1159%2F000113688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000113688%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DP.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DP.%26aulast%3DDelgado%26aufirst%3DE.%26aulast%3DDe%2BAustria%26aufirst%3DC.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPotent%2520beta-amyloid%2520modulators%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2008%26volume%3D5%26spage%3D153%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Spuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antequera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, E.</span><span> </span><span class="NLM_article-title">A new tacrine–melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1007%2Fs12640-009-9121-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=19774434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1SjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=421-431&author=C.+Spuchauthor=D.+Antequeraauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=E.+Carro&title=A+new+tacrine%E2%80%93melatonin+hybrid+reduces+amyloid+burden+and+behavioral+deficits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Spuch, Carlos; Antequera, Desiree; Fernandez-Bachiller, M. Isabel; Rodriguez-Franco, M. Isabel; Carro, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-431</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive degenerative disorder characterized by the presence of amyloid deposits, neurofibrillary tangles and neuron loss.  Emerging evidence indicates that antioxidants could be useful either for the prevention or treatment of AD.  Tacrine and melatonin are well-known drugs which act as an acetylcholinesterase inhibitor and a free radical scavenger, resp.  In this study, we evaluated the effects of a new tacrine-melatonin hybrid on behavior and the biochem. and neuropathol. changes obsd. in amyloid precursor protein/presenilin 1 (APP/Ps1) transgenic mice.  Our findings showed that direct intracerebral administration of this hybrid decreased amyloid β peptide (Aβ)-induced cell death and amyloid burden in the brain parenchyma of APP/Ps1 mice.  This redn. in Aβ pathol. was accompanied by a recovery in cognitive function.  Since this tacrine-melatonin hybrid apparently reduces brain Aβ and behavioral deficits, we believe this drug has remarkable and significant neuroprotective effects and might be considered a potential therapeutic strategy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVLHUwA0i4NLVg90H21EOLACvtfcHk0ljyU0D4yG8ttA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1SjsLs%253D&md5=12f3bb1844570daeaf931584b4af1661</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12640-009-9121-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12640-009-9121-2%26sid%3Dliteratum%253Aachs%26aulast%3DSpuch%26aufirst%3DC.%26aulast%3DAntequera%26aufirst%3DD.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DCarro%26aufirst%3DE.%26atitle%3DA%2520new%2520tacrine%25E2%2580%2593melatonin%2520hybrid%2520reduces%2520amyloid%2520burden%2520and%2520behavioral%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2010%26volume%3D17%26spage%3D421%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Antequera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, E.</span><span> </span><span class="NLM_article-title">Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Abeta accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2Fj.nbd.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22426395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1ekt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=682-691&author=D.+Antequeraauthor=M.+Bolosauthor=C.+Spuchauthor=C.+Pascualauthor=I.+Ferrerauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=E.+Carro&title=Effects+of+a+tacrine-8-hydroxyquinoline+hybrid+%28IQM-622%29+on+Abeta+accumulation+and+cell+death%3A+Involvement+in+hippocampal+neuronal+loss+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer's disease</span></div><div class="casAuthors">Antequera, Desiree; Bolos, Marta; Spuch, Carlos; Pascual, Consuelo; Ferrer, Isidro; Fernandez-Bachiller, Maria Isabel; Rodriguez-Franco, Maria Isabel; Carro, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">682-691</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Several studies have implicated the enzyme acetylcholinesterase (AChE) as well as several biometals in the pathogenesis of Alzheimer's disease (AD).  A multifunctional mol., the hybrid tacrine-8-hydroxyquinoline (named IQM-622), displays cholinergic, antioxidant, copper-complexing and neuroprotective properties.  Using in vitro and in vivo models, we investigated the modulating effects of IQM-622 on amyloid β-protein (Aβ)-induced pathol. as well as on chem. induced neurodegeneration by domoic acid.  In the first exptl. model, we obsd. a significant decrease in brain Aβ deposits in IQM-622-treated APP/Ps1 mice for four weeks.  Moreover, IQM-622 promoted the degrdn. of intracellular Aβ in astrocytes, and protected against Aβ toxicity in cultured astrocytes and neurons.  These findings suggest that the neuroprotective effect of IQM-622 is not only related to AChE inhibition, but also involves other mechanisms, including the modulation of Aβ-degrdn. pathways in AD brain.  In this study we also compare the neuronal loss in CA1 hippocampal field of AD patients and of mice treated with domoic acid, giving similar patterns.  Thus, we used a second exptl. model by killing hippocampal neurons by domoic acid damage, in which IQM-622 increased survival in the CA1 and dentate gyrus regions of the hippocampus.  Our observations suggest that administration of IQM-622 may have significant beneficial effects in neurodegenerative diseases, including AD, which course with acute or progressive neuronal death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH3NNhchqTHrVg90H21EOLACvtfcHk0lgGXY9DO7IO9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1ekt74%253D&md5=00b3a59863cd529979830c465a81b0dc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DAntequera%26aufirst%3DD.%26aulast%3DBolos%26aufirst%3DM.%26aulast%3DSpuch%26aufirst%3DC.%26aulast%3DPascual%26aufirst%3DC.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DCarro%26aufirst%3DE.%26atitle%3DEffects%2520of%2520a%2520tacrine-8-hydroxyquinoline%2520hybrid%2520%2528IQM-622%2529%2520on%2520Abeta%2520accumulation%2520and%2520cell%2520death%253A%2520Involvement%2520in%2520hippocampal%2520neuronal%2520loss%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D46%26spage%3D682%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lorrio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Rangel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negredo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal-Cim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span> </span><span class="NLM_article-title">Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=403-411&author=S.+Lorrioauthor=V.+G%C3%B3mez-Rangelauthor=P.+Negredoauthor=J.+Egeaauthor=R.+Le%C3%B3nauthor=A.+Romeroauthor=T.+Dal-Cimauthor=M.+Villarroyaauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=S.+Condeauthor=M.+P.+Arceauthor=J.+M.+Rodaauthor=A.+G.+Garc%C3%ADaauthor=M.+G.+L%C3%B3pez&title=Novel+multitarget+ligand+ITH33%2FIQM9.21+provides+neuroprotection+in+in+vitro+and+in+vivo+models+related+to+brain+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLorrio%26aufirst%3DS.%26aulast%3DG%25C3%25B3mez-Rangel%26aufirst%3DV.%26aulast%3DNegredo%26aufirst%3DP.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DDal-Cim%26aufirst%3DT.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRoda%26aufirst%3DJ.%2BM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26atitle%3DNovel%2520multitarget%2520ligand%2520ITH33%252FIQM9.21%2520provides%2520neuroprotection%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520related%2520to%2520brain%2520ischemia%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D67%26spage%3D403%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ansari, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheff, S. W.</span><span> </span><span class="NLM_article-title">Oxidative stress in the progression of Alzheimer disease in the frontal cortex</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1097%2FNEN.0b013e3181cb5af4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=20084018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1emtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=155-167&author=M.+A.+Ansariauthor=S.+W.+Scheff&title=Oxidative+stress+in+the+progression+of+Alzheimer+disease+in+the+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex</span></div><div class="casAuthors">Ansari, Mubeen A.; Scheff, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-167</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We investigated oxidative stress in human postmortem frontal cortex from individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9).  Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls.  The short postmortem interval brain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions.  Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances.  The tissue was also analyzed for possible changes in protein damage using neurochem. markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, and acrolein.  All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers.  The highest changes were obsd. in the synaptosomal fraction.  Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase).  Levels of oxidative markers significantly correlated with Mini-Mental Status Examn. scores.  Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion.  These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrifB5Jov2B6rVg90H21EOLACvtfcHk0lgGXY9DO7IO9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1emtb4%253D&md5=1920b63a2e904935f22fef3ce04563af</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e3181cb5af4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e3181cb5af4%26sid%3Dliteratum%253Aachs%26aulast%3DAnsari%26aufirst%3DM.%2BA.%26aulast%3DScheff%26aufirst%3DS.%2BW.%26atitle%3DOxidative%2520stress%2520in%2520the%2520progression%2520of%2520Alzheimer%2520disease%2520in%2520the%2520frontal%2520cortex%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2010%26volume%3D69%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2008&pages=44-48&author=F.+Guauthor=M.+Zhuauthor=J.+Shiauthor=Y.+Huauthor=Z.+Zhao&title=Enhanced+oxidative+stress+is+an+early+event+during+development+of+Alzheimer-like+pathologies+in+presenilin+conditional+knock-out+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DEnhanced%2520oxidative%2520stress%2520is%2520an%2520early%2520event%2520during%2520development%2520of%2520Alzheimer-like%2520pathologies%2520in%2520presenilin%2520conditional%2520knock-out%2520mice%26jtitle%3DNeurosci.%2520Lett.%26date%3D2008%26volume%3D440%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Caldeira, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rego, A. C.</span><span> </span><span class="NLM_article-title">Impaired transcription in Alzheimer’s disease: Key role in mitochondrial dysfunction and oxidative stress</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=23364141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADC%252BC3szjvVyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=115-131&author=G.+L.+Caldeiraauthor=I.+L.+Ferreiraauthor=A.+C.+Rego&title=Impaired+transcription+in+Alzheimer%E2%80%99s+disease%3A+Key+role+in+mitochondrial+dysfunction+and+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress</span></div><div class="casAuthors">Caldeira Gladys L; Ferreira I Luisa; Rego A Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the major cause of dementia in the world.  Abnormal extracellular accumulation of amyloid-β (Aβ) peptide and tau hyperphosphorylation, forming neurofibrillary tangles in the brain, are hallmarks of the disease.  Oxidative stress, neuroinflammation, and mitochondrial and synaptic dysfunction are also observed in AD and often correlated to intracellular Aβ.  This peptide results from the cleavage of the amyloid-β protein precursor by β- and γ-secretases and tends to be secreted after its production.  However, secreted Aβ can be internalized by the interaction with membrane receptors, namely N-methyl-D-aspartate receptors, advanced glycation end products receptors, and/or alpha 7 nicotinic acetylcholine receptors.  Inside the cell, Aβ interacts with several organelles, including mitochondria and nucleus, and there is growing evidence pointing to a possible role of Aβ in the regulation of gene transcription.  Accordingly, transcriptional deregulation was observed in several AD models and human samples from AD patients through modified expression, phosphorylation levels, function, and subcellular localization of some transcription factors, resulting in the suppression of neuroprotective transcription both in the nucleus and the mitochondria.  In this review we focus on key transcription regulators related with mitochondrial biogenesis and antioxidant defenses that seem to be altered in AD models and also on the role of intranuclear Aβ in the pathogenesis of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbA3B1kac05jAEfvC7EH1LfW6udTcc2eZO3ttE67fS97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szjvVyjsA%253D%253D&md5=a6b269f0f69174c9a06d63211b4237f6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldeira%26aufirst%3DG.%2BL.%26aulast%3DFerreira%26aufirst%3DI.%2BL.%26aulast%3DRego%26aufirst%3DA.%2BC.%26atitle%3DImpaired%2520transcription%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Key%2520role%2520in%2520mitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D115%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluise, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Clair, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markesbery, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Potential in vivo amelioration by N-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: Toward therapeutic modulation of mild cognitive impairment</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2618</span><span class="NLM_x">–</span> <span class="NLM_lpage">2629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=20648652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVantbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=2618-2629&author=Q.+Huangauthor=C.+D.+Aluiseauthor=G.+Joshiauthor=R.+Sultanaauthor=D.+K.+St+Clairauthor=W.+R.+Markesberyauthor=D.+A.+Butterfield&title=Potential+in+vivo+amelioration+by+N-acetyl-l-cysteine+of+oxidative+stress+in+brain+in+human+double+mutant+APP%2FPS-1+knock-in+mice%3A+Toward+therapeutic+modulation+of+mild+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment</span></div><div class="casAuthors">Huang, Quanzhen; Aluise, Christopher D.; Joshi, Gururaj; Sultana, Rukhsana; St. Clair, Daret K.; Markesbery, William R.; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2618-2629</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most prevalent form of dementia among the elderly.  Although the underlying cause has yet to be established, numerous data have shown that oxidative stress is implicated in AD as well as in preclin. stages of AD, such as mild cognitive impairment (MCI).  The oxidative stress obsd. in brains of subjects with AD and MCI may be due, either fully or in part, to increased free radicals mediated by amyloid-β peptide (Aβ).  By using double human mutant APP/PS-1 knock-in mice as the AD model, the present work demonstrates that the APP/PS-1 double mutation results in elevated protein oxidn. (as indexed by protein carbonyls), protein nitration (as indexed by 3-nitrotyrosine), as well as lipid peroxidn. (as indexed by protein-bound 4-hydroxy-2-nonenal) in brains of mice aged 9 mo and 12 mo.  APP/PS-1 mice also exhibited lower levels of brain glutathione peroxidase (GPx) in both age groups studied, whereas glutathione reductase (GR) levels in brain were unaffected by the mutation.  The activities of both of these antioxidant enzymes were significantly decreased in APP/PS-1 mouse brains, whereas the activity of glucose-6-phosphate dehydrogenase (G6PDH) was increased relative to controls in both age groups.  Levels of peptidyl prolyl isomerase 1 (Pin1) were significantly decreased in APP/PS-1 mouse brain aged 9 and 12 mo.  Administration of N-acetyl-L-cysteine (NAC), a glutathione precursor, to APP/PS-1 mice via drinking water suppressed increased protein oxidn. and nitration and also significantly augmented levels and activity of GPx in brain from both age groups.  Oral administration of NAC also increased the diminished activity of GR and protected against lipid peroxidn. in brains of 9-mo-old APP/PS-1 mice only.  Pin1 levels, GR levels, and G6PDH activity in brain were unaffected by oral administration of NAC in both age groups.  These results are discussed with ref. to the therapeutic potential of this brain-accessible glutathione precursor in the treatment of MCI and AD. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GhQM6Rf4PbVg90H21EOLACvtfcHk0ljHjMjgvApMEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVantbY%253D&md5=be4f1911caeef1f20315aa4f02a416e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DAluise%26aufirst%3DC.%2BD.%26aulast%3DJoshi%26aufirst%3DG.%26aulast%3DSultana%26aufirst%3DR.%26aulast%3DSt%2BClair%26aufirst%3DD.%2BK.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DPotential%2520in%2520vivo%2520amelioration%2520by%2520N-acetyl-l-cysteine%2520of%2520oxidative%2520stress%2520in%2520brain%2520in%2520human%2520double%2520mutant%2520APP%252FPS-1%2520knock-in%2520mice%253A%2520Toward%2520therapeutic%2520modulation%2520of%2520mild%2520cognitive%2520impairment%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2010%26volume%3D88%26spage%3D2618%26epage%3D2629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Altman, J.</span><span> </span><span class="NLM_article-title">Are new neurons formed in the brains of adult mammals?</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1127</span><span class="NLM_x">–</span> <span class="NLM_lpage">1128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=1962&pages=1127-1128&author=J.+Altman&title=Are+new+neurons+formed+in+the+brains+of+adult+mammals%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DJ.%26atitle%3DAre%2520new%2520neurons%2520formed%2520in%2520the%2520brains%2520of%2520adult%2520mammals%253F%26jtitle%3DScience%26date%3D1962%26volume%3D135%26spage%3D1127%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Eriksson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perfilieva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björk-Eriksson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alborn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordborg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Neurogenesis in the adult human hippocampus</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1038%2F3305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=9809557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaK1cXntlaktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1313-1317&author=P.+S.+Erikssonauthor=E.+Perfilievaauthor=T.+Bj%C3%B6rk-Erikssonauthor=A.+M.+Albornauthor=C.+Nordborgauthor=D.+A.+Petersonauthor=F.+H.+Gage&title=Neurogenesis+in+the+adult+human+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenesis in the adult human hippocampus</span></div><div class="casAuthors">Eriksson, Peter S.; Perfilieva, Ekaterina; Bjork-Eriksson, Thomas; Alborn, Ann-Marie; Nordrorg, Claes; Peterson, Daniel A.; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The genesis of new cells, including neurons, in the adult human brain has not yet been demonstrated.  This study was undertaken to investigate whether neurogenesis occurs in the adult human brain, in regions previously identified as neurogenic in adult rodents and monkeys.  Human brain tissue was obtained postmortem from patients who had been treated with the thymidine analog, bromodeoxyuridine (BrdU), that labels DNA during the S phase.  Using immunofluorescent labeling for BrdU and for one of the neuronal markers, NeuN, calbindin or neuron specific enolase (NSE), we demonstrate that new neurons, as defined by these markers, are generated from dividing progenitor cells in the dentate gyrus of adult humans.  Our results further indicate that the human hippocampus retains its ability to generate neurons throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcTe1-ZnHXc7Vg90H21EOLACvtfcHk0ljHjMjgvApMEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlaktb4%253D&md5=032e3adc0c2e863d6c7192eb93b09dda</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F3305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F3305%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DP.%2BS.%26aulast%3DPerfilieva%26aufirst%3DE.%26aulast%3DBj%25C3%25B6rk-Eriksson%26aufirst%3DT.%26aulast%3DAlborn%26aufirst%3DA.%2BM.%26aulast%3DNordborg%26aufirst%3DC.%26aulast%3DPeterson%26aufirst%3DD.%2BA.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DNeurogenesis%2520in%2520the%2520adult%2520human%2520hippocampus%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1313%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Spalding, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkass, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttner, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boström, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerlund, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possnert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisén, J.</span><span> </span><span class="NLM_article-title">Dynamics of hippocampal neurogenesis in adult humans</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2013&pages=1219-1227&author=K.+L.+Spaldingauthor=O.+Bergmannauthor=K.+Alkassauthor=S.+Bernardauthor=M.+Salehpourauthor=H.+B.+Huttnerauthor=E.+Bostr%C3%B6mauthor=I.+Westerlundauthor=C.+Vialauthor=B.+A.+Buchholzauthor=G.+Possnertauthor=D.+C.+Mashauthor=H.+Druidauthor=J.+Fris%C3%A9n&title=Dynamics+of+hippocampal+neurogenesis+in+adult+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpalding%26aufirst%3DK.%2BL.%26aulast%3DBergmann%26aufirst%3DO.%26aulast%3DAlkass%26aufirst%3DK.%26aulast%3DBernard%26aufirst%3DS.%26aulast%3DSalehpour%26aufirst%3DM.%26aulast%3DHuttner%26aufirst%3DH.%2BB.%26aulast%3DBostr%25C3%25B6m%26aufirst%3DE.%26aulast%3DWesterlund%26aufirst%3DI.%26aulast%3DVial%26aufirst%3DC.%26aulast%3DBuchholz%26aufirst%3DB.%2BA.%26aulast%3DPossnert%26aufirst%3DG.%26aulast%3DMash%26aufirst%3DD.%2BC.%26aulast%3DDruid%26aufirst%3DH.%26aulast%3DFris%25C3%25A9n%26aufirst%3DJ.%26atitle%3DDynamics%2520of%2520hippocampal%2520neurogenesis%2520in%2520adult%2520humans%26jtitle%3DCell%26date%3D2013%26volume%3D153%26spage%3D1219%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Abdipranoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stayte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissel, B.</span><span> </span><span class="NLM_article-title">The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F187152708784083858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=18537646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslCitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=187-210&author=A.+Abdipranotoauthor=S.+Wuauthor=S.+Stayteauthor=B.+Vissel&title=The+role+of+neurogenesis+in+neurodegenerative+diseases+and+its+implications+for+therapeutic+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development</span></div><div class="casAuthors">Abdipranoto, Andrea; Wu, Sara; Stayte, Sandy; Vissel, Bryce</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-210</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are characterized by a net loss of neurons from specific regions of the central nervous system (CNS).  Until recently, research has focused on identifying mechanisms that lead to neurodegeneration, while therapeutic approaches have been primarily targeted to prevent neuronal loss.  This has had limited success and marketed pharmaceuticals do not have dramatic benefits.  Here we suggest that the future success of therapeutic strategies will depend on consideration and understanding of the role of neurogenesis in the adult CNS.  We summarize evidence suggesting that neurogenesis is impaired in neurodegenerative diseases such as Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis, while it is enhanced in stroke.  We review studies where stimulation of neurogenesis is assocd. with restored function in animal models of these diseases, suggesting that neurogenesis is functionally important.  We show that many current therapeutics, developed to block degeneration or to provide symptomatic relief, serendipitously stimulate neurogenesis or, at least, do not interfere with it.  Importantly, many receptors, ion channels and ligand-gated channels implicated in neurodegeneration, such as NMDA, AMPA, GABA and nicotinic acetylcholine receptors, also play an important role in neurogenesis and regeneration.  Therefore, new therapeutics targeted to block degeneration by antagonizing these channels may have limited benefit as they may also block regeneration.  Our conclusion is that future drug development must consider neurogenesis.  It appears unlikely that drugs being developed to treat neurodegenerative diseases will be beneficial if they impair neurogenesis.  And, most tantalizing, therapeutic approaches that stimulate neurogenesis might stimulate repair and even recovery from these devastating diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeesGdW1nlzbVg90H21EOLACvtfcHk0liSmblvN1Yg1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslCitLk%253D&md5=4df96eb6a7a0927db8f2e90fd3931fba</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F187152708784083858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708784083858%26sid%3Dliteratum%253Aachs%26aulast%3DAbdipranoto%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DStayte%26aufirst%3DS.%26aulast%3DVissel%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520neurogenesis%2520in%2520neurodegenerative%2520diseases%2520and%2520its%2520implications%2520for%2520therapeutic%2520development%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D187%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bubenik, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konturek, S. J.</span><span> </span><span class="NLM_article-title">Melatonin and aging: Prospects for human treatment</span> <span class="citation_source-journal">J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=21451205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFagsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2011&pages=13-19&author=G.+A.+Bubenikauthor=S.+J.+Konturek&title=Melatonin+and+aging%3A+Prospects+for+human+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin and aging: prospects for human treatment</span></div><div class="casAuthors">Bubenik, G. A.; Konturek, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-19</span>CODEN:
                <span class="NLM_cas:coden">JPHPEI</span>;
        ISSN:<span class="NLM_cas:issn">0867-5910</span>.
    
            (<span class="NLM_cas:orgname">Polish Physiological Society</span>)
        </div><div class="casAbstract">A review.  Human life span, with or without modern medicine is around 85-95 years.  All living creatures have their inner clock that measures their daily (circadian) and their seasonal (circannual) time.  These time changes are mediated by the alteration of levels of melatonin, an evolutionary ancient hormone, which is produced in many body tissues, including the pineal gland, retina and the gastrointestinal tract (GIT).  Light is blocking the prodn. of melatonin in the pineal gland, darkness is stimulating it.  So, the diurnal changes of light intensity of melatonin, provide a "daily clock" and the seasonal changes provide a "seasonal clock".  Finally, the redn. of melatonin obsd. with aging, may indicate the presence of an "age clock".  Melatonin is a strong antioxidant (often it is called scavenger of free radicals), which protects the body from the effects of noxious compds.  Therefore it was hypothesized that the redn. of melatonin levels with age contributes to the aging process.  So far, the only remedy to extend the life span was a 40% redn. in caloric intake, which prolonged the life in mice, rats, dogs and monkeys by 30-50%.  A large group of people imitate these expts. performed on animals, but the results of these expts. will not be known for several decades.  How is being hungry prolonging the life span.  There is a connection between caloric redn. and melatonin levels in GIT.  Several expts. indicate that fasting in animals substantially increased their prodn. of GIT melatonin.  Therefore, instead of being permanently hungry, a prolongation of human life could be achieved by a replacement melatonin therapy.  A daily intake of melatonin before bed time might achieve the same effect as fasting e.g. an increase of body melatonin levels, which will protect the individual from the ravages of old age.  That includes Parkinson's disease and Alzheimer's disease.  There is a large group of people taking melatonin daily who believe that melatonin is the "fountain of youth".  Those are the subjects which will one day provide an exptl. evidence of the efficacy of melatonin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWWOWhgyFmI7Vg90H21EOLACvtfcHk0liSmblvN1Yg1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFagsrg%253D&md5=8d32e375f02180bdedf6f09540d9d91e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubenik%26aufirst%3DG.%2BA.%26aulast%3DKonturek%26aufirst%3DS.%2BJ.%26atitle%3DMelatonin%2520and%2520aging%253A%2520Prospects%2520for%2520human%2520treatment%26jtitle%3DJ.%2520Physiol.%2520Pharmacol.%26date%3D2011%26volume%3D62%26spage%3D13%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Reiter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. X.</span><span> </span><span class="NLM_article-title">Neurotoxins: Free radical mechanisms and melatonin protection</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F157015910792246236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=21358970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=194-210&author=R.+J.+Reiterauthor=L.+C.+Manchesterauthor=D.+X.+Tan&title=Neurotoxins%3A+Free+radical+mechanisms+and+melatonin+protection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxins: free radical mechanisms and melatonin protection</span></div><div class="casAuthors">Reiter, Russel J.; Manchester, Lucien C.; Tan, Dun-Xian</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-210</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxins that pass through the blood-brain barrier put neurons and glia in peril.  The damage inflicted is usually a consequence of the ability of these toxic agents to induce free radical generation within cells but esp. at the level of the mitochondria.  The elevated prodn. of oxygen and nitrogen-based radicals and related non-radical products leads to the oxidn. of essential macromols. including lipids, proteins and DNA.  The resultant damage is referred to as oxidative and nitrosative stress and, when the mol. destruction is sufficiently severe, it causes apoptosis or necrosis of neurons and glia.  Loss of brain cells compromises the functions of the central nervous system expressed as motor, sensory and cognitive deficits and psychol. alterations.  In this survey we summarize the publications related to the following neurotoxins and the protective actions of melatonin: aminolevulinic acid, cyanide, domoic acid, kainic acid, metals, methamphetamine, polychlorinated biphenyls, rotenone, toluene and 6-hydroxydopamine.  Given the potent direct free radical scavenging activities of melatonin and its metabolites, their ability to indirectly stimulate antioxidative enzymes and their efficacy in reducing electron leakage from mitochondria, it would be expected that these mols. would protect the brain from oxidative and nitrosative mol. mutilation.  The studies summarized in this review indicate that this is indeed the case, an action that is obviously assisted by the fact that melatonin readily crosses the blood brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcOwOv1M5VV7Vg90H21EOLACvtfcHk0liSmblvN1Yg1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtrvI&md5=c18bc9fb326167358209cdd17b89ffd5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F157015910792246236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015910792246236%26sid%3Dliteratum%253Aachs%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26aulast%3DManchester%26aufirst%3DL.%2BC.%26aulast%3DTan%26aufirst%3DD.%2BX.%26atitle%3DNeurotoxins%253A%2520Free%2520radical%2520mechanisms%2520and%2520melatonin%2520protection%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2010%26volume%3D8%26spage%3D194%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Reiter, R. J.</span><span> </span><span class="NLM_article-title">Oxidative damage in the central nervous system: Protection by melatonin</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0301-0082%2898%2900052-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=9770244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaK1cXmtFKhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=359-384&author=R.+J.+Reiter&title=Oxidative+damage+in+the+central+nervous+system%3A+Protection+by+melatonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage in the central nervous system: protection by melatonin</span></div><div class="casAuthors">Reiter, Russel J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-384</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with ∼275 refs.  Melatonin was recently reported to be an effective free radical scavenger and antioxidant.  Melatonin is believed to scavenge the highly toxic hydroxyl radical, the peroxynitrite anion, and possibly the peroxyl radical.  Also, secondarily, it reportedly scavenges the superoxide anion radical and it quenches singlet oxygen.  Addnl., it stimulates mRNA levels for superoxide dismutase and the activities of glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase (all of which are antioxidative enzymes), thereby increasing its antioxidative capacity.  Also, melatonin, at least at some sites, inhibits nitric oxide synthase, a pro-oxidative enzyme.  In both in vivo and in vitro expts. melatonin has been shown to reduce lipid peroxidn. and oxidative damage to nuclear DNA.  While these effects have been obsd. primarily using pharmacol. doses of melatonin, in a small no. of expts. melatonin has been found to be physiol. relevant as an antioxidant as well.  The efficacy of melatonin in inhibiting oxidative damage has been tested in a variety of neurol. disease models where free radicals have been implicated as being in part causative of the condition.  Thus, melatonin has been shown prophylactically to reduce amyloid β protein toxicity of Alzheimer's disease, to reduce oxidative damage in several models of Parkinson's disease (dopamine auto-oxidn., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine), to protect against glutamate excitotoxicity, to reduce ischemia-reperfusion injury, to lower neural damage due to δ-aminolevulinic acid (porphyria), hyperbaric hyperoxia and a variety of neural toxins.  Since endogenous melatonin levels fall markedly in advanced age, the implication of these findings is that the loss of this antioxidant may contribute to the incidence or severity of some age-assocd. neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbMBfTYQqFtLVg90H21EOLACvtfcHk0liSmblvN1Yg1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtFKhtbc%253D&md5=2518032c1c106627bdef1151ab5d269f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2898%2900052-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252898%252900052-5%26sid%3Dliteratum%253Aachs%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26atitle%3DOxidative%2520damage%2520in%2520the%2520central%2520nervous%2520system%253A%2520Protection%2520by%2520melatonin%26jtitle%3DProg.%2520Neurobiol.%26date%3D1998%26volume%3D56%26spage%3D359%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pandi-Perumal, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BaHammam, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharti, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardeland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardinali, D. P.</span><span> </span><span class="NLM_article-title">Melatonin antioxidative defense: Therapeutical implications for aging and neurodegenerative processes</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1007%2Fs12640-012-9337-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22739839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFOit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=267-300&author=S.+R.+Pandi-Perumalauthor=A.+S.+BaHammamauthor=G.+M.+Brownauthor=D.+W.+Spenceauthor=V.+K.+Bhartiauthor=C.+Kaurauthor=R.+Hardelandauthor=D.+P.+Cardinali&title=Melatonin+antioxidative+defense%3A+Therapeutical+implications+for+aging+and+neurodegenerative+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes</span></div><div class="casAuthors">Pandi-Perumal, Seithikurippu R.; BaHammam, Ahmed S.; Brown, Gregory M.; Spence, D. Warren; Bharti, Vijay K.; Kaur, Charanjit; Hardeland, Ruediger; Cardinali, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-300</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The pineal product melatonin has remarkable antioxidant properties.  It is secreted during darkness and plays a key role in various physiol. responses including regulation of circadian rhythms, sleep homeostasis, retinal neuromodulation, and vasomotor responses.  It scavenges hydroxyl, carbonate, and various org. radicals as well as a no. of reactive nitrogen species.  Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes including superoxide dismutase, glutathione peroxidase, and glutathione reductase, and by augmenting glutathione levels.  Melatonin preserves mitochondrial homeostasis, reduces free radical generation and protects mitochondrial ATP synthesis by stimulating Complexes I and IV activities.  The decline in melatonin prodn. in aged individuals has been suggested as one of the primary contributing factors for the development of age-assocd. neurodegenerative diseases.  The efficacy of melatonin in preventing oxidative damage in either cultured neuronal cells or in the brains of animals treated with various neurotoxic agents, suggests that melatonin has a potential therapeutic value as a neuroprotective drug in treatment of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), stroke, and brain trauma.  Therapeutic trials with melatonin indicate that it has a potential therapeutic value as a neuroprotective drug in treatment of AD, ALS, and HD.  In the case of other neurol. conditions, like PD, the evidence is less compelling.  Melatonin's efficacy in combating free radical damage in the brain suggests that it can be a valuable therapeutic agent in the treatment of cerebral edema following traumatic brain injury or stroke.  Clin. trials employing melatonin doses in the range of 50-100 mg/day are warranted before its relative merits as a neuroprotective agent is definitively established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKtx6fhXb13LVg90H21EOLACvtfcHk0liw1qykyQEUAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFOit7g%253D&md5=9a6620bc929220deaf0b046ca790fadd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs12640-012-9337-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12640-012-9337-4%26sid%3Dliteratum%253Aachs%26aulast%3DPandi-Perumal%26aufirst%3DS.%2BR.%26aulast%3DBaHammam%26aufirst%3DA.%2BS.%26aulast%3DBrown%26aufirst%3DG.%2BM.%26aulast%3DSpence%26aufirst%3DD.%2BW.%26aulast%3DBharti%26aufirst%3DV.%2BK.%26aulast%3DKaur%26aufirst%3DC.%26aulast%3DHardeland%26aufirst%3DR.%26aulast%3DCardinali%26aufirst%3DD.%2BP.%26atitle%3DMelatonin%2520antioxidative%2520defense%253A%2520Therapeutical%2520implications%2520for%2520aging%2520and%2520neurodegenerative%2520processes%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2013%26volume%3D23%26spage%3D267%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span> </span><span class="NLM_article-title">Melatonin in Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">14575</span><span class="NLM_x">–</span> <span class="NLM_lpage">14593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.3390%2Fijms140714575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=14575-14593&author=L.+Linauthor=Q.+X.+Huangauthor=S.+S.+Yangauthor=J.+Chuauthor=J.+Z.+Wangauthor=Q.+Tian&title=Melatonin+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin in Alzheimer's disease</span></div><div class="casAuthors">Lin, Li; Huang, Qiong-Xia; Yang, Shu-Sheng; Chu, Jiang; Wang, Jian-Zhi; Tian, Qing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">14575-14593, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), an age-related neurodegenerative disorder with progressive cognition deficit, is characterized by extracellular senile plaques (SP) of aggregated β-amyloid (Aβ) and intracellular neurofibrillary tangles, mainly contg. the hyperphosphorylated microtubule-assocd. protein tau.  Multiple factors contribute to the etiol. of AD in terms of initiation and progression.  Melatonin is an endogenously produced hormone in the brain and decreases during aging and in patients with AD.  Data from clin. trials indicate that melatonin supplementation improves sleep, ameliorates sundowning and slows down the progression of cognitive impairment in AD patients.  Melatonin efficiently protects neuronal cells from Aβ-mediated toxicity via antioxidant and anti-amyloid properties.  It not only inhibits Aβ generation, but also arrests the formation of amyloid fibrils by a structure-dependent interaction with Aβ.  Our studies have demonstrated that melatonin efficiently attenuates Alzheimer-like tau hyperphosphorylation.  Although the exact mechanism is still not fully understood, a direct regulatory influence of melatonin on the activities of protein kinases and protein phosphatases is proposed.  Addnl., melatonin also plays a role in protecting the cholinergic system and in anti-inflammation.  The aim of this review is to stimulate interest in melatonin as a potentially useful agent in the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr72I0hQZs34LVg90H21EOLACvtfcHk0liw1qykyQEUAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvK&md5=16d19b4085258e91cbcff16887a3903a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fijms140714575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140714575%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DQ.%2BX.%26aulast%3DYang%26aufirst%3DS.%2BS.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DTian%26aufirst%3DQ.%26atitle%3DMelatonin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D14575%26epage%3D14593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ramírez-Rodríguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klempin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benítez-King, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempermann, G.</span><span> </span><span class="NLM_article-title">Melatonin modulates cell survival of new neurons in the hippocampus of adult mice</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2180</span><span class="NLM_x">–</span> <span class="NLM_lpage">2191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=2180-2191&author=G.+Ram%C3%ADrez-Rodr%C3%ADguezauthor=F.+Klempinauthor=H.+Babuauthor=G.+Ben%C3%ADtez-Kingauthor=G.+Kempermann&title=Melatonin+modulates+cell+survival+of+new+neurons+in+the+hippocampus+of+adult+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez-Rodr%25C3%25ADguez%26aufirst%3DG.%26aulast%3DKlempin%26aufirst%3DF.%26aulast%3DBabu%26aufirst%3DH.%26aulast%3DBen%25C3%25ADtez-King%26aufirst%3DG.%26aulast%3DKempermann%26aufirst%3DG.%26atitle%3DMelatonin%2520modulates%2520cell%2520survival%2520of%2520new%2520neurons%2520in%2520the%2520hippocampus%2520of%2520adult%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D2180%26epage%3D2191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Domínguez-Alonso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez-Rodríguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benítez-King, G.</span><span> </span><span class="NLM_article-title">Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures</span> <span class="citation_source-journal">J. Pineal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1111%2Fj.1600-079X.2011.00957.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22257024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=427-436&author=A.+Dom%C3%ADnguez-Alonsoauthor=G.+Ram%C3%ADrez-Rodr%C3%ADguezauthor=G.+Ben%C3%ADtez-King&title=Melatonin+increases+dendritogenesis+in+the+hilus+of+hippocampal+organotypic+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures</span></div><div class="casAuthors">Dominguez-Alonso, Aline; Ramirez-Rodriguez, Gerardo; Benitez-King, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">427-436</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Neuropsychiatric disorders are characterized by hippocampus decreased vol. and loss of dendrite arborizations in the subiculum and prefrontal cortex.  These structural changes are assocd. with diminished memory performance.  Hilar neurons of the hippocampus integrate spatial memory and are lost in dementia.  They receive information from dentate gyrus neurons through dendrites, while they send axonal tracts to the CA3 region.  Dendrites are complex structures of neurons that receive chem. information from presynaptic and postsynaptic terminals.  Melatonin, the main product of the pineal gland, has neuroprotective actions through its free radical-scavenging properties and decreases neuronal apoptosis.  Recently, we found that melatonin increases dendrite maturation and complexity in new neurons formed in the dentate gyrus of mice.  In addn., in N1E-115 cultured cells, the indole stimulates early stages of neurite formation, a process that is known to antecede dendrite formation and maturation.  Thus, in this study, we explored whether melatonin stimulates dendrite formation and complexity in the adult rat hippocampus in organotypic slice cultures, which is a model that preserves the hippocampal circuitry and their tridimensional organizations of connectivity.  The effects of melatonin were studied in nonpathol. conditions and in the absence of harmful agents.  The results showed that the indole at nocturnal concns. reached in the cerebrospinal fluid stimulates dendritogenesis at formation, growth, and maturation stages.  Also, data showed that dendrites formed became competent to form presynaptic specializations.  Evidence strongly suggests that melatonin may be useful in the treatment of neuropsychiatric diseases to repair the loss of dendrites and re-establish lost synaptic connections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE9u2zi62ygLVg90H21EOLACvtfcHk0ljvWy6wDtcZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyluro%253D&md5=78e5986508795dc86a9ad8b8caa48b90</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2011.00957.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2011.00957.x%26sid%3Dliteratum%253Aachs%26aulast%3DDom%25C3%25ADnguez-Alonso%26aufirst%3DA.%26aulast%3DRam%25C3%25ADrez-Rodr%25C3%25ADguez%26aufirst%3DG.%26aulast%3DBen%25C3%25ADtez-King%26aufirst%3DG.%26atitle%3DMelatonin%2520increases%2520dendritogenesis%2520in%2520the%2520hilus%2520of%2520hippocampal%2520organotypic%2520cultures%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2012%26volume%3D52%26spage%3D427%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somera-Molina, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubocovich, M. L.</span><span> </span><span class="NLM_article-title">Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus</span> <span class="citation_source-journal">J. Pineal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1111%2Fjpi.12023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=23190173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=222-231&author=J.+Liuauthor=K.+C.+Somera-Molinaauthor=R.+L.+Hudsonauthor=M.+L.+Dubocovich&title=Melatonin+potentiates+running+wheel-induced+neurogenesis+in+the+dentate+gyrus+of+adult+C3H%2FHeN+mice+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus</span></div><div class="casAuthors">Liu, Jiabei; Somera-Molina, Kathleen C.; Hudson, Randall L.; Dubocovich, Margarita L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This study assessed the role of melatonin in modulating running wheel(RW)-induced hippocampal neurogenesis in adult C3H/HeN mice.  Chronic melatonin (0.02 mg/mL, oral for 12 days) treatment did not affect cell proliferation or cell survival detd. by the no. of BrdU-pos. cells in dentate gyrus of mice with access to fixed wheel (FW).  RW activity significantly increased cell proliferation [RW (n = 8) vs. FW (n = 6): dorsal, 199 ± 18 vs. 125 ± 12, P < 0.01; ventral, 211 ± 15 vs. 123 ± 13, P < 0.01] and newborn cell survival [RW (n = 7) vs. FW (n = 8): dorsal, 45 ± 8.5 vs. 15 ± 1.8, P < 0.01; ventral, 48 ± 8.1 vs. 15 ± 1.4] in the dorsal and ventral dentate gyrus.  Oral melatonin treatment further potentiated RW activity-induced cell survival in both areas of the dentate gyrus [melatonin (n = 10) vs. vehicle (n = 7): dorsal, 63 ± 5.4 vs. 45 ± 8.5 P < 0.05; ventral, 75 ± 7.9 vs. 48 ± 8.1, P < 0.01] and neurogenesis [melatonin (n = 8) vs. vehicle (n = 8): dorsal, 46 ± 3.4, vs. 34 ± 4.5, P < 0.05; ventral, 41 ± 3.4 vs. 25 ± 2.4, P < 0.01].  We conclude that melatonin potentiates RW-induced hippocampal neurogenesis by enhancing neuronal survival suggesting that the combination of phys. exercise and melatonin may be an effective treatment for diseases affecting the hippocampus neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT3S8HMJJ8zLVg90H21EOLACvtfcHk0ljvWy6wDtcZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCqsLc%253D&md5=ba198eef56e191f22d1700295d2c0986</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fjpi.12023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjpi.12023%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSomera-Molina%26aufirst%3DK.%2BC.%26aulast%3DHudson%26aufirst%3DR.%2BL.%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26atitle%3DMelatonin%2520potentiates%2520running%2520wheel-induced%2520neurogenesis%2520in%2520the%2520dentate%2520gyrus%2520of%2520adult%2520C3H%252FHeN%2520mice%2520hippocampus%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2013%26volume%3D54%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0ljvWy6wDtcZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0liBv_Z7FcJ2wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garc%C3%ADaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0liBv_Z7FcJ2wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A small molecule targeting the multifactorial nature of Alzheimer’s disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+small+molecule+targeting+the+multifactorial+nature+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520small%2520molecule%2520targeting%2520the%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Capurro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busquet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56870-1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e56870-8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56870-1-e56870-8&author=V.+Capurroauthor=P.+Busquetauthor=J.+P.+Lopesauthor=R.+Bertorelliauthor=G.+Tarozzoauthor=M.+L.+Bolognesiauthor=D.+Piomelliauthor=A.+Reggianiauthor=A.+Cavalli&title=Pharmacological+characterization+of+memoquin%2C+a+multi-target+compound+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DLopes%26aufirst%3DJ.%2BP.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520memoquin%252C%2520a%2520multi-target%2520compound%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56870-1%26epage%3De56870-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Ladostigil: A novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F138945012799499794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22280345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslCmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=483-494&author=O.+Weinrebauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+B.+Youdim&title=Ladostigil%3A+A+novel+multimodal+neuroprotective+drug+with+cholinesterase+and+brain-selective+monoamine+oxidase+inhibitory+activities+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment</span></div><div class="casAuthors">Weinreb, Orly; Amit, Tamar; Bar-Am, Orit; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">483-494</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ladostigil [(N-propargyl-(3R) aminoindan-5yl)-Et Me carbamate] is a dual acetylcholine-butyrylcholineesterase and brain selective monoamine oxidase (MAO)-A and -B inhibitor in vivo (with little or no MAO inhibitory effect in the liver and small intestine), intended for the treatment of dementia co-morbid with extrapyramidal disorders and depression (presently in a Phase IIb clin. study).  This suggests that the drug should not cause a significant potentiation of the cardiovascular response to tyramine, thereby making it a potentially safer antidepressant than other irreversible MAO-A inhibitors.  Ladostigil was shown to antagonize scopolamine-induced impairment in spatial memory, indicating that it can cause significant increases in rat brain cholinergic activity.  Furthermore, ladostigil prevented gliosis and oxidative-nitrative stress and reduced the deficits in episodic and spatial memory induced by intracerebroventricular injection of streptozotocin in rats.  Ladostigil was demonstrated to possess potent anti-apoptotic and neuroprotective activities in vitro and in various neurodegenerative rat models, (e.g. hippocampal damage induced by global ischemia in gerbils and cerebral edema induced in mice by closed head injury).  These neuroprotective activities involve regulation of amyloid precursor protein processing; activation of protein kinase C and mitogen-activated protein kinase signaling pathways; inhibition of neuronal death markers; prevention of the fall in mitochondrial membrane potential and upregulation of neurotrophic factors and antioxidative activity.  Recent findings demonstrated that the major metabolite of ladostigil, hydroxy-1-(R)-aminoindan has also a neuroprotective activity and thus, may contribute to the overt activity of its parent compd.  This review will discuss the scientific evidence for the therapeutic potential use of ladostigil in Alzheimer's and Lewy Body diseases and the mol. signaling pathways that are considered to be involved in the biol. activities of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSPLqLnccsGLVg90H21EOLACvtfcHk0liBv_Z7FcJ2wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslCmurY%253D&md5=2272d945e6eaf132035b6dfc43d2e569</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138945012799499794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945012799499794%26sid%3Dliteratum%253Aachs%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DLadostigil%253A%2520A%2520novel%2520multimodal%2520neuroprotective%2520drug%2520with%2520cholinesterase%2520and%2520brain-selective%2520monoamine%2520oxidase%2520inhibitory%2520activities%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2012%26volume%3D13%26spage%3D483%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badía, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junyent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Novel huprine derivatives with inhibitory activity toward beta-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1855-1870&author=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=L.+Ram%C3%ADrezauthor=M.+Ratiaauthor=A.+Bad%C3%ADaauthor=M.+V.+Closauthor=E.+Verdaguerauthor=F.+Junyentauthor=A.+Caminsauthor=M.+Pallasauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+huprine+derivatives+with+inhibitory+activity+toward+beta-amyloid+aggregation+and+formation+as+disease-modifying+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBad%25C3%25ADa%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520huprine%2520derivatives%2520with%2520inhibitory%2520activity%2520toward%2520beta-amyloid%2520aggregation%2520and%2520formation%2520as%2520disease-modifying%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DChemMedChem.%26date%3D2010%26volume%3D5%26spage%3D1855%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giménez-Llort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badía, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huprine, X.</span><span> </span><span class="NLM_article-title">and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer’s disease in triple transgenic mice (3xTg-AD)</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1159%2F000336427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22626981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=129-140&author=M.+Ratiaauthor=L.+Gim%C3%A9nez-Llortauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torreroauthor=B.+P%C3%A9rezauthor=M.+V.+Closauthor=A.+Bad%C3%ADaauthor=X.+Huprine&title=and+huperzine+A+improve+cognition+and+regulate+some+neurochemical+processes+related+with+Alzheimer%E2%80%99s+disease+in+triple+transgenic+mice+%283xTg-AD%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine X and Huperzine A Improve Cognition and Regulate Some Neurochemical Processes Related with Alzheimer's Disease in Triple Transgenic Mice (3xTg-AD)</span></div><div class="casAuthors">Ratia, M.; Gimenez-Llort, L.; Camps, P.; Munoz-Torrero, D.; Perez, B.; Clos, M. V.; Badia, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">129-140</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Different studies have established that cholinergic neurodegeneration could be a major pathol. feature of Alzheimer's disease (AD).  Thus, enhancement of the central cholinergic neurotransmission has been regarded as one of the most promising strategies for the symptomatic treatment of AD, mainly by means of reversible acetylcholinesterase inhibitors (AChEIs).  The cognitive-enhancing properties of both huprine X, a new AChEI, and the structurally related huperzine A, as well as their effects on the regulation of several neurochem. processes related to AD have been studied in triple transgenic mice (3xTg-AD).  Methods: Seven-month-old homozygous 3xTg-AD male mice, which received chronic i.p. treatment with either saline, huprine X (0.12 μmol·kg-1) or huperzine A (0.8 μmol·kg-1) were subjected to a battery of behavioral tests after 3 wk of treatment and thereafter the brains were dissected to study the neurochem. effects induced by the two AChEIs.  Results: Treatments with huprine X and huperzine A improved learning and memory in the Morris water maze and some indicators of emotionality without inducing important adverse effects.  Moreover, huprine X and huperzine A activate protein kinase C/mitogen-activated protein kinase pathway signalling, α-secretases (ADAM 10 and TACE) and increase the fraction of phospho-glycogen synthase kinase 3-β.  Conclusion: Results obtained herein using a sample of 3xTg-AD animals strongly suggest that the treatment with the two AChEIs not only improves the cognitive performance of the animals but also induces some neurochem. changes that could contribute to the beneficial effects obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4hYSxNmqNQLVg90H21EOLACvtfcHk0lh3z4EORwOq3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWitbg%253D&md5=9abfb99b4d64cfac36a38f10fcce5eb7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1159%2F000336427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000336427%26sid%3Dliteratum%253Aachs%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DGim%25C3%25A9nez-Llort%26aufirst%3DL.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBad%25C3%25ADa%26aufirst%3DA.%26aulast%3DHuprine%26aufirst%3DX.%26atitle%3Dand%2520huperzine%2520A%2520improve%2520cognition%2520and%2520regulate%2520some%2520neurochemical%2520processes%2520related%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520triple%2520transgenic%2520mice%2520%25283xTg-AD%2529%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2013%26volume%3D11%26spage%3D129%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New tacrine–4-oxo-4<i>H</i>-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine%E2%80%934-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+beta-amyloid-reducing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine%25E2%2580%25934-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520beta-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100329q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4927-4937&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=S.+Condeauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Novel+tacrine-8-hydroxyquinoline+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+neuroprotective%2C+cholinergic%2C+antioxidant%2C+and+copper-complexing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm100329q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100329q%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNovel%2520tacrine-8-hydroxyquinoline%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520neuroprotective%252C%2520cholinergic%252C%2520antioxidant%252C%2520and%2520copper-complexing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4927%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span> </span><span class="NLM_article-title">Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7249</span><span class="NLM_x">–</span> <span class="NLM_lpage">7257</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900628z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7249-7257&author=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=C.+P%C3%A9rezauthor=B.+L%C3%B3pezauthor=M.+Villarroyaauthor=M.+G.+L%C3%B3pezauthor=A.+G.+Garc%C3%ADaauthor=S.+Conde&title=Neuroprotective+and+cholinergic+properties+of+multifunctional+glutamic+acid+derivatives+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm900628z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900628z%26sid%3Dliteratum%253Aachs%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DL%25C3%25B3pez%26aufirst%3DB.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DConde%26aufirst%3DS.%26atitle%3DNeuroprotective%2520and%2520cholinergic%2520properties%2520of%2520multifunctional%2520glutamic%2520acid%2520derivatives%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7249%26epage%3D7257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández-Ledesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, B.</span><span> </span><span class="NLM_article-title">Novel tacrine–melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=B.+Hern%C3%A1ndez-Ledesmaauthor=B.+Bartolom%C3%A9&title=Novel+tacrine%E2%80%93melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DHern%25C3%25A1ndez-Ledesma%26aufirst%3DB.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DNovel%2520tacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Páez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">Tacrine–melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and neuroprotective properties</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=828-841&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=N.+E.+Campilloauthor=J.+A.+P%C3%A1ezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=A.+Mart%C3%ADnezauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Tacrine%E2%80%93melatonin+hybrids+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DTacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520neuroprotective%2520properties%26jtitle%3DChemMedChem.%26date%3D2009%26volume%3D4%26spage%3D828%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: A dual function lead for Alzheimer’s disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalliauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+Valentiauthor=M.+Recanatini&title=3-%284-%5B%5BBenzyl%28methyl%29amino%5Dmethyl%5Dphenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation%3A+A+dual+function+lead+for+Alzheimer%E2%80%99s+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3D3-%25284-%255B%255BBenzyl%2528methyl%2529amino%255Dmethyl%255Dphenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%253A%2520A%2520dual%2520function%2520lead%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4250</span><span class="NLM_x">–</span> <span class="NLM_lpage">4254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070100g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4250-4254&author=L.+Piazziauthor=A.+Cavalliauthor=F.+Bellutiauthor=A.+Bisiauthor=S.+Gobbiauthor=S.+Rizzoauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=M.+Recanatiniauthor=A.+Rampa&title=Extensive+SAR+and+computational+studies+of+3-%7B4-%5B%28benzylmethylamino%29methyl%5Dphenyl%7D-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070100g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070100g%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DExtensive%2520SAR%2520and%2520computational%2520studies%2520of%25203-%257B4-%255B%2528benzylmethylamino%2529methyl%255Dphenyl%257D-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4250%26epage%3D4254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1749</span><span class="NLM_x">–</span> <span class="NLM_lpage">1760</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1749-1760&author=S.+Rizzoauthor=M.+Bartoliniauthor=L.+Ceccariniauthor=L.+Piazziauthor=S.+Gobbiauthor=A.+Cavalliauthor=M.+Recanatiniauthor=V.+Andrisanoauthor=A.+Rampa&title=Targeting+Alzheimer%E2%80%99s+disease%3A+Novel+indanone+hybrids+bearing+a+pharmacophoric+fragment+of+AP2238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCeccarini%26aufirst%3DL.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DTargeting%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Novel%2520indanone%2520hybrids%2520bearing%2520a%2520pharmacophoric%2520fragment%2520of%2520AP2238%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D1749%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gilman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailie, J. C.</span><span> </span><span class="NLM_article-title">Relative reactivities of organometallic compounds. XVII. The azo linkage</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1937</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01224a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1937&pages=84-94&author=H.+Gilmanauthor=J.+C.+Bailie&title=Relative+reactivities+of+organometallic+compounds.+XVII.+The+azo+linkage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo01224a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01224a010%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DH.%26aulast%3DBailie%26aufirst%3DJ.%2BC.%26atitle%3DRelative%2520reactivities%2520of%2520organometallic%2520compounds.%2520XVII.%2520The%2520azo%2520linkage%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1937%26volume%3D2%26spage%3D84%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0ljxHunsSRuCLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Brunhofer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallarero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopi Mohan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, P.</span><span> </span><span class="NLM_article-title">Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6669</span><span class="NLM_x">–</span> <span class="NLM_lpage">6679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6669-6679&author=G.+Brunhoferauthor=A.+Fallareroauthor=D.+Karlssonauthor=A.+Batista-Gonzalezauthor=P.+Shindeauthor=C.+Gopi+Mohanauthor=P.+Vuorela&title=Exploration+of+natural+compounds+as+sources+of+new+bifunctional+scaffolds+targeting+cholinesterases+and+beta+amyloid+aggregation%3A+The+case+of+chelerythrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunhofer%26aufirst%3DG.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DD.%26aulast%3DBatista-Gonzalez%26aufirst%3DA.%26aulast%3DShinde%26aufirst%3DP.%26aulast%3DGopi%2BMohan%26aufirst%3DC.%26aulast%3DVuorela%26aufirst%3DP.%26atitle%3DExploration%2520of%2520natural%2520compounds%2520as%2520sources%2520of%2520new%2520bifunctional%2520scaffolds%2520targeting%2520cholinesterases%2520and%2520beta%2520amyloid%2520aggregation%253A%2520The%2520case%2520of%2520chelerythrine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6669%26epage%3D6679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-García, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramón, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: Synthesis, pharmacological evaluation and mechanistic studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=141-152&author=O.+Di+Pietroauthor=E.+Viaynaauthor=E.+Vicente-Garc%C3%ADaauthor=M.+Bartoliniauthor=R.+Ram%C3%B3nauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=V.+Andrisanoauthor=F.+J.+Luqueauthor=R.+Lavillaauthor=D.+Mu%C3%B1oz-Torrero&title=1%2C2%2C3%2C4-Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridines+as+a+new+family+of+potent+peripheral-to-midgorge-site+inhibitors+of+acetylcholinesterase%3A+Synthesis%2C+pharmacological+evaluation+and+mechanistic+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DVicente-Garc%25C3%25ADa%26aufirst%3DE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DRam%25C3%25B3n%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3D1%252C2%252C3%252C4-Tetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridines%2520as%2520a%2520new%2520family%2520of%2520potent%2520peripheral-to-midgorge-site%2520inhibitors%2520of%2520acetylcholinesterase%253A%2520Synthesis%252C%2520pharmacological%2520evaluation%2520and%2520mechanistic%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D73%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappi, S.</span><span> </span><span class="NLM_article-title">Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1997</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00680a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1989-1997&author=P.+Taylorauthor=S.+Lappi&title=Interaction+of+fluorescence+probes+with+acetylcholinesterase.+The+site+and+specificity+of+propidium+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi00680a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00680a029%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLappi%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520fluorescence%2520probes%2520with%2520acetylcholinesterase.%2520The%2520site%2520and%2520specificity%2520of%2520propidium%2520binding%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D1989%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0ljxHunsSRuCLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Dávalos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Cordovés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, B.</span><span> </span><span class="NLM_article-title">Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&author=A.+D%C3%A1valosauthor=C.+G%C3%B3mez-Cordov%C3%A9sauthor=B.+Bartolom%C3%A9&title=Extending+applicability+of+the+oxygen+radical+absorbance+capacity+%28ORAC-fluorescein%29+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A1valos%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Cordov%25C3%25A9s%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DExtending%2520applicability%2520of%2520the%2520oxygen%2520radical%2520absorbance%2520capacity%2520%2528ORAC-fluorescein%2529%2520assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26spage%3D48%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sofic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimpapa, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundurovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapcanin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustembegovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G.</span><span> </span><span class="NLM_article-title">Antioxidant capacity of the neurohormone melatonin</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2005&pages=349-358&author=E.+Soficauthor=Z.+Rimpapaauthor=Z.+Kundurovicauthor=A.+Sapcaninauthor=I.+Tahirovicauthor=A.+Rustembegovicauthor=G.+Cao&title=Antioxidant+capacity+of+the+neurohormone+melatonin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSofic%26aufirst%3DE.%26aulast%3DRimpapa%26aufirst%3DZ.%26aulast%3DKundurovic%26aufirst%3DZ.%26aulast%3DSapcanin%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DI.%26aulast%3DRustembegovic%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DG.%26atitle%3DAntioxidant%2520capacity%2520of%2520the%2520neurohormone%2520melatonin%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2005%26volume%3D112%26spage%3D349%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span> </span><span class="NLM_article-title">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1111%2Fj.1471-4159.2007.04665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=17540012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1842-1852&author=J.+Egeaauthor=A.+O.+Rosaauthor=A.+Cuadradoauthor=A.+G.+Garc%C3%ADaauthor=M.+G.+L%C3%B3pez&title=Nicotinic+receptor+activation+by+epibatidine+induces+heme+oxygenase-1+and+protects+chromaffin+cells+against+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span></div><div class="casAuthors">Egea, Javier; Rosa, Angelo O.; Cuadrado, Antonio; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1842-1852</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Activation of neuronal nicotinic acetylcholine receptors (nAChR) provides neuroprotection against different toxic stimuli that often lead to overprodn. of reactive oxygen species (ROS) and cell death.  ROS prodn. has been related with disease progression in several neurodegenerative pathologies such as Alzheimer's or Parkinson's diseases.  In this context, we investigated here if the exposure of bovine chromaffin cells to the potent nAChR agonist epibatidine protected against rotenone (30 μmol/L) plus oligomycin (10 μmol/L) (rot/oligo) toxicity, an in vitro model of mitochondrial ROS prodn.  Epibatidine induced a concn.- and time-dependent protection, which was maximal at 3 μmol/L after 24 h.  Pre-incubation with dantrolene (100 μmol/L) (a blocker of the ryanodine receptor channel), chelerythrine (1 μmol/L) (a protein kinase C inhibitor), or PD98059 (50 μmol/L) (a MEK inhibitor), aborted epibatidine-elicited cytoprotection.  Mitochondrial depolarization, ROS, and caspase 3 active produced by rot/oligo were also prevented by epibatidine.  Epibatidine doubled the amt. of heme oxygenase-1 (HO-1), a crit. cell defense enzyme against oxidative stress.  Furthermore, the HO-1 inhibitor Sn(IV) protoporphyrin IX dichloride reversed the epibatidine protecting effects and HO-1 inducer Co (III) protoporphyrin IX dichloride exhibited neuroprotective effects by itself.  The results of this study point to HO-1 as the cytoprotective target of nAChR activation through the following pathway: endoplasmic reticulum Ca2+-induced Ca2+-release activates the protein kinase C/extracellular regulated kinase/HO-1 axis to mitigate mitochondrial depolarization and ROS prodn.  This study provides a mechanistic insight on how nAChR activation translates into an antioxidant and antiapoptotic signal through up-regulation of HO-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3XG5b3a4IOLVg90H21EOLACvtfcHk0ljQHlSKIMhLVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF&md5=689683073dac18206961fec581367cd9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04665.x%26sid%3Dliteratum%253Aachs%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DA.%2BO.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26atitle%3DNicotinic%2520receptor%2520activation%2520by%2520epibatidine%2520induces%2520heme%2520oxygenase-1%2520and%2520protects%2520chromaffin%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D102%26spage%3D1842%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Maroto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Fuente, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artalejo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Sancho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span> </span><span class="NLM_article-title">Effects of Ca<sup>2+</sup> channel antagonists on chromaffin cell death and cytosolic Ca<sup>2+</sup> oscillations induced by veratridine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=7805782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaK2cXlsVyqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1994&pages=331-339&author=R.+Marotoauthor=M.+T.+De+la+Fuenteauthor=A.+R.+Artalejoauthor=F.+Abadauthor=M.+G.+L%C3%B3pezauthor=J.+Garc%C3%ADa-Sanchoauthor=A.+G.+Garc%C3%ADa&title=Effects+of+Ca2%2B+channel+antagonists+on+chromaffin+cell+death+and+cytosolic+Ca2%2B+oscillations+induced+by+veratridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine</span></div><div class="casAuthors">Maroto, Rosario; Fuente, Maria-Teresa De la; Artalejo, Antonio R.; Abad, Francisco; Lopez, Manuela G.; Garcia-Sancho, Javier; Garcia, Antonio G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Environmental Toxicology and Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">331-9</span>CODEN:
                <span class="NLM_cas:coden">EPEPEG</span>;
        ISSN:<span class="NLM_cas:issn">0926-6917</span>.
    </div><div class="casAbstract">Exposure of bovine chromaffin cells to 30 μM veratridine for 24 h led to 70-80% cell death as reflected by phase contrast microscopy, trypan blue exclusion, lactate dehydrogenase (LDH) release and cell catecholamine contents.  Na+ deprivation, Ca2+ deletion or tetrodotoxin (5 μM) prevented the veratridine-induced cell damage.  Nimodipine and verapamil, but not ω-conotoxin GVIA afforded 20-30% protection.  Flunarizine protected the cells by 80% and R56865 by 60%.  Stimulation of fura-2-loaded single bovine chromaffin cells with 30 μM of 1,1-dimethyl-4-phenylpiperazinium (DMPP) or 59 mM K+ caused fast increases in cytosolic Ca2+ concns., ([Ca2+]i).  The [Ca2+]i rose from 0.1 to peaks of 1.9 μM, which quickly declined to near basal levels with a t1/2 of around 30 s.  In spite of sustained stimulation with these two depolarizing agents, the [Ca2+]i remained low and did not undergo oscillations.  In contrast, veratridine (30 μM) caused large and frequent oscillatory changes in the [Ca2+]i which were long-lasting and did not disappear even 30 min after washing out the toxin.  The [Ca2+]i oscillations were reversibly suppressed by Na+ or Ca2+ removal and by 5 μM tetrodotoxin.  Selective L-type Ca2+ channel blockers (10 μM nimodipine or verapamil) or N-type Ca2+ channel blockers (1 μM ω-conotoxin GVIA) did not affect the [Ca2+]i oscillations.  In contrast, flunarizine or R56865 (10 μM each) suppressed the oscillations of [Ca2+]i.  The results demonstrate that bovine chromaffin cells have the necessary machinery to develop prolonged and repetitive [Ca2+]i oscillations in the presence of veratridine; however, 'physiol.' depolarizing stimuli did not cause oscillations.  These non-inactivating [Ca2+]i oscillations may induce Ca2+ overload, thus explaining the well known cytotoxic effects of veratridine in neuronal and chromaffin cell cultures.  Drugs such as flunarizine and the novel cytoprotective agent R56865, which prevent such oscillations, avoid Ca2+ overload and cell damage.  The results also suggest that external Ca2+ entry through N- or L-type Ca2+ channels can equally be assocd. with the veratridine-evoked cell damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCytoybk0wArVg90H21EOLACvtfcHk0ljQHlSKIMhLVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsVyqsbY%253D&md5=210984ed13f3a5a92451bfa4c59c9ca2</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaroto%26aufirst%3DR.%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DM.%2BT.%26aulast%3DArtalejo%26aufirst%3DA.%2BR.%26aulast%3DAbad%26aufirst%3DF.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DGarc%25C3%25ADa-Sancho%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26atitle%3DEffects%2520of%2520Ca2%252B%2520channel%2520antagonists%2520on%2520chromaffin%2520cell%2520death%2520and%2520cytosolic%2520Ca2%252B%2520oscillations%2520induced%2520by%2520veratridine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D270%26spage%3D331%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ferrón, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu-Agullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marqués-Torrejón, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinas, I.</span><span> </span><span class="NLM_article-title">A combined ex/in vivo assay to detect effects of exogenously added factors in neural stem cells</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=849-859&author=S.+R.+Ferr%C3%B3nauthor=C.+Andreu-Agulloauthor=H.+Miraauthor=P.+S%C3%A1nchezauthor=M.+A.+Marqu%C3%A9s-Torrej%C3%B3nauthor=I.+Farinas&title=A+combined+ex%2Fin+vivo+assay+to+detect+effects+of+exogenously+added+factors+in+neural+stem+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25B3n%26aufirst%3DS.%2BR.%26aulast%3DAndreu-Agullo%26aufirst%3DC.%26aulast%3DMira%26aufirst%3DH.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DP.%26aulast%3DMarqu%25C3%25A9s-Torrej%25C3%25B3n%26aufirst%3DM.%2BA.%26aulast%3DFarinas%26aufirst%3DI.%26atitle%3DA%2520combined%2520ex%252Fin%2520vivo%2520assay%2520to%2520detect%2520effects%2520of%2520exogenously%2520added%2520factors%2520in%2520neural%2520stem%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D849%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Morales-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luna-Medina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfaro-Cervello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Canteli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Verdugo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, A.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=293-307&author=J.+A.+Morales-Garc%C3%ADaauthor=R.+Luna-Medinaauthor=C.+Alfaro-Cervelloauthor=M.+Cortes-Canteliauthor=A.+Santosauthor=J.+M.+Garc%C3%ADa-Verdugoauthor=A.+P%C3%A9rez-Castillo&title=Peroxisome+proliferator-activated+receptor+gamma+ligands+regulate+neural+stem+cell+proliferation+and+differentiation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DLuna-Medina%26aufirst%3DR.%26aulast%3DAlfaro-Cervello%26aufirst%3DC.%26aulast%3DCortes-Canteli%26aufirst%3DM.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DGarc%25C3%25ADa-Verdugo%26aufirst%3DJ.%2BM.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma%2520ligands%2520regulate%2520neural%2520stem%2520cell%2520proliferation%2520and%2520differentiation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DGlia%26date%3D2011%26volume%3D59%26spage%3D293%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Morales-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luna-Medina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso-Gil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Sancristóbal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300110c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=963-971&author=J.+A.+Morales-Garc%C3%ADaauthor=R.+Luna-Medinaauthor=S.+Alonso-Gilauthor=M.+Sanz-Sancrist%C3%B3balauthor=V.+Palomoauthor=C.+Gilauthor=A.+Santosauthor=A.+Mart%C3%ADnezauthor=A.+P%C3%A9rez-Castillo&title=Glycogen+synthase+kinase+3+inhibition+promotes+adult+hippocampal+neurogenesis+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo</span></div><div class="casAuthors">Morales-Garcia, Jose A.; Luna-Medina, Rosario; Alonso-Gil, Sandra; Sanz-SanCristobal, Marina; Palomo, Valle; Gil, Carmen; Santos, Angel; Martinez, Ana; Perez-Castillo, Ana</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">963-971</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase originally identified as a regulator of glycogen metab. but it also plays a pivotal role in numerous cellular functions, including differentiation, cell cycle regulation, and proliferation.  The dentate gyrus of the hippocampus, together with the subventricular zone of the lateral ventricles, is one of the regions in which neurogenesis takes place in the adult brain.  Here, using a chem. genetic approach that involves the use of several diverse inhibitors of GSK-3 as pharmacol. tools, we show that inhibition of GSK-3 induces proliferation, migration, and differentiation of neural stem cells toward a neuronal phenotype in in vitro studies.  Also, we demonstrate that inhibition of GSK-3 with the small mol. NP03112, called tideglusib, induces neurogenesis in the dentate gyrus of the hippocampus of adult rats.  Taken together, our results suggest that GSK-3 should be considered as a new target mol. for modulating the prodn. and integration of new neurons in the hippocampus as a treatment for neurodegenerative diseases or brain injury and, consequently, its inhibitors may represent new potential therapeutic drugs in neuroregenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZkY2VITeIN7Vg90H21EOLACvtfcHk0lh0SmHKl1yCVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLbM&md5=8ec3f8126b23b3a635ace8a11b0911b0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcn300110c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300110c%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DLuna-Medina%26aufirst%3DR.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DSanz-Sancrist%25C3%25B3bal%26aufirst%3DM.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520inhibition%2520promotes%2520adult%2520hippocampal%2520neurogenesis%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D963%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampsch-Woodill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, R. L.</span><span> </span><span class="NLM_article-title">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4619</span><span class="NLM_x">–</span> <span class="NLM_lpage">4626</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+validation+of+an+improved+oxygen+radical+absorbance+capacity+assay+using+fluorescein+as+the+fluorescent+probe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0lh0SmHKl1yCVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520an%2520improved%2520oxygen%2520radical%2520absorbance%2520capacity%2520assay%2520using%2520fluorescein%2520as%2520the%2520fluorescent%2520probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26spage%3D4619%26epage%3D4626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+colorimetric+assay+for+cell+growth+and+survival.+Modifications+to+the+tetrazolium+dye+procedure+giving+improved+sensitivity+and+reliability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2eZ0l26kZ0xl9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cell%2520growth%2520and%2520survival.%2520Modifications%2520to%2520the%2520tetrazolium%2520dye%2520procedure%2520giving%2520improved%2520sensitivity%2520and%2520reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 63 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Dushyant
V. Patel, Nirav R. Patel, Ashish M. Kanhed, Sagar P. Patel, Anshuman Sinha, Deep D. Kansara, Annie R. Mecwan, Sarvangee B. Patel, Pragnesh N. Upadhyay, Kishan B. Patel, Dharti B. Shah, Navnit K. Prajapati, Prashant R. Murumkar, Kirti V. Patel, <span class="NLM_string-name hlFld-ContribAuthor">Mange Ram Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 3635-3661. <a href="https://doi.org/10.1021/acschemneuro.9b00226" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00226%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMultitarget%252BDirected%252BTriazinoindole%252BDerivatives%252Bas%252BAnti-Alzheimer%252BAgents%26aulast%3DPatel%26aufirst%3DDushyant%2BV.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13042019%26date%3D16072019%26date%3D29072019%26date%3D16072019%26volume%3D10%26issue%3D8%26spage%3D3635%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Jinhui Hu, Xiaoping Yang, Xing Feng, Xingshu Li, Ling Huang, <span class="NLM_string-name hlFld-ContribAuthor">Albert S. C. Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1871-1894. <a href="https://doi.org/10.1021/acs.jmedchem.7b01417" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BOrally%252BBioavailable%252BQuinoline%2525E2%252580%252593Indole%252BDerivatives%252Bas%252BInnovative%252BMultitarget-Directed%252BLigands%25253A%252BPromotion%252Bof%252BCell%252BProliferation%252Bin%252Bthe%252BAdult%252BMurine%252BHippocampus%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D23092017%26date%3D15022018%26date%3D08022018%26volume%3D61%26issue%3D5%26spage%3D1871%26epage%3D1894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiren  Wang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Wenrui  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, and <span class="hlFld-ContribAuthor ">Xingshu  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8616-8637. <a href="https://doi.org/10.1021/acs.jmedchem.5b01222" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01222%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BOrally%252BAvailable%252BClioquinol-Moracin%252BM%252BHybrids%252Bas%252BMultitarget-Directed%252BLigands%252Bfor%252BCognitive%252BImprovement%252Bin%252Ba%252BRat%252BModel%252Bof%252BNeurodegeneration%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D02082015%26date%3D27102015%26date%3D12112015%26date%3D16102015%26volume%3D58%26issue%3D21%26spage%3D8616%26epage%3D8637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario  de la Fuente Revenga</span>, <span class="hlFld-ContribAuthor ">Nerea  Fernández-Sáez</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Sandra  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Daniel-Henri  Caignard</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, and <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (12)
                                     , 4998-5014. <a href="https://doi.org/10.1021/acs.jmedchem.5b00245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00245%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BN-Acetyl%252BBioisosteres%252Bof%252BMelatonin%25253A%252BMelatonergic%252BReceptor%252BPharmacology%25252C%252BPhysicochemical%252BStudies%25252C%252Band%252BPhenotypic%252BAssessment%252Bof%252BTheir%252BNeurogenic%252BPotential%26aulast%3Dde%2Bla%2BFuente%2BRevenga%26aufirst%3DMario%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11022015%26date%3D10062015%26date%3D25062015%26date%3D29052015%26volume%3D58%26issue%3D12%26spage%3D4998%26epage%3D5014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario  de la Fuente Revenga</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Sandra  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Daniel-Henri  Caignard</span>, <span class="hlFld-ContribAuthor ">Matilde  Yáñez</span>, <span class="hlFld-ContribAuthor ">Ana M.  Gamo</span>, and <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin–Pinoline Hybrids. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 800-810. <a href="https://doi.org/10.1021/acschemneuro.5b00041" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00041%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNeurogenic%252BPotential%252BAssessment%252Band%252BPharmacological%252BCharacterization%252Bof%252B6-Methoxy-1%25252C2%25252C3%25252C4-tetrahydro-%2525CE%2525B2-carboline%252B%252528Pinoline%252529%252Band%252BMelatonin%2525E2%252580%252593Pinoline%252BHybrids%26aulast%3Dde%2Bla%2BFuente%2BRevenga%26aufirst%3DMario%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29012015%26date%3D24032015%26date%3D09042015%26date%3D20052015%26date%3D27032015%26volume%3D6%26issue%3D5%26spage%3D800%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Izaskun  Buendia</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Esther  Parada</span>, <span class="hlFld-ContribAuthor ">Elisa  Navarro</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, and <span class="hlFld-ContribAuthor ">Manuela G.  López</span>  . </span><span class="cited-content_cbyCitation_article-title">The Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrid ITH91/IQM157 Affords Neuroprotection in an in Vitro Alzheimer’s Model via Hemo-oxygenase-1 Induction. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (2)
                                     , 288-296. <a href="https://doi.org/10.1021/cn5002073" title="DOI URL">https://doi.org/10.1021/cn5002073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn5002073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn5002073%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DThe%252BMelatonin%2525E2%252580%252593N%25252CN-Dibenzyl%252528N-methyl%252529amine%252BHybrid%252BITH91%25252FIQM157%252BAffords%252BNeuroprotection%252Bin%252Ban%252Bin%252BVitro%252BAlzheimer%2525E2%252580%252599s%252BModel%252Bvia%252BHemo-oxygenase-1%252BInduction%26aulast%3DBuendia%26aufirst%3DIzaskun%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08092014%26date%3D13112014%26date%3D25112014%26date%3D18022015%26date%3D13112014%26volume%3D6%26issue%3D2%26spage%3D288%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar M.  Bautista-Aguilera</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Slavica  Filipic</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Lucía  de Andrés</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Francesco  Ortuso</span>, <span class="hlFld-ContribAuthor ">Matilde  Yañez</span>, and <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>  . </span><span class="cited-content_cbyCitation_article-title">N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (24)
                                     , 10455-10463. <a href="https://doi.org/10.1021/jm501501a" title="DOI URL">https://doi.org/10.1021/jm501501a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501501a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501501a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Methyl-N-%252528%2525281-methyl-5-%2525283-%2525281-%2525282-methylbenzyl%252529piperidin-4-yl%252529propoxy%252529-1H-indol-2-yl%252529methyl%252529prop-2-yn-1-amine%25252C%252Ba%252BNew%252BCholinesterase%252Band%252BMonoamine%252BOxidase%252BDual%252BInhibitor%26aulast%3DBautista-Aguilera%26aufirst%3DOscar%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18092014%26date%3D08122014%26date%3D26122014%26date%3D24112014%26volume%3D57%26issue%3D24%26spage%3D10455%26epage%3D10463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Cheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Ying-Fan  Liang</span>, <span class="hlFld-ContribAuthor ">Yi  Huang</span>, <span class="hlFld-ContribAuthor ">Gui-Xiang  Yang</span>, <span class="hlFld-ContribAuthor ">Lu-Lu  Zheng</span>, <span class="hlFld-ContribAuthor ">Jia-Min  Sun</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Fu-Li  Zhu</span>, <span class="hlFld-ContribAuthor ">He-Wen  Qian</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113426. <a href="https://doi.org/10.1016/j.ejmech.2021.113426" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113426%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bdiosgenin-indole%252Bderivatives%252Bas%252Bdual-functional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhou%26aufirst%3DLi-Cheng%26date%3D2021%26volume%3D219%26spage%3D113426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Lu</span>, <span class="hlFld-ContribAuthor ">Yijun  Liu</span>, <span class="hlFld-ContribAuthor ">Nan  Qin</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Yuting  Qiao</span>, <span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">You  Zhou</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and activity of miconazole derivatives as dual BChE/IDO1 inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (13)
                                     , 1105-1125. <a href="https://doi.org/10.4155/fmc-2021-0039" title="DOI URL">https://doi.org/10.4155/fmc-2021-0039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2021-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2021-0039%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bactivity%252Bof%252Bmiconazole%252Bderivatives%252Bas%252Bdual%252BBChE%25252FIDO1%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLu%26aufirst%3DXin%26date%3D2021%26volume%3D13%26issue%3D13%26spage%3D1105%26epage%3D1125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarfaraz  Shaikh</span>, <span class="hlFld-ContribAuthor ">Ganesh  Pavale</span>, <span class="hlFld-ContribAuthor ">Pratik  Dhavan</span>, <span class="hlFld-ContribAuthor ">Pinky  Singh</span>, <span class="hlFld-ContribAuthor ">Jasmin  Uparkar</span>, <span class="hlFld-ContribAuthor ">S.P.  Vaidya</span>, <span class="hlFld-ContribAuthor ">B.L.  Jadhav</span>, <span class="hlFld-ContribAuthor ">M.M.V.  Ramana</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of dihydropyranoindole derivatives as potential cholinesterase inhibitors against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104770. <a href="https://doi.org/10.1016/j.bioorg.2021.104770" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104770%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bdihydropyranoindole%252Bderivatives%252Bas%252Bpotential%252Bcholinesterase%252Binhibitors%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DShaikh%26aufirst%3DSarfaraz%26date%3D2021%26volume%3D110%26spage%3D104770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashish M.  Kanhed</span>, <span class="hlFld-ContribAuthor ">Dushyant V.  Patel</span>, <span class="hlFld-ContribAuthor ">Nirav R.  Patel</span>, <span class="hlFld-ContribAuthor ">Anshuman  Sinha</span>, <span class="hlFld-ContribAuthor ">Priyanka S.  Thakor</span>, <span class="hlFld-ContribAuthor ">Kishan B.  Patel</span>, <span class="hlFld-ContribAuthor ">Navnit K.  Prajapati</span>, <span class="hlFld-ContribAuthor ">Kirti V.  Patel</span>, <span class="hlFld-ContribAuthor ">Mange Ram  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>41 </em>, 1-18. <a href="https://doi.org/10.1080/07391102.2020.1840441" title="DOI URL">https://doi.org/10.1080/07391102.2020.1840441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1840441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1840441%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIndoloquinoxaline%252Bderivatives%252Bas%252Bpromising%252Bmulti-functional%252Banti-Alzheimer%252Bagents%26aulast%3DKanhed%26aufirst%3DAshish%2BM.%26date%3D2020%26date%3D2020%26volume%3D41%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada-Valencia</span>, <span class="hlFld-ContribAuthor ">Olaia  Martí-Marí</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Mario  de la Fuente Revenga</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Villalba-Galea</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112403. <a href="https://doi.org/10.1016/j.ejmech.2020.112403" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112403%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptical%252Bcontrol%252Bof%252Bmuscular%252Bnicotinic%252Bchannels%252Bwith%252Bazocuroniums%25252C%252Bphotoswitchable%252Bazobenzenes%252Bbearing%252Btwo%252BN-methyl-N-carbocyclic%252Bquaternary%252Bammonium%252Bgroups%26aulast%3DHerrera-Arozamena%26aufirst%3DClara%26date%3D2020%26volume%3D200%26spage%3D112403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suresh K.  Bowroju</span>, <span class="hlFld-ContribAuthor ">Nirjal  Mainali</span>, <span class="hlFld-ContribAuthor ">Srinivas  Ayyadevara</span>, <span class="hlFld-ContribAuthor ">Narsimha R.  Penthala</span>, <span class="hlFld-ContribAuthor ">Sesha  Krishnamachari</span>, <span class="hlFld-ContribAuthor ">Samuel  Kakraba</span>, <span class="hlFld-ContribAuthor ">Robert J. Shmookler  Reis</span>, <span class="hlFld-ContribAuthor ">Peter A.  Crooks</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ Aggregation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3610. <a href="https://doi.org/10.3390/molecules25163610" title="DOI URL">https://doi.org/10.3390/molecules25163610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163610%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BHybrid%252B8-Hydroxy%252BQuinoline-Indole%252BDerivatives%252Bas%252BInhibitors%252Bof%252BA%2525CE%2525B2%252BSelf-Aggregation%252Band%252BMetal%252BChelation-Induced%252BA%2525CE%2525B2%252BAggregation%26aulast%3DBowroju%26aufirst%3DSuresh%2BK.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Albertini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Salerno</span>, <span class="hlFld-ContribAuthor ">Pedro  Sena Murteira Pinheiro</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.1002/med.21699" title="DOI URL">https://doi.org/10.1002/med.21699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21699%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DFrom%252Bcombinations%252Bto%252Bmultitarget%2525E2%252580%252590directed%252Bligands%25253A%252BA%252Bcontinuum%252Bin%252BAlzheimer%252527s%252Bdisease%252Bpolypharmacology%26aulast%3DAlbertini%26aufirst%3DClaudia%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia P. Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Caio Miranda  Damasio</span>, <span class="hlFld-ContribAuthor ">Mayara Chagas  Rosa</span>, <span class="hlFld-ContribAuthor ">Thâmara Gaspar  Campos</span>, <span class="hlFld-ContribAuthor ">Dyecika Souza  Couto</span>, <span class="hlFld-ContribAuthor ">Kris Simone  Tranches Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Neuropharmacology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (5)
                                     , 348-407. <a href="https://doi.org/10.2174/1385272823666191021124443" title="DOI URL">https://doi.org/10.2174/1385272823666191021124443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666191021124443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666191021124443%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neuropharmacology%26atitle%3DMolecular%252BHybridization%252Bas%252Ba%252BTool%252Bin%252Bthe%252BDesign%252Bof%252BMulti-target%252BDirected%252BDrug%252BCandidates%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DGontijo%26aufirst%3DVanessa%2BSilva%26date%3D2020%26volume%3D18%26issue%3D5%26spage%3D348%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarida  Espadinha</span>, <span class="hlFld-ContribAuthor ">Lucía  Viejo</span>, <span class="hlFld-ContribAuthor ">Ricardo M.R.M.  Lopes</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Elies  Molins</span>, <span class="hlFld-ContribAuthor ">Daniel J.V.A.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Lídia  Gonçalves</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Cristóbal de los  Ríos</span>, <span class="hlFld-ContribAuthor ">Maria M.M.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>194 </em>, 112242. <a href="https://doi.org/10.1016/j.ejmech.2020.112242" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112242%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Btetracyclic%252Blactams%252Bas%252BNMDA%252Breceptor%252Bantagonists%252Bwith%252Bpotential%252Bapplication%252Bin%252Bneurological%252Bdisorders%26aulast%3DEspadinha%26aufirst%3DMargarida%26date%3D2020%26volume%3D194%26spage%3D112242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziyi  Yang</span>, <span class="hlFld-ContribAuthor ">Qing  Song</span>, <span class="hlFld-ContribAuthor ">Zhongcheng  Cao</span>, <span class="hlFld-ContribAuthor ">Guangjun  Yu</span>, <span class="hlFld-ContribAuthor ">Zhuoling  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenghuai  Tan</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of flurbiprofen-clioquinol hybrids as multitarget-directed ligands against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (7)
                                     , 115374. <a href="https://doi.org/10.1016/j.bmc.2020.115374" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115374%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bflurbiprofen-clioquinol%252Bhybrids%252Bas%252Bmultitarget-directed%252Bligands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DYang%26aufirst%3DZiyi%26date%3D2020%26volume%3D28%26issue%3D7%26spage%3D115374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada-Valencia</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Laura  Lagartera</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Juan Felipe  Franco-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Patrycja  Michalska</span>, <span class="hlFld-ContribAuthor ">Pablo  Duarte</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Alberto  Mills</span>, <span class="hlFld-ContribAuthor ">Federico  Gago</span>, <span class="hlFld-ContribAuthor ">Ángel Juan  García-Yagüe</span>, <span class="hlFld-ContribAuthor ">Raquel  Fernández-Ginés</span>, <span class="hlFld-ContribAuthor ">Antonio  Cuadrado</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112090. <a href="https://doi.org/10.1016/j.ejmech.2020.112090" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112090%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTuning%252Bmelatonin%252Breceptor%252Bsubtype%252Bselectivity%252Bin%252Boxadiazolone-based%252Banalogues%25253A%252BDiscovery%252Bof%252BQR2%252Bligands%252Band%252BNRF2%252Bactivators%252Bwith%252Bneurogenic%252Bproperties%26aulast%3DHerrera-Arozamena%26aufirst%3DClara%26date%3D2020%26volume%3D190%26spage%3D112090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveen P.N.  Rao</span>, <span class="hlFld-ContribAuthor ">Amy Trinh  Pham</span>, <span class="hlFld-ContribAuthor ">Arash  Shakeri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecules for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 289-322. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00011-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00011-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00011-X%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRao%26aufirst%3DPraveen%2BP.N.%26date%3D2020%26spage%3D289%26epage%3D322%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020%26volume%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shravankumar  Kankala</span>, <span class="hlFld-ContribAuthor ">Ravinder  Vadde</span>. </span><span class="cited-content_cbyCitation_article-title">Gold mediated sp
              3
              αC-H functionalization of steroidal diglycoside and their anti-cancer evaluation. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Research</span><span> <strong>2019,</strong> <em>134 </em>, 1-8. <a href="https://doi.org/10.1080/14786419.2019.1696789" title="DOI URL">https://doi.org/10.1080/14786419.2019.1696789</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14786419.2019.1696789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14786419.2019.1696789%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Research%26atitle%3DGold%252Bmediated%252Bsp%252B3%252B%2525CE%2525B1C-H%252Bfunctionalization%252Bof%252Bsteroidal%252Bdiglycoside%252Band%252Btheir%252Banti-cancer%252Bevaluation%26aulast%3DKankala%26aufirst%3DShravankumar%26date%3D2019%26date%3D2019%26volume%3D134%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Tanvir  Kabir</span>, <span class="hlFld-ContribAuthor ">Mohammad A.  Sufian</span>, <span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Mst. Marium  Begum</span>, <span class="hlFld-ContribAuthor ">Shammi  Akhter</span>, <span class="hlFld-ContribAuthor ">Ariful  Islam</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Md. Siddiqul  Islam</span>, <span class="hlFld-ContribAuthor ">Md. Shah  Amran</span>, <span class="hlFld-ContribAuthor ">Ghulam  Md. Ashraf</span>. </span><span class="cited-content_cbyCitation_article-title">NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (33)
                                     , 3506-3518. <a href="https://doi.org/10.2174/1381612825666191011102444" title="DOI URL">https://doi.org/10.2174/1381612825666191011102444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666191011102444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666191011102444%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DNMDA%252BReceptor%252BAntagonists%25253A%252BRepositioning%252Bof%252BMemantine%252Bas%252Ba%252BMultitargeting%252BAgent%252Bfor%252BAlzheimer%252527s%252BTherapy%26aulast%3DKabir%26aufirst%3DMd.%2BTanvir%26date%3D2019%26volume%3D25%26issue%3D33%26spage%3D3506%26epage%3D3518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Katarina  Chalupova</span>, <span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Lukas  Gorecki</span>, <span class="hlFld-ContribAuthor ">Lukas  Prchal</span>, <span class="hlFld-ContribAuthor ">David  Malinak</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Alzheimer Research</span><span> <strong>2019,</strong> <em>16 </em>
                                    (9)
                                     , 772-800. <a href="https://doi.org/10.2174/1567205016666190228122956" title="DOI URL">https://doi.org/10.2174/1567205016666190228122956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1567205016666190228122956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1567205016666190228122956%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Alzheimer%2520Research%26atitle%3DDonepezil%252BDerivatives%252BTargeting%252BAmyloid-%2525CE%2525B2%252BCascade%252Bin%252BAlzheimer%252527s%252BDisease%26aulast%3DMezeiova%26aufirst%3DEva%26date%3D2019%26volume%3D16%26issue%3D9%26spage%3D772%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj  Mishra</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Gautam  Panda</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (6)
                                     , 895-930. <a href="https://doi.org/10.1016/j.bmc.2019.01.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.01.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.01.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAnti-cholinesterase%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252B%2525281998%2525E2%252580%2525932018%252529%26aulast%3DMishra%26aufirst%3DPankaj%26date%3D2019%26volume%3D27%26issue%3D6%26spage%3D895%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitya  Beriwal</span>, <span class="hlFld-ContribAuthor ">Tashi  Namgyal</span>, <span class="hlFld-ContribAuthor ">Pema  Sangay</span>, <span class="hlFld-ContribAuthor ">Asmaa Monther  Al Quraan</span>. </span><span class="cited-content_cbyCitation_article-title">Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies. </span><span class="cited-content_cbyCitation_journal-name">Heliyon</span><span> <strong>2019,</strong> <em>5 </em>
                                    (1)
                                     , e01190. <a href="https://doi.org/10.1016/j.heliyon.2019.e01190" title="DOI URL">https://doi.org/10.1016/j.heliyon.2019.e01190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.heliyon.2019.e01190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.heliyon.2019.e01190%26sid%3Dliteratum%253Aachs%26jtitle%3DHeliyon%26atitle%3DRole%252Bof%252Bimmune-pineal%252Baxis%252Bin%252Bneurodegenerative%252Bdiseases%25252C%252Bunraveling%252Bnovel%252Bhybrid%252Bdark%252Bhormone%252Btherapies%26aulast%3DBeriwal%26aufirst%3DNitya%26date%3D2019%26volume%3D5%26issue%3D1%26spage%3De01190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martín  Estrada-Valencia</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Erik  Laurini</span>, <span class="hlFld-ContribAuthor ">Sabrina  Pricl</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">New flavonoid –
              N
              ,
              N
              -dibenzyl(
              N
              -methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 712-727. <a href="https://doi.org/10.1080/14756366.2019.1581184" title="DOI URL">https://doi.org/10.1080/14756366.2019.1581184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1581184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1581184%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bflavonoid%252B%2525E2%252580%252593%252BN%252B%25252C%252BN%252B-dibenzyl%252528%252BN%252B-methyl%252529amine%252Bhybrids%25253A%252BMulti-target-directed%252Bagents%252Bfor%252BAlzheimer%2525C2%2525B4s%252Bdisease%252Bendowed%252Bwith%252Bneurogenic%252Bproperties%26aulast%3DEstrada-Valencia%26aufirst%3DMart%25C3%25ADn%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D712%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martín  Estrada Valencia</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Lucía  de Andrés</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Matilde  Yáñez</span>, <span class="hlFld-ContribAuthor ">Erik  Laurini</span>, <span class="hlFld-ContribAuthor ">Sabrina  Pricl</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>156 </em>, 534-553. <a href="https://doi.org/10.1016/j.ejmech.2018.07.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.07.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.07.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNeurogenic%252Band%252Bneuroprotective%252Bdonepezil-flavonoid%252Bhybrids%252Bwith%252Bsigma-1%252Baffinity%252Band%252Binhibition%252Bof%252Bkey%252Benzymes%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DEstrada%2BValencia%26aufirst%3DMart%25C3%25ADn%26date%3D2018%26volume%3D156%26spage%3D534%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepti  Goyal</span>, <span class="hlFld-ContribAuthor ">Amandeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Bhupesh  Goyal</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (13)
                                     , 1275-1299. <a href="https://doi.org/10.1002/cmdc.201800156" title="DOI URL">https://doi.org/10.1002/cmdc.201800156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800156%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBenzofuran%252Band%252BIndole%25253A%252BPromising%252BScaffolds%252Bfor%252BDrug%252BDevelopment%252Bin%252BAlzheimer%252527s%252BDisease%26aulast%3DGoyal%26aufirst%3DDeepti%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D13%26spage%3D1275%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shalki  Choudhary</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Himanshu  Verma</span>, <span class="hlFld-ContribAuthor ">Harpreet  Singh</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Success stories of natural product-based hybrid molecules for multi-factorial diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 62-97. <a href="https://doi.org/10.1016/j.ejmech.2018.03.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSuccess%252Bstories%252Bof%252Bnatural%252Bproduct-based%252Bhybrid%252Bmolecules%252Bfor%252Bmulti-factorial%252Bdiseases%26aulast%3DChoudhary%26aufirst%3DShalki%26date%3D2018%26volume%3D151%26spage%3D62%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paloma T.  Birmann</span>, <span class="hlFld-ContribAuthor ">Fernanda S.S.  Sousa</span>, <span class="hlFld-ContribAuthor ">Daniela H.  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Micaela  Domingues</span>, <span class="hlFld-ContribAuthor ">Beatriz M.  Vieira</span>, <span class="hlFld-ContribAuthor ">Eder J.  Lenardão</span>, <span class="hlFld-ContribAuthor ">Lucielli  Savegnago</span>. </span><span class="cited-content_cbyCitation_article-title">3-(4-Chlorophenylselanyl)-1-methyl-1 H -indole, a new selenium compound elicits an antinociceptive and anti-inflammatory effect in mice. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2018,</strong> <em>827 </em>, 71-79. <a href="https://doi.org/10.1016/j.ejphar.2018.03.005" title="DOI URL">https://doi.org/10.1016/j.ejphar.2018.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2018.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2018.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3D3-%2525284-Chlorophenylselanyl%252529-1-methyl-1%252BH%252B-indole%25252C%252Ba%252Bnew%252Bselenium%252Bcompound%252Belicits%252Ban%252Bantinociceptive%252Band%252Banti-inflammatory%252Beffect%252Bin%252Bmice%26aulast%3DBirmann%26aufirst%3DPaloma%2BT.%26date%3D2018%26volume%3D827%26spage%3D71%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia Pereira Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Kris Simone Tranches  Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 255-351. <a href="https://doi.org/10.1007/7653_2018_2" title="DOI URL">https://doi.org/10.1007/7653_2018_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_2%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BMulti-target%252BDirected%252BLigands%252Bas%252Ba%252BModern%252BApproach%252Bfor%252Bthe%252BDevelopment%252Bof%252BInnovative%252BDrug%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DOrtiz%26aufirst%3DCindy%2BJuliet%2BCristancho%26date%3D2018%26date%3D2018%26spage%3D255%26epage%3D351%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Indoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 285-321. <a href="https://doi.org/10.1016/B978-0-08-102083-8.00008-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-102083-8.00008-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102083-8.00008-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102083-8.00008-X%26sid%3Dliteratum%253Aachs%26atitle%3DIndoles%26aulast%3DChadha%26aufirst%3DNavriti%26date%3D2018%26spage%3D285%26epage%3D321%26pub%3DElsevier%26atitle%3DKey%252BHeterocycle%252BCores%252Bfor%252BDesigning%252BMultitargeting%252BMolecules%26date%3D2018%26volume%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco G.  Cirujano</span>, <span class="hlFld-ContribAuthor ">Elena  López-Maya</span>, <span class="hlFld-ContribAuthor ">Marleny  Rodríguez-Albelo</span>, <span class="hlFld-ContribAuthor ">Elisa  Barea</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Navarro</span>, <span class="hlFld-ContribAuthor ">Dirk E.  De Vos</span>. </span><span class="cited-content_cbyCitation_article-title">Selective One-Pot Two-Step C−C Bond Formation using Metal-Organic Frameworks with Mild Basicity as Heterogeneous Catalysts. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2017,</strong> <em>9 </em>
                                    (21)
                                     , 4019-4023. <a href="https://doi.org/10.1002/cctc.201700784" title="DOI URL">https://doi.org/10.1002/cctc.201700784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201700784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201700784%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DSelective%252BOne-Pot%252BTwo-Step%252BC%2525E2%252588%252592C%252BBond%252BFormation%252Busing%252BMetal-Organic%252BFrameworks%252Bwith%252BMild%252BBasicity%252Bas%252BHeterogeneous%252BCatalysts%26aulast%3DCirujano%26aufirst%3DFrancisco%2BG.%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D21%26spage%3D4019%26epage%3D4023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 68-83. <a href="https://doi.org/10.1016/j.ejmech.2017.07.077" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.077%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bcinnamamide-dibenzylamine%252Bhybrids%25253A%252BPotent%252Bneurogenic%252Bagents%252Bwith%252Bantioxidant%25252C%252Bcholinergic%25252C%252Band%252Bneuroprotective%252Bproperties%252Bas%252Binnovative%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DWang%26aufirst%3DJin%26date%3D2017%26volume%3D139%26spage%3D68%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Xingye  Li</span>, <span class="hlFld-ContribAuthor ">Matthew T.V.  Chan</span>, <span class="hlFld-ContribAuthor ">William Ka Kei  Wu</span>, <span class="hlFld-ContribAuthor ">DunXian  Tan</span>, <span class="hlFld-ContribAuthor ">Jianxiong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin antagonizes interleukin-18-mediated inhibition on neural stem cell proliferation and differentiation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 2163-2171. <a href="https://doi.org/10.1111/jcmm.13140" title="DOI URL">https://doi.org/10.1111/jcmm.13140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.13140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.13140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DMelatonin%252Bantagonizes%252Binterleukin-18-mediated%252Binhibition%252Bon%252Bneural%252Bstem%252Bcell%252Bproliferation%252Band%252Bdifferentiation%26aulast%3DLi%26aufirst%3DZheng%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D9%26spage%3D2163%26epage%3D2171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela M  Casaril</span>, <span class="hlFld-ContribAuthor ">Micaela  Domingues</span>, <span class="hlFld-ContribAuthor ">Mariana  Fronza</span>, <span class="hlFld-ContribAuthor ">Beatriz  Vieira</span>, <span class="hlFld-ContribAuthor ">Karine  Begnini</span>, <span class="hlFld-ContribAuthor ">Eder J  Lenardão</span>, <span class="hlFld-ContribAuthor ">Fabiana K  Seixas</span>, <span class="hlFld-ContribAuthor ">Tiago  Collares</span>, <span class="hlFld-ContribAuthor ">Cristina W  Nogueira</span>, <span class="hlFld-ContribAuthor ">Lucielli  Savegnago</span>. </span><span class="cited-content_cbyCitation_article-title">Antidepressant-like effect of a new selenium-containing compound is accompanied by a reduction of neuroinflammation and oxidative stress in lipopolysaccharide-challenged mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2017,</strong> <em>31 </em>
                                    (9)
                                     , 1263-1273. <a href="https://doi.org/10.1177/0269881117711713" title="DOI URL">https://doi.org/10.1177/0269881117711713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881117711713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881117711713%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DAntidepressant-like%252Beffect%252Bof%252Ba%252Bnew%252Bselenium-containing%252Bcompound%252Bis%252Baccompanied%252Bby%252Ba%252Breduction%252Bof%252Bneuroinflammation%252Band%252Boxidative%252Bstress%252Bin%252Blipopolysaccharide-challenged%252Bmice%26aulast%3DCasaril%26aufirst%3DAngela%2BM%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D9%26spage%3D1263%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehmet Emin  Onger</span>, <span class="hlFld-ContribAuthor ">Süleyman  Kaplan</span>, <span class="hlFld-ContribAuthor ">Stefano  Geuna</span>, <span class="hlFld-ContribAuthor ">Aysin Pinar  Türkmen</span>, <span class="hlFld-ContribAuthor ">Luisa  Muratori</span>, <span class="hlFld-ContribAuthor ">Gamze  Altun</span>, <span class="hlFld-ContribAuthor ">Berrin Zuhal  Altunkaynak</span>. </span><span class="cited-content_cbyCitation_article-title">Possible effects of some agents on the injured nerve in obese rats: A stereological and electron microscopic study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cranio-Maxillofacial Surgery</span><span> <strong>2017,</strong> <em>45 </em>
                                    (8)
                                     , 1258-1267. <a href="https://doi.org/10.1016/j.jcms.2017.05.004" title="DOI URL">https://doi.org/10.1016/j.jcms.2017.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcms.2017.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcms.2017.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cranio-Maxillofacial%2520Surgery%26atitle%3DPossible%252Beffects%252Bof%252Bsome%252Bagents%252Bon%252Bthe%252Binjured%252Bnerve%252Bin%252Bobese%252Brats%25253A%252BA%2525C2%2525A0stereological%252Band%252Belectron%252Bmicroscopic%252Bstudy%26aulast%3DOnger%26aufirst%3DMehmet%2BEmin%26date%3D2017%26volume%3D45%26issue%3D8%26spage%3D1258%26epage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">A critical overview of therapeutic strategy and advancement for Alzheimer's disease treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Taiwan Institute of Chemical Engineers</span><span> <strong>2017,</strong> <em>77 </em>, 92-105. <a href="https://doi.org/10.1016/j.jtice.2017.05.011" title="DOI URL">https://doi.org/10.1016/j.jtice.2017.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtice.2017.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtice.2017.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Taiwan%2520Institute%2520of%2520Chemical%2520Engineers%26atitle%3DA%252Bcritical%252Boverview%252Bof%252Btherapeutic%252Bstrategy%252Band%252Badvancement%252Bfor%252BAlzheimer%252527s%252Bdisease%252Btreatment%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2017%26volume%3D77%26spage%3D92%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     <a href="https://doi.org/10.4155/fmc-2017-0014" title="DOI URL">https://doi.org/10.4155/fmc-2017-0014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0014%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMelatonin%252Bas%252Ba%252Bversatile%252Bmolecule%252Bto%252Bdesign%252Bnovel%252Bmultitarget%252Bhybrids%252Bagainst%252Bneurodegeneration%26aulast%3DRamos%26aufirst%3DEva%26date%3D2017%26volume%3D9%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarida  Espadinha</span>, <span class="hlFld-ContribAuthor ">Jorge  Dourado</span>, <span class="hlFld-ContribAuthor ">Rocio  Lajarin-Cuesta</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Lidia M. D.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Cristobal  de los Rios</span>, <span class="hlFld-ContribAuthor ">Maria M. M.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Bicyclic Lactam Derivatives as NMDA Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (7)
                                     , 537-545. <a href="https://doi.org/10.1002/cmdc.201700037" title="DOI URL">https://doi.org/10.1002/cmdc.201700037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700037%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DOptimization%252Bof%252BBicyclic%252BLactam%252BDerivatives%252Bas%252BNMDA%252BReceptor%252BAntagonists%26aulast%3DEspadinha%26aufirst%3DMargarida%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D7%26spage%3D537%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leticia  Monjas</span>, <span class="hlFld-ContribAuthor ">Mariana P.  Arce</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymatic and solid-phase synthesis of new donepezil-based L- and d -glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 60-72. <a href="https://doi.org/10.1016/j.ejmech.2017.02.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnzymatic%252Band%252Bsolid-phase%252Bsynthesis%252Bof%252Bnew%252Bdonepezil-based%252BL-%252Band%252Bd%252B-glutamic%252Bacid%252Bderivatives%252Band%252Btheir%252Bpharmacological%252Bevaluation%252Bin%252Bmodels%252Brelated%252Bto%252BAlzheimer%252527s%252Bdisease%252Band%252Bcerebral%252Bischemia%26aulast%3DMonjas%26aufirst%3DLeticia%26date%3D2017%26volume%3D130%26spage%3D60%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">María do Carmo  Carreiras</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget-Directed Antioxidants as Therapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 5-46. <a href="https://doi.org/10.1016/B978-0-08-101011-2.00002-7" title="DOI URL">https://doi.org/10.1016/B978-0-08-101011-2.00002-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101011-2.00002-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101011-2.00002-7%26sid%3Dliteratum%253Aachs%26atitle%3DMultitarget-Directed%252BAntioxidants%252Bas%252BTherapeutic%252BAgents%26aulast%3DIsmaili%26aufirst%3DLhassane%26date%3D2017%26spage%3D5%26epage%3D46%26pub%3DElsevier%26atitle%3DDesign%252Bof%252BHybrid%252BMolecules%252Bfor%252BDrug%252BDevelopment%26date%3D2017%26volume%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 1459-1467. <a href="https://doi.org/10.1039/C7MD00199A" title="DOI URL">https://doi.org/10.1039/C7MD00199A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00199A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00199A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bmulti-functional%252Bhomoisoflavonoid%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Bmonoamine%252Boxidase%252BB%252Band%252Bcholinesterase%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLiu%26aufirst%3DQiao-Hong%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D7%26spage%3D1459%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (sup3)
                                     , 41-53. <a href="https://doi.org/10.1080/14756366.2016.1201814" title="DOI URL">https://doi.org/10.1080/14756366.2016.1201814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1201814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1201814%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bdonepezil-based%252Bagents%252Bas%252Bnew%252Bcholinesterase%25252Fmonoamine%252Boxidase%252Binhibitors%252Bfor%252Bthe%252Bpotential%252Bapplication%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLi%26aufirst%3DFan%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3Dsup3%26spage%3D41%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malose J.  Mphahlele</span>, <span class="hlFld-ContribAuthor ">Tshepiso J.  Makhafola</span>, <span class="hlFld-ContribAuthor ">Mmakwena M.  Mmonwa</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (19)
                                     , 4576-4586. <a href="https://doi.org/10.1016/j.bmc.2016.07.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.07.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.07.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bvitro%252Bcytotoxicity%252Bof%252Bnovel%252B2%25252C5%25252C7-tricarbo-substituted%252Bindoles%252Bderived%252Bfrom%252B2-amino-5-bromo-3-iodoacetophenone%26aulast%3DMphahlele%26aufirst%3DMalose%2BJ.%26date%3D2016%26volume%3D24%26issue%3D19%26spage%3D4576%26epage%3D4586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">New cinnamic – N-benzylpiperidine and cinnamic – N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 376-386. <a href="https://doi.org/10.1016/j.ejmech.2016.05.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bcinnamic%252B%2525E2%252580%252593%252BN-benzylpiperidine%252Band%252Bcinnamic%252B%2525E2%252580%252593%252BN%25252CN-dibenzyl%252528N-methyl%252529amine%252Bhybrids%252Bas%252BAlzheimer-directed%252Bmultitarget%252Bdrugs%252Bwith%252Bantioxidant%25252C%252Bcholinergic%25252C%252Bneuroprotective%252Band%252Bneurogenic%252Bproperties%26aulast%3DEstrada%26aufirst%3DMart%25C3%25ADn%26date%3D2016%26volume%3D121%26spage%3D376%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Xue-Mei  Li</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer’s disease based on the fusion of donepezil and melatonin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (18)
                                     , 4324-4338. <a href="https://doi.org/10.1016/j.bmc.2016.07.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.07.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.07.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bmulti-target-directed%252Bligands%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bbased%252Bon%252Bthe%252Bfusion%252Bof%252Bdonepezil%252Band%252Bmelatonin%26aulast%3DWang%26aufirst%3DJin%26date%3D2016%26volume%3D24%26issue%3D18%26spage%3D4324%26epage%3D4338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Olaia  Martí-Marí</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">Mario  de la Fuente Revenga</span>, <span class="hlFld-ContribAuthor ">María  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (9)
                                     , 1165. <a href="https://doi.org/10.3390/molecules21091165" title="DOI URL">https://doi.org/10.3390/molecules21091165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21091165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21091165%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252BNeurogenic%252BSmall%252BMolecules%252Bas%252BInnovative%252BTreatments%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DHerrera-Arozamena%26aufirst%3DClara%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D9%26spage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Erik  Laurini</span>, <span class="hlFld-ContribAuthor ">Maurizio  Romano</span>, <span class="hlFld-ContribAuthor ">Sabrina  Pricl</span>, <span class="hlFld-ContribAuthor ">José A  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (11)
                                     , 1191-1207. <a href="https://doi.org/10.4155/fmc-2016-0036" title="DOI URL">https://doi.org/10.4155/fmc-2016-0036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0036%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bneurogenic%252Blipoic-based%252Bhybrids%252Bas%252Binnovative%252BAlzheimer%252527s%252Bdrugs%252Bwith%252B%2525CF%252583-1%252Bagonism%252Band%252B%2525CE%2525B2-secretase%252Binhibition%26aulast%3DEstrada%26aufirst%3DMart%25C3%25ADn%26date%3D2016%26volume%3D8%26issue%3D11%26spage%3D1191%26epage%3D1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of donepezil–ferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 990-998. <a href="https://doi.org/10.1039/C6MD00053C" title="DOI URL">https://doi.org/10.1039/C6MD00053C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00053C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00053C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bdonepezil%2525E2%252580%252593ferulic%252Bacid%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DXu%26aufirst%3DWei%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D5%26spage%3D990%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Su</span>, <span class="hlFld-ContribAuthor ">Tianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Shishun  Xie</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep21826" title="DOI URL">https://doi.org/10.1038/srep21826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep21826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep21826%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Bnovel%252BPDE9%252Binhibitors%252Bcapable%252Bof%252Binhibiting%252BA%2525CE%2525B2%252Baggregation%252Bas%252Bpotential%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSu%26aufirst%3DTao%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjinder  Singh</span>, <span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids: a new paradigm to treat Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2016,</strong> <em>20 </em>
                                    (1)
                                     , 271-297. <a href="https://doi.org/10.1007/s11030-015-9628-9" title="DOI URL">https://doi.org/10.1007/s11030-015-9628-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-015-9628-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-015-9628-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DHybrids%25253A%252Ba%252Bnew%252Bparadigm%252Bto%252Btreat%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSingh%26aufirst%3DManjinder%26date%3D2016%26date%3D2015%26volume%3D20%26issue%3D1%26spage%3D271%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Paloma  Patiño</span>, <span class="hlFld-ContribAuthor ">José Luis  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Ramón  Cacabelos</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 91-99. <a href="https://doi.org/10.1007/978-81-322-2803-5_7" title="DOI URL">https://doi.org/10.1007/978-81-322-2803-5_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-81-322-2803-5_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-81-322-2803-5_7%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BPotential%252Bof%252BMelatonin%252Bin%252BCombination%252Bwith%252BOther%252BDrugs%252BAgainst%252BNeurodegeneration%26aulast%3DRamos%26aufirst%3DEva%26date%3D2016%26date%3D2016%26spage%3D91%26epage%3D99%26pub%3DSpringer%2520India%26atitle%3DMelatonin%25252C%252BNeuroprotective%252BAgents%252Band%252BAntidepressant%252BTherapy%26aulast%3DL%25C3%25B3pez-Mu%25C3%25B1oz%26aufirst%3DFrancisco%26date%3D2016%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaqi  Chu</span>, <span class="hlFld-ContribAuthor ">Yalin  Tu</span>, <span class="hlFld-ContribAuthor ">Jingkao  Chen</span>, <span class="hlFld-ContribAuthor ">Dunxian  Tan</span>, <span class="hlFld-ContribAuthor ">Xingguo  Liu</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of melatonin and its analogues on neural stem cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2016,</strong> <em>420 </em>, 169-179. <a href="https://doi.org/10.1016/j.mce.2015.10.012" title="DOI URL">https://doi.org/10.1016/j.mce.2015.10.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2015.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2015.10.012%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DEffects%252Bof%252Bmelatonin%252Band%252Bits%252Banalogues%252Bon%252Bneural%252Bstem%252Bcells%26aulast%3DChu%26aufirst%3DJiaqi%26date%3D2016%26volume%3D420%26spage%3D169%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiren  Wang</span>, <span class="hlFld-ContribAuthor ">Wenrui  Li</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Xiruo  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of clioquinol–ebselen hybrids as multi-target-directed ligands against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (9)
                                     , 7139-7158. <a href="https://doi.org/10.1039/C5RA26797H" title="DOI URL">https://doi.org/10.1039/C5RA26797H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA26797H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA26797H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bclioquinol%2525E2%252580%252593ebselen%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D9%26spage%3D7139%26epage%3D7158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Premkumar</span>, <span class="hlFld-ContribAuthor ">R. Mohamed  Asath</span>, <span class="hlFld-ContribAuthor ">T. N.  Rekha</span>, <span class="hlFld-ContribAuthor ">A.  Jawahar</span>, <span class="hlFld-ContribAuthor ">T.  Mathavan</span>, <span class="hlFld-ContribAuthor ">A. Milton Franklin  Benial</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking studies of (X-methylphenyl)-5-nitro-6-amino-3-pyridinecarboxmide (X=2,3,4,5,6) as potential inhibitors for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 040005. <a href="https://doi.org/10.1063/1.4947641" title="DOI URL">https://doi.org/10.1063/1.4947641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1063/1.4947641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1063%2F1.4947641%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252Bdocking%252Bstudies%252Bof%252B%252528X-methylphenyl%252529-5-nitro-6-amino-3-pyridinecarboxmide%252B%252528X%25253D2%25252C3%25252C4%25252C5%25252C6%252529%252Bas%252Bpotential%252Binhibitors%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DPremkumar%26aufirst%3DS.%26date%3D2016%26spage%3D040005%26pub%3DAuthor%2528s%2529%26date%3D2016%26volume%3D1731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria João  Matos</span>, <span class="hlFld-ContribAuthor ">Fernanda  Rodríguez-Enríquez</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">Lourdes  Santana</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Reyes  Laguna</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>. </span><span class="cited-content_cbyCitation_article-title">3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , 2071-2079. <a href="https://doi.org/10.1002/cmdc.201500408" title="DOI URL">https://doi.org/10.1002/cmdc.201500408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500408%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D3-Amidocoumarins%252Bas%252BPotential%252BMultifunctional%252BAgents%252Bagainst%252BNeurodegenerative%252BDiseases%26aulast%3DMatos%26aufirst%3DMaria%2BJo%25C3%25A3o%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D2071%26epage%3D2079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Ting  Luo</span>, <span class="hlFld-ContribAuthor ">Chun-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen-Guang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>103 </em>, 302-311. <a href="https://doi.org/10.1016/j.ejmech.2015.08.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bmultifunctional%252Bmelatonin-derived%252Bbenzylpyridinium%252Bbromides%252Bwith%252Bpotent%252Bcholinergic%25252C%252Bantioxidant%25252C%252Band%252Bneuroprotective%252Bproperties%252Bas%252Binnovative%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DLuo%26aufirst%3DXiao-Ting%26date%3D2015%26volume%3D103%26spage%3D302%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Spallarossa</span>, <span class="hlFld-ContribAuthor ">Chiara  Caneva</span>, <span class="hlFld-ContribAuthor ">Matteo  Caviglia</span>, <span class="hlFld-ContribAuthor ">Silvana  Alfei</span>, <span class="hlFld-ContribAuthor ">Stefania  Butini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>, <span class="hlFld-ContribAuthor ">Daniela M.  Zisterer</span>, <span class="hlFld-ContribAuthor ">Sandra A.  Bright</span>, <span class="hlFld-ContribAuthor ">Clive D.  Williams</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Sanna</span>, <span class="hlFld-ContribAuthor ">Ilenia  Delogu</span>, <span class="hlFld-ContribAuthor ">Gabriella  Collu</span>, <span class="hlFld-ContribAuthor ">Roberta  Loddo</span>. </span><span class="cited-content_cbyCitation_article-title">Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 648-660. <a href="https://doi.org/10.1016/j.ejmech.2015.08.009" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnconventional%252BKnoevenagel-type%252Bindoles%25253A%252BSynthesis%252Band%252Bcell-based%252Bstudies%252Bfor%252Bthe%252Bidentification%252Bof%252Bpro-apoptotic%252Bagents%26aulast%3DSpallarossa%26aufirst%3DAndrea%26date%3D2015%26volume%3D102%26spage%3D648%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Daniele  Pala</span>, <span class="hlFld-ContribAuthor ">Annalida  Bedini</span>, <span class="hlFld-ContribAuthor ">Gilberto  Spadoni</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 425-441. <a href="https://doi.org/10.1517/13543776.2014.1001739" title="DOI URL">https://doi.org/10.1517/13543776.2014.1001739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.1001739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.1001739%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTherapeutic%252Buses%252Bof%252Bmelatonin%252Band%252Bmelatonin%252Bderivatives%25253A%252Ba%252Bpatent%252Breview%252B%2525282012%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DRivara%26aufirst%3DSilvia%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D425%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Benchekroun</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Marc  Pudlo</span>, <span class="hlFld-ContribAuthor ">Vincent  Luzet</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">María-Luisa  Jimeno</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Sarah  Wehle</span>, <span class="hlFld-ContribAuthor ">Tijani  Gharbi</span>, <span class="hlFld-ContribAuthor ">Bernard  Refouvelet</span>, <span class="hlFld-ContribAuthor ">Lucía  de Andrés</span>, <span class="hlFld-ContribAuthor ">Clara  Herrera-Arozamena</span>, <span class="hlFld-ContribAuthor ">Barbara  Monti</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Michael  Decker</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Tacrine-Grafted Ugi Adducts as Multipotent Anti-Alzheimer Drugs: A Synthetic Renewal in Tacrine-Ferulic Acid Hybrids. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (3)
                                     , 523-539. <a href="https://doi.org/10.1002/cmdc.201402409" title="DOI URL">https://doi.org/10.1002/cmdc.201402409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402409%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BTacrine-Grafted%252BUgi%252BAdducts%252Bas%252BMultipotent%252BAnti-Alzheimer%252BDrugs%25253A%252BA%252BSynthetic%252BRenewal%252Bin%252BTacrine-Ferulic%252BAcid%252BHybrids%26aulast%3DBenchekroun%26aufirst%3DMohamed%26date%3D2015%26date%3D2014%26volume%3D10%26issue%3D3%26spage%3D523%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria João  Matos</span>, <span class="hlFld-ContribAuthor ">Fernanda  Rodríguez-Enríquez</span>, <span class="hlFld-ContribAuthor ">Santiago  Vilar</span>, <span class="hlFld-ContribAuthor ">Lourdes  Santana</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">George  Hripcsak</span>, <span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 642-648. <a href="https://doi.org/10.1016/j.bmcl.2014.12.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252Bselective%252BMAO-B%252Binhibitory%252Bactivity%25253A%252BAmino-%252Bversus%252Bnitro-3-arylcoumarin%252Bderivatives%26aulast%3DMatos%26aufirst%3DMaria%2BJo%25C3%25A3o%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D642%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Ornella  Di Pietro</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Anna  Vallverdú-Queralt</span>, <span class="hlFld-ContribAuthor ">Carles  Galdeano</span>, <span class="hlFld-ContribAuthor ">Ilaria M.  Ragusa</span>, <span class="hlFld-ContribAuthor ">Elisabet  Viayna</span>, <span class="hlFld-ContribAuthor ">Catherine  Guillou</span>, <span class="hlFld-ContribAuthor ">M. Victòria  Clos</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Rosa M.  Lamuela-Raventós</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (19)
                                     , 5298-5307. <a href="https://doi.org/10.1016/j.bmc.2014.07.053" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.07.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DShogaol%2525E2%252580%252593huprine%252Bhybrids%25253A%252BDual%252Bantioxidant%252Band%252Banticholinesterase%252Bagents%252Bwith%252B%2525CE%2525B2-amyloid%252Band%252Btau%252Banti-aggregating%252Bproperties%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2014%26volume%3D22%26issue%3D19%26spage%3D5298%26epage%3D5307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Pala</span>, <span class="hlFld-ContribAuthor ">Laura  Scalvini</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Lisa  Flammini</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Barocelli</span>, <span class="hlFld-ContribAuthor ">Valeria  Lucini</span>, <span class="hlFld-ContribAuthor ">Francesco  Scaglione</span>, <span class="hlFld-ContribAuthor ">Silvia  Bartolucci</span>, <span class="hlFld-ContribAuthor ">Annalida  Bedini</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Gilberto  Spadoni</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2014,</strong> <em>15 </em>
                                    (9)
                                     , 16114-16133. <a href="https://doi.org/10.3390/ijms150916114" title="DOI URL">https://doi.org/10.3390/ijms150916114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms150916114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms150916114%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252BNew%252BBivalent%252BAgents%252Bas%252BMelatonin-%252Band%252BHistamine%252BH3-Ligands%26aulast%3DPala%26aufirst%3DDaniele%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D9%26spage%3D16114%26epage%3D16133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of melatonin, AP2238, and new melatonin– <i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids (<b>1</b>–<b>14</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Melatonin–<i>N</i>,<i>N</i>-Dibenzyl(<i>N</i>-methyl)amine Hybrids (<b>1</b>–<b>14</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of compounds <b>1</b>–<b>14</b> and melatonin on cell death induced by the combination of rotenone and oligomycin A. Human neuroblastoma SH-SY5Y cells were exposed for 24 h to compounds (1.0 μM) and then exposed for another 24 h to the combination of rotenone (30 μM) and oligomycin A (10 μM) in the presence of compounds. Cell viability was assessed by measuring LDH release. Data are expressed as the mean ± SEM of triplicates of seven different batches of cells. ***<i>p</i> < 0.001 with respect to toxic agents alone (ANOVA followed by Bonferroni post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Neural stem cell cultures (neurospheres), derived from the subgranular zone of the dentate gyrus of the hippocampus of adult Wistar rats, treated with vehicle (basal), melatonin, luzindole (MT antagonist), <b>3</b>, <b>11</b>, and <b>14</b> at 10 μM for 48 h. Neuronal cells were detected using an anti-β-tubulin antibody (TuJ1 clone, green) as an early neurogenesis marker. DAPI (blue) was used for nuclear staining. Scale bar, 200 μm. Quantification of TuJ<sup>+</sup> cells in neurospheres is shown. Values are the mean ± SD from five neurospheres per condition. *** <i>p</i> ≤ 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/medium/jm-2014-000613_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Neural stem cell cultures (neurospheres), derived from the subgranular zone of the dentate gyrus of the hippocampus of adult Wistar rats, treated with vehicle (basal), melatonin, luzindole (MT antagonist), <b>3</b>, <b>11</b>, and <b>14</b> at 10 μM for 48 h. MAP-2 (red) was used as a marker that is associated with neuronal maturation, and DAPI (blue) was used for nuclear staining. Scale bar, 200 μm. Quantification of MAP-2<sup>+</sup> cells in neurospheres is shown. Values are the mean ± SD from five neurospheres per condition. *** <i>p</i> ≤ 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm5000613/production/images/large/jm-2014-000613_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5000613&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sloane, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchindran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boustani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudha, S.</span><span> </span><span class="NLM_article-title">The public health impact of Alzheimer’s disease, 2000–2050: Potential implication of treatment advances</span> <span class="citation_source-journal">Annu. Rev. Public Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1146%2Fannurev.publhealth.23.100901.140525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=11910061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADC%252BD387ns1OrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=213-231&author=P.+D.+Sloaneauthor=S.+Zimmermanauthor=C.+Suchindranauthor=P.+Reedauthor=L.+Wangauthor=M.+Boustaniauthor=S.+Sudha&title=The+public+health+impact+of+Alzheimer%E2%80%99s+disease%2C+2000%E2%80%932050%3A+Potential+implication+of+treatment+advances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances</span></div><div class="casAuthors">Sloane Philip D; Zimmerman Sheryl; Suchindran Chirayath; Reed Peter; Wang Lily; Boustani Malaz; Sudha S</div><div class="citationInfo"><span class="NLM_cas:title">Annual review of public health</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213-31</span>
        ISSN:<span class="NLM_cas:issn">0163-7525</span>.
    </div><div class="casAbstract">Recent developments in basic research suggest that therapeutic breakthroughs may occur in Alzheimer's disease treatment over the coming decades.  To model the potential magnitude and nature of the effect of these advances, historical data from congestive heart failure and Parkinson's disease were used.  Projections indicate that therapies which delay disease onset will markedly reduce overall disease prevalence, whereas therapies to treat existing disease will alter the proportion of cases that are mild as opposed to moderate/severe.  The public health impact of such changes would likely involve both the amount and type of health services needed.  Particularly likely to arise are new forms of outpatient services, such as disease-specific clinics and centers.  None of our models predicts less than a threefold rise in the total number of persons with Alzheimer's disease between 2000 and 2050.  Therefore, Alzheimer's care is likely to remain a major public health problem during the coming decades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRD3ruq-t6fkLjnyZkbE8yXfW6udTcc2ebrTG2heNOS6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ns1OrsA%253D%253D&md5=457b171729773d62e360bd5c210530c0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.publhealth.23.100901.140525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.publhealth.23.100901.140525%26sid%3Dliteratum%253Aachs%26aulast%3DSloane%26aufirst%3DP.%2BD.%26aulast%3DZimmerman%26aufirst%3DS.%26aulast%3DSuchindran%26aufirst%3DC.%26aulast%3DReed%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBoustani%26aufirst%3DM.%26aulast%3DSudha%26aufirst%3DS.%26atitle%3DThe%2520public%2520health%2520impact%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%25202000%25E2%2580%25932050%253A%2520Potential%2520implication%2520of%2520treatment%2520advances%26jtitle%3DAnnu.%2520Rev.%2520Public%2520Health%26date%3D2002%26volume%3D23%26spage%3D213%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0ljp_76CpAj-fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miners, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moxham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thokala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wailoo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffreys, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, C.</span><span> </span><span class="NLM_article-title">The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of technology appraisal no. 111): A systematic review and economic model</span> <span class="citation_source-journal">Health Technol. Assess.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22541366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADC%252BC38roslKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1-470&author=M.+Bondauthor=G.+Rogersauthor=J.+Petersauthor=R.+Andersonauthor=M.+Hoyleauthor=A.+Minersauthor=T.+Moxhamauthor=S.+Davisauthor=P.+Thokalaauthor=A.+Wailooauthor=M.+Jeffreysauthor=C.+Hyde&title=The+effectiveness+and+cost-effectiveness+of+donepezil%2C+galantamine%2C+rivastigmine+and+memantine+for+the+treatment+of+Alzheimer%E2%80%99s+disease+%28review+of+technology+appraisal+no.+111%29%3A+A+systematic+review+and+economic+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model</span></div><div class="casAuthors">Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C</div><div class="citationInfo"><span class="NLM_cas:title">Health technology assessment (Winchester, England)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1-470</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Alzheimer's disease (AD) is the most commonly occurring form of dementia.  It is predominantly a disease of later life, affecting 5% of those over 65 in the UK.  OBJECTIVES:  Review and update guidance to the NHS in England and Wales on the clinical effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine [acetylcholinesterase inhibitors (AChEIs)] and memantine within their licensed indications for the treatment of AD, which was issued in November 2006 (amended September 2007 and August 2009).  DATA SOURCES:  Electronic databases were searched for systematic reviews and/or metaanalyses, randomised controlled trials (RCTs) and ongoing research in November 2009 and updated in March 2010; this updated search revealed no new includable studies.  The databases searched included The Cochrane Library (2009 Issue 4, Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials), MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, PsycINFO, EconLit, ISI Web of Science Databases--Science Citation Index, Conference Proceedings Citation Index, and BIOSIS; the Centre for Reviews and Dissemination (CRD) databases--NHS Economic Evaluation Database, Health Technology Assessment, and Database of Abstracts of Reviews of Effects.  REVIEW METHODS:  The clinical effectiveness systematic review was undertaken following the principles published by the NHS CRD.  We included RCTs whose population was people with AD.  The intervention and comparators depended on disease severity, measured by the Mini Mental State Examination (MMSE).  Interventions: mild AD (MMSE 21-26)--donepezil, galantamine and rivastigmine; moderate AD (MMSE 10-20)--donepezil, galantamine, rivastigmine and memantine; severe AD (MMSE < 10)--memantine.  Comparators: mild AD (MMSE 21-26)--placebo or best supportive care (BSC); moderate AD (MMSE 10-20)--donepezil, galantamine, rivastigmine, memantine, placebo or BSC; severe AD (MMSE < 10)--placebo or BSC.  The outcomes were clinical, global, functional, behavioural, quality of life, adverse events, costs and cost-effectiveness.  Where appropriate, data were pooled using pair-wise meta-analysis, multiple outcome measures, metaregression and mixedtreatment comparisons.  The decision model was based broadly on the structure of the three-state Markov model described in the previous technology assessment report, based upon time to institutionalisation, parameterised with updated estimates of effectiveness, costs and utilities.  RESULTS:  Notwithstanding the uncertainty of our results, we found in the base case that the AChEIs are probably cost saving at a willingness-to-pay (WTP) of £'30,000 per qualityadjusted life-year (QALY) for people with mild-to-moderate AD.  For this class of drugs, there is a > 99% probability that the AChEIs are more cost-effective than BSC.  These analyses assume that the AChEIs have no effect on survival.  For the AChEIs, in people with mild to moderate AD, the probabilistic sensitivity analyses suggested that donepezil is the most cost-effective, with a 28% probability of being the most cost-effective option at a WTP of £'30,000 per QALY (27% at a WTP of £'20,000 per QALY).  In the deterministic results, donepezil dominates the other drugs and BSC, which, along with rivastigmine patches, are associated with greater costs and fewer QALYs.  Thus, although galantamine has a slightly cheaper total cost than donepezil (£'69,592 vs £'69,624), the slightly greater QALY gains from donepezil (1.616 vs 1.617) are enough for donepezil to dominate galantamine.The probability that memantine is cost-effective in a moderate to severe cohort compared with BSC at a WTP of £'30,000 per QALY is 38% (and 28% at a WTP of £'20,000 per QALY).  The deterministic ICER for memantine is £'32,100 per/QALY and the probabilistic ICER is £'36,700 per/QALY.  LIMITATIONS:  Trials were of 6 months maximum follow-up, lacked reporting of key outcomes, provided no subgroup analyses and used insensitive measures.  Searches were limited to English language, The model does not include behavioural symptoms and there is uncertainty about the model structure and parameters.  CONCLUSIONS:  The additional clinical effectiveness evidence identified continues to suggest clinical benefit from the AChEIs in alleviating AD symptoms, although there is debate about the magnitude of the effect.  Although there is also new evidence on the effectiveness of memantine, it remains less supportive of this drug's use than the evidence for AChEIs.  The conclusions concerning cost-effectiveness are quite different from the previous assessment.  This is because both the changes in effectiveness and costs between drug use and non-drug use underlying the ICERs are very small.  This leads to highly uncertain results, which are very sensitive to change.  RESEARCH PRIORITIES: RCTs to include mortality, time to institutionalisation and quality of life, powered for subgroup analysis.  FUNDING:  The National Institute for Health Research Health Technology Assessment programme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqn3zHwwrT-Bcr74wzj5o5fW6udTcc2eaNH5TRdDhJmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38roslKqsg%253D%253D&md5=28160bcdfa6f9cc71ce3efb90ea57266</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBond%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DR.%26aulast%3DHoyle%26aufirst%3DM.%26aulast%3DMiners%26aufirst%3DA.%26aulast%3DMoxham%26aufirst%3DT.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DThokala%26aufirst%3DP.%26aulast%3DWailoo%26aufirst%3DA.%26aulast%3DJeffreys%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DC.%26atitle%3DThe%2520effectiveness%2520and%2520cost-effectiveness%2520of%2520donepezil%252C%2520galantamine%252C%2520rivastigmine%2520and%2520memantine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520%2528review%2520of%2520technology%2520appraisal%2520no.%2520111%2529%253A%2520A%2520systematic%2520review%2520and%2520economic%2520model%26jtitle%3DHealth%2520Technol.%2520Assess.%26date%3D2012%26volume%3D16%26spage%3D1%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wilkinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebel, C.</span><span> </span><span class="NLM_article-title">Memantine in patients with moderate to severe Alzheimer’s disease: Meta-analyses using realistic definitions of response</span> <span class="citation_source-journal">Dementia Geriatr. Cognit. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1159%2F000353801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=24107324" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2013&pages=71-85&author=D.+Wilkinsonauthor=Y.+Wirthauthor=C.+Goebel&title=Memantine+in+patients+with+moderate+to+severe+Alzheimer%E2%80%99s+disease%3A+Meta-analyses+using+realistic+definitions+of+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1159%2F000353801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000353801%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DWirth%26aufirst%3DY.%26aulast%3DGoebel%26aufirst%3DC.%26atitle%3DMemantine%2520in%2520patients%2520with%2520moderate%2520to%2520severe%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Meta-analyses%2520using%2520realistic%2520definitions%2520of%2520response%26jtitle%3DDementia%2520Geriatr.%2520Cognit.%2520Disord.%26date%3D2013%26volume%3D37%26spage%3D71%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinamarca, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span> </span><span class="NLM_article-title">Amyloid–cholinesterase interactions. Implications for Alzheimer’s disease</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=625-632&author=N.+C.+Inestrosaauthor=M.+C.+Dinamarcaauthor=A.+Alvarez&title=Amyloid%E2%80%93cholinesterase+interactions.+Implications+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DDinamarca%26aufirst%3DM.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26atitle%3DAmyloid%25E2%2580%2593cholinesterase%2520interactions.%2520Implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D625%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rees, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soreq, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brimijoin, S.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0197-4580%2802%2900230-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=12927760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVeisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=777-787&author=T.+Reesauthor=P.+I.+Hammondauthor=H.+Soreqauthor=S.+Younkinauthor=S.+Brimijoin&title=Acetylcholinesterase+promotes+beta-amyloid+plaques+in+cerebral+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex</span></div><div class="casAuthors">Rees, T.; Hammond, P. I.; Soreq, H.; Younkin, S.; Brimijoin, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">777-787</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Studies in vitro have suggested that acetylcholinesterase (AChE) may interact with beta-amyloid to promote deposition of amyloid plaques in the brain of patients with Alzheimer's disease.  To test that hypothesis in vivo, the authors crossed Tg2576 mice, which express human amyloid precursor protein and develop plaques at 9 mo, with transgenic mice expressing human AChE.  The resulting F1 hybrids (FVB/N×[C57B6×SJL/J]) expressed both transgenes in brain.  By 6 mo of age, their cerebral cortex showed authentic plaques that stained both by thioflavin S and by beta-amyloid 1-40 and 1-42 immunohistochem.  The plaques also stained pos. for other components including Cd11b, GFAP, and AChE.  Plaque onset in the hybrids occurred 30-50% sooner than in the parental lines.  Plaque nos. increased with age and plaques remained more numerous in the doubly transgenic animals at 9 and 12 mo.  Quant. immunoassay via ELISA also showed an increase of total amyloid content in brain at 9-12 mo.  These histol. and biochem. results support the conclusion that AChE may play a role in pathogenesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5qyVg2WZCmbVg90H21EOLACvtfcHk0lhjA6kEOrS6Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVeisrg%253D&md5=68451e268783be8af8f6e53671b8c4d7</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2802%2900230-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252802%252900230-0%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DT.%26aulast%3DHammond%26aufirst%3DP.%2BI.%26aulast%3DSoreq%26aufirst%3DH.%26aulast%3DYounkin%26aufirst%3DS.%26aulast%3DBrimijoin%26aufirst%3DS.%26atitle%3DAcetylcholinesterase%2520promotes%2520beta-amyloid%2520plaques%2520in%2520cerebral%2520cortex%26jtitle%3DNeurobiol.%2520Aging%26date%3D2003%26volume%3D24%26spage%3D777%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Ferrari, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10447</span><span class="NLM_x">–</span> <span class="NLM_lpage">10457</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0101392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10447-10457&author=G.+V.+De+Ferrariauthor=M.+A.+Canalesauthor=I.+Shinauthor=L.+M.+Weinerauthor=I.+Silmanauthor=N.+C.+Inestrosa&title=A+structural+motif+of+acetylcholinesterase+that+promotes+amyloid+beta-peptide+fibril+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi0101392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0101392%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFerrari%26aufirst%3DG.%2BV.%26aulast%3DCanales%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DI.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DA%2520structural%2520motif%2520of%2520acetylcholinesterase%2520that%2520promotes%2520amyloid%2520beta-peptide%2520fibril%2520formation%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10447%26epage%3D10457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cavriniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0lgTZo0jUdj1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Dual inhibitors of beta-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F15680266113139990139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=23931440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1820-1842&author=E.+Viaynaauthor=R.+Sabateauthor=D.+Mu%C3%B1oz-Torrero&title=Dual+inhibitors+of+beta-amyloid+aggregation+and+acetylcholinesterase+as+multi-target+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Sabate, Raimon; Muaoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1820-1842</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Notwithstanding the functional role that the aggregates of some amyloidogenic proteins can play in different organisms, protein aggregation plays a pivotal role in the pathogenesis of a large no. of human diseases.  One of such diseases is Alzheimer's disease (AD), where the overprodn. and aggregation of the β-amyloid peptide (A β) are regarded as early crit. factors.  Another protein that seems to occupy a prominent position within the complex pathol. network of AD is the enzyme acetylcholinesterase (AChE), with classical and non-classical activities involved at the late (cholinergic deficit) and early (A β aggregation) phases of the disease.  Dual inhibitors of A aggregation and AChE are thus emerging as promising multi-target agents with potential to efficiently modify the natural course of AD.  In the initial phases of the drug discovery process of such compds., in vitro evaluation of the inhibition of Aβ β aggregation is rather troublesome, as it is very sensitive to exptl. assay conditions, and requires expensive synthetic Aβ peptides, which makes cost-prohibitive the screening of large compd. libraries.  Herein, we review recently developed multitarget anti-Alzheimer compds. that exhibit both Aβ aggregation and AChE inhibitory activities, and, in some cases also addnl. valuable activities such as BACE-1 inhibition or antioxidant properties.  We also discuss the development of simplified in vivo methods for the rapid, simple, reliable, unexpensive, and high-throughput amenable screening of Aβ aggregation inhibitors that rely on the overexpression of Aβ42 alone or fused with reporter proteins in Escherichia coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyUwDaYut4bVg90H21EOLACvtfcHk0lgTZo0jUdj1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M&md5=5df3642ce69af587b82d1dac92014f0d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990139%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DDual%2520inhibitors%2520of%2520beta-amyloid%2520aggregation%2520and%2520acetylcholinesterase%2520as%2520multi-target%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1820%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Potent beta-amyloid modulators</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1159%2F000113688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=18322376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=153-156&author=E.+Garc%C3%ADa-Palomeroauthor=P.+Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=P.+Garc%C3%ADaauthor=E.+Delgadoauthor=C.+De+Austriaauthor=R.+Valenzuelaauthor=L.+Rubioauthor=M.+Medinaauthor=A.+Martinez&title=Potent+beta-amyloid+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Potent β-Amyloid Modulators</span></div><div class="casAuthors">Garcia-Palomero, E.; Munoz, P.; Usan, P.; Garcia, P.; Delgado, E.; De Austria, C.; Valenzuela, R.; Rubio, L.; Medina, M.; Martinez, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">153-156</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Currently, the potential to interfere with the pathol. of β-amyloid targeting a well-known drugable enzyme, the acetylcholinesterase (AChE), is opened.  Peripheral or dual binding site inhibitors of AChE may simultaneously alleviate the cognitive and behavioral deficits in Alzheimer's disease (AD) patients and, more importantly, act as disease-modifying agents delaying amyloid plaque formation.  As part of a rational drug design program directed to find dual binding site AChE inhibitors, several families of compds. have been synthesized as potent AChE inhibitors.  From these series, several drug candidates were selected based on their potent and selective inhibition of AChE (subnanomolar activity) and their interference with the β-amyloid aggregation in vitro (IC50 in the low micromolar range).  First in vivo data confirm our initial hypothesis.  Oral treatment with NP-61 for 3 mo is able to reverse the cognitive impairment (Morris water maze test) and to reduce plaque load in the brains of human amyloid precursor protein transgenic mice (Swedish mutation).  These results suggest that NP-61, a potent β-amyloid modulator, is able to reverse the AD-like neurodegenerative phenotype in transgenic mice, indicating a promising disease-modifying agent for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzLEGLsdWOyrVg90H21EOLACvtfcHk0lgTZo0jUdj1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7w%253D&md5=5d4e5f59b1ac00d6ee78e38705d95fda</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1159%2F000113688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000113688%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DP.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DP.%26aulast%3DDelgado%26aufirst%3DE.%26aulast%3DDe%2BAustria%26aufirst%3DC.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPotent%2520beta-amyloid%2520modulators%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2008%26volume%3D5%26spage%3D153%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Spuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antequera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, E.</span><span> </span><span class="NLM_article-title">A new tacrine–melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1007%2Fs12640-009-9121-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=19774434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1SjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=421-431&author=C.+Spuchauthor=D.+Antequeraauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=E.+Carro&title=A+new+tacrine%E2%80%93melatonin+hybrid+reduces+amyloid+burden+and+behavioral+deficits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Spuch, Carlos; Antequera, Desiree; Fernandez-Bachiller, M. Isabel; Rodriguez-Franco, M. Isabel; Carro, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-431</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive degenerative disorder characterized by the presence of amyloid deposits, neurofibrillary tangles and neuron loss.  Emerging evidence indicates that antioxidants could be useful either for the prevention or treatment of AD.  Tacrine and melatonin are well-known drugs which act as an acetylcholinesterase inhibitor and a free radical scavenger, resp.  In this study, we evaluated the effects of a new tacrine-melatonin hybrid on behavior and the biochem. and neuropathol. changes obsd. in amyloid precursor protein/presenilin 1 (APP/Ps1) transgenic mice.  Our findings showed that direct intracerebral administration of this hybrid decreased amyloid β peptide (Aβ)-induced cell death and amyloid burden in the brain parenchyma of APP/Ps1 mice.  This redn. in Aβ pathol. was accompanied by a recovery in cognitive function.  Since this tacrine-melatonin hybrid apparently reduces brain Aβ and behavioral deficits, we believe this drug has remarkable and significant neuroprotective effects and might be considered a potential therapeutic strategy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVLHUwA0i4NLVg90H21EOLACvtfcHk0lieVefgzdeKmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1SjsLs%253D&md5=12f3bb1844570daeaf931584b4af1661</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12640-009-9121-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12640-009-9121-2%26sid%3Dliteratum%253Aachs%26aulast%3DSpuch%26aufirst%3DC.%26aulast%3DAntequera%26aufirst%3DD.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DCarro%26aufirst%3DE.%26atitle%3DA%2520new%2520tacrine%25E2%2580%2593melatonin%2520hybrid%2520reduces%2520amyloid%2520burden%2520and%2520behavioral%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2010%26volume%3D17%26spage%3D421%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Antequera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spuch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascual, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carro, E.</span><span> </span><span class="NLM_article-title">Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Abeta accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2Fj.nbd.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22426395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1ekt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=682-691&author=D.+Antequeraauthor=M.+Bolosauthor=C.+Spuchauthor=C.+Pascualauthor=I.+Ferrerauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=E.+Carro&title=Effects+of+a+tacrine-8-hydroxyquinoline+hybrid+%28IQM-622%29+on+Abeta+accumulation+and+cell+death%3A+Involvement+in+hippocampal+neuronal+loss+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer's disease</span></div><div class="casAuthors">Antequera, Desiree; Bolos, Marta; Spuch, Carlos; Pascual, Consuelo; Ferrer, Isidro; Fernandez-Bachiller, Maria Isabel; Rodriguez-Franco, Maria Isabel; Carro, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">682-691</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Several studies have implicated the enzyme acetylcholinesterase (AChE) as well as several biometals in the pathogenesis of Alzheimer's disease (AD).  A multifunctional mol., the hybrid tacrine-8-hydroxyquinoline (named IQM-622), displays cholinergic, antioxidant, copper-complexing and neuroprotective properties.  Using in vitro and in vivo models, we investigated the modulating effects of IQM-622 on amyloid β-protein (Aβ)-induced pathol. as well as on chem. induced neurodegeneration by domoic acid.  In the first exptl. model, we obsd. a significant decrease in brain Aβ deposits in IQM-622-treated APP/Ps1 mice for four weeks.  Moreover, IQM-622 promoted the degrdn. of intracellular Aβ in astrocytes, and protected against Aβ toxicity in cultured astrocytes and neurons.  These findings suggest that the neuroprotective effect of IQM-622 is not only related to AChE inhibition, but also involves other mechanisms, including the modulation of Aβ-degrdn. pathways in AD brain.  In this study we also compare the neuronal loss in CA1 hippocampal field of AD patients and of mice treated with domoic acid, giving similar patterns.  Thus, we used a second exptl. model by killing hippocampal neurons by domoic acid damage, in which IQM-622 increased survival in the CA1 and dentate gyrus regions of the hippocampus.  Our observations suggest that administration of IQM-622 may have significant beneficial effects in neurodegenerative diseases, including AD, which course with acute or progressive neuronal death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH3NNhchqTHrVg90H21EOLACvtfcHk0lieVefgzdeKmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1ekt74%253D&md5=00b3a59863cd529979830c465a81b0dc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DAntequera%26aufirst%3DD.%26aulast%3DBolos%26aufirst%3DM.%26aulast%3DSpuch%26aufirst%3DC.%26aulast%3DPascual%26aufirst%3DC.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DCarro%26aufirst%3DE.%26atitle%3DEffects%2520of%2520a%2520tacrine-8-hydroxyquinoline%2520hybrid%2520%2528IQM-622%2529%2520on%2520Abeta%2520accumulation%2520and%2520cell%2520death%253A%2520Involvement%2520in%2520hippocampal%2520neuronal%2520loss%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D46%26spage%3D682%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lorrio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Rangel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negredo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal-Cim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span> </span><span class="NLM_article-title">Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=403-411&author=S.+Lorrioauthor=V.+G%C3%B3mez-Rangelauthor=P.+Negredoauthor=J.+Egeaauthor=R.+Le%C3%B3nauthor=A.+Romeroauthor=T.+Dal-Cimauthor=M.+Villarroyaauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=S.+Condeauthor=M.+P.+Arceauthor=J.+M.+Rodaauthor=A.+G.+Garc%C3%ADaauthor=M.+G.+L%C3%B3pez&title=Novel+multitarget+ligand+ITH33%2FIQM9.21+provides+neuroprotection+in+in+vitro+and+in+vivo+models+related+to+brain+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLorrio%26aufirst%3DS.%26aulast%3DG%25C3%25B3mez-Rangel%26aufirst%3DV.%26aulast%3DNegredo%26aufirst%3DP.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DDal-Cim%26aufirst%3DT.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRoda%26aufirst%3DJ.%2BM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26atitle%3DNovel%2520multitarget%2520ligand%2520ITH33%252FIQM9.21%2520provides%2520neuroprotection%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520related%2520to%2520brain%2520ischemia%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D67%26spage%3D403%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ansari, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheff, S. W.</span><span> </span><span class="NLM_article-title">Oxidative stress in the progression of Alzheimer disease in the frontal cortex</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1097%2FNEN.0b013e3181cb5af4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=20084018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1emtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=155-167&author=M.+A.+Ansariauthor=S.+W.+Scheff&title=Oxidative+stress+in+the+progression+of+Alzheimer+disease+in+the+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex</span></div><div class="casAuthors">Ansari, Mubeen A.; Scheff, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-167</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">We investigated oxidative stress in human postmortem frontal cortex from individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9).  Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls.  The short postmortem interval brain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions.  Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances.  The tissue was also analyzed for possible changes in protein damage using neurochem. markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, and acrolein.  All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers.  The highest changes were obsd. in the synaptosomal fraction.  Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase).  Levels of oxidative markers significantly correlated with Mini-Mental Status Examn. scores.  Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion.  These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrifB5Jov2B6rVg90H21EOLACvtfcHk0ljWtOUMtJo-sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1emtb4%253D&md5=1920b63a2e904935f22fef3ce04563af</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e3181cb5af4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e3181cb5af4%26sid%3Dliteratum%253Aachs%26aulast%3DAnsari%26aufirst%3DM.%2BA.%26aulast%3DScheff%26aufirst%3DS.%2BW.%26atitle%3DOxidative%2520stress%2520in%2520the%2520progression%2520of%2520Alzheimer%2520disease%2520in%2520the%2520frontal%2520cortex%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2010%26volume%3D69%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2008&pages=44-48&author=F.+Guauthor=M.+Zhuauthor=J.+Shiauthor=Y.+Huauthor=Z.+Zhao&title=Enhanced+oxidative+stress+is+an+early+event+during+development+of+Alzheimer-like+pathologies+in+presenilin+conditional+knock-out+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DEnhanced%2520oxidative%2520stress%2520is%2520an%2520early%2520event%2520during%2520development%2520of%2520Alzheimer-like%2520pathologies%2520in%2520presenilin%2520conditional%2520knock-out%2520mice%26jtitle%3DNeurosci.%2520Lett.%26date%3D2008%26volume%3D440%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Caldeira, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rego, A. C.</span><span> </span><span class="NLM_article-title">Impaired transcription in Alzheimer’s disease: Key role in mitochondrial dysfunction and oxidative stress</span> <span class="citation_source-journal">J. Alzheimers Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=23364141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADC%252BC3szjvVyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=115-131&author=G.+L.+Caldeiraauthor=I.+L.+Ferreiraauthor=A.+C.+Rego&title=Impaired+transcription+in+Alzheimer%E2%80%99s+disease%3A+Key+role+in+mitochondrial+dysfunction+and+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress</span></div><div class="casAuthors">Caldeira Gladys L; Ferreira I Luisa; Rego A Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is the major cause of dementia in the world.  Abnormal extracellular accumulation of amyloid-β (Aβ) peptide and tau hyperphosphorylation, forming neurofibrillary tangles in the brain, are hallmarks of the disease.  Oxidative stress, neuroinflammation, and mitochondrial and synaptic dysfunction are also observed in AD and often correlated to intracellular Aβ.  This peptide results from the cleavage of the amyloid-β protein precursor by β- and γ-secretases and tends to be secreted after its production.  However, secreted Aβ can be internalized by the interaction with membrane receptors, namely N-methyl-D-aspartate receptors, advanced glycation end products receptors, and/or alpha 7 nicotinic acetylcholine receptors.  Inside the cell, Aβ interacts with several organelles, including mitochondria and nucleus, and there is growing evidence pointing to a possible role of Aβ in the regulation of gene transcription.  Accordingly, transcriptional deregulation was observed in several AD models and human samples from AD patients through modified expression, phosphorylation levels, function, and subcellular localization of some transcription factors, resulting in the suppression of neuroprotective transcription both in the nucleus and the mitochondria.  In this review we focus on key transcription regulators related with mitochondrial biogenesis and antioxidant defenses that seem to be altered in AD models and also on the role of intranuclear Aβ in the pathogenesis of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbA3B1kac05jAEfvC7EH1LfW6udTcc2eb3VWzW4xQ0zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szjvVyjsA%253D%253D&md5=a6b269f0f69174c9a06d63211b4237f6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldeira%26aufirst%3DG.%2BL.%26aulast%3DFerreira%26aufirst%3DI.%2BL.%26aulast%3DRego%26aufirst%3DA.%2BC.%26atitle%3DImpaired%2520transcription%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Key%2520role%2520in%2520mitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D115%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluise, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Clair, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markesbery, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Potential in vivo amelioration by N-acetyl-<span class="smallcaps smallerCapital">l</span>-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: Toward therapeutic modulation of mild cognitive impairment</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2618</span><span class="NLM_x">–</span> <span class="NLM_lpage">2629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=20648652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVantbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=2618-2629&author=Q.+Huangauthor=C.+D.+Aluiseauthor=G.+Joshiauthor=R.+Sultanaauthor=D.+K.+St+Clairauthor=W.+R.+Markesberyauthor=D.+A.+Butterfield&title=Potential+in+vivo+amelioration+by+N-acetyl-l-cysteine+of+oxidative+stress+in+brain+in+human+double+mutant+APP%2FPS-1+knock-in+mice%3A+Toward+therapeutic+modulation+of+mild+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment</span></div><div class="casAuthors">Huang, Quanzhen; Aluise, Christopher D.; Joshi, Gururaj; Sultana, Rukhsana; St. Clair, Daret K.; Markesbery, William R.; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2618-2629</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most prevalent form of dementia among the elderly.  Although the underlying cause has yet to be established, numerous data have shown that oxidative stress is implicated in AD as well as in preclin. stages of AD, such as mild cognitive impairment (MCI).  The oxidative stress obsd. in brains of subjects with AD and MCI may be due, either fully or in part, to increased free radicals mediated by amyloid-β peptide (Aβ).  By using double human mutant APP/PS-1 knock-in mice as the AD model, the present work demonstrates that the APP/PS-1 double mutation results in elevated protein oxidn. (as indexed by protein carbonyls), protein nitration (as indexed by 3-nitrotyrosine), as well as lipid peroxidn. (as indexed by protein-bound 4-hydroxy-2-nonenal) in brains of mice aged 9 mo and 12 mo.  APP/PS-1 mice also exhibited lower levels of brain glutathione peroxidase (GPx) in both age groups studied, whereas glutathione reductase (GR) levels in brain were unaffected by the mutation.  The activities of both of these antioxidant enzymes were significantly decreased in APP/PS-1 mouse brains, whereas the activity of glucose-6-phosphate dehydrogenase (G6PDH) was increased relative to controls in both age groups.  Levels of peptidyl prolyl isomerase 1 (Pin1) were significantly decreased in APP/PS-1 mouse brain aged 9 and 12 mo.  Administration of N-acetyl-L-cysteine (NAC), a glutathione precursor, to APP/PS-1 mice via drinking water suppressed increased protein oxidn. and nitration and also significantly augmented levels and activity of GPx in brain from both age groups.  Oral administration of NAC also increased the diminished activity of GR and protected against lipid peroxidn. in brains of 9-mo-old APP/PS-1 mice only.  Pin1 levels, GR levels, and G6PDH activity in brain were unaffected by oral administration of NAC in both age groups.  These results are discussed with ref. to the therapeutic potential of this brain-accessible glutathione precursor in the treatment of MCI and AD. © 2010 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GhQM6Rf4PbVg90H21EOLACvtfcHk0lixHvV2XBqt_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVantbY%253D&md5=be4f1911caeef1f20315aa4f02a416e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DAluise%26aufirst%3DC.%2BD.%26aulast%3DJoshi%26aufirst%3DG.%26aulast%3DSultana%26aufirst%3DR.%26aulast%3DSt%2BClair%26aufirst%3DD.%2BK.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DPotential%2520in%2520vivo%2520amelioration%2520by%2520N-acetyl-l-cysteine%2520of%2520oxidative%2520stress%2520in%2520brain%2520in%2520human%2520double%2520mutant%2520APP%252FPS-1%2520knock-in%2520mice%253A%2520Toward%2520therapeutic%2520modulation%2520of%2520mild%2520cognitive%2520impairment%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2010%26volume%3D88%26spage%3D2618%26epage%3D2629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Altman, J.</span><span> </span><span class="NLM_article-title">Are new neurons formed in the brains of adult mammals?</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1127</span><span class="NLM_x">–</span> <span class="NLM_lpage">1128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=1962&pages=1127-1128&author=J.+Altman&title=Are+new+neurons+formed+in+the+brains+of+adult+mammals%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DJ.%26atitle%3DAre%2520new%2520neurons%2520formed%2520in%2520the%2520brains%2520of%2520adult%2520mammals%253F%26jtitle%3DScience%26date%3D1962%26volume%3D135%26spage%3D1127%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Eriksson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perfilieva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Björk-Eriksson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alborn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordborg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Neurogenesis in the adult human hippocampus</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1038%2F3305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=9809557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaK1cXntlaktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=1313-1317&author=P.+S.+Erikssonauthor=E.+Perfilievaauthor=T.+Bj%C3%B6rk-Erikssonauthor=A.+M.+Albornauthor=C.+Nordborgauthor=D.+A.+Petersonauthor=F.+H.+Gage&title=Neurogenesis+in+the+adult+human+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenesis in the adult human hippocampus</span></div><div class="casAuthors">Eriksson, Peter S.; Perfilieva, Ekaterina; Bjork-Eriksson, Thomas; Alborn, Ann-Marie; Nordrorg, Claes; Peterson, Daniel A.; Gage, Fred H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The genesis of new cells, including neurons, in the adult human brain has not yet been demonstrated.  This study was undertaken to investigate whether neurogenesis occurs in the adult human brain, in regions previously identified as neurogenic in adult rodents and monkeys.  Human brain tissue was obtained postmortem from patients who had been treated with the thymidine analog, bromodeoxyuridine (BrdU), that labels DNA during the S phase.  Using immunofluorescent labeling for BrdU and for one of the neuronal markers, NeuN, calbindin or neuron specific enolase (NSE), we demonstrate that new neurons, as defined by these markers, are generated from dividing progenitor cells in the dentate gyrus of adult humans.  Our results further indicate that the human hippocampus retains its ability to generate neurons throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcTe1-ZnHXc7Vg90H21EOLACvtfcHk0liOHaKq-va44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntlaktb4%253D&md5=032e3adc0c2e863d6c7192eb93b09dda</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F3305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F3305%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DP.%2BS.%26aulast%3DPerfilieva%26aufirst%3DE.%26aulast%3DBj%25C3%25B6rk-Eriksson%26aufirst%3DT.%26aulast%3DAlborn%26aufirst%3DA.%2BM.%26aulast%3DNordborg%26aufirst%3DC.%26aulast%3DPeterson%26aufirst%3DD.%2BA.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DNeurogenesis%2520in%2520the%2520adult%2520human%2520hippocampus%26jtitle%3DNat.%2520Med.%26date%3D1998%26volume%3D4%26spage%3D1313%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Spalding, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alkass, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salehpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttner, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boström, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerlund, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possnert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mash, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frisén, J.</span><span> </span><span class="NLM_article-title">Dynamics of hippocampal neurogenesis in adult humans</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2013&pages=1219-1227&author=K.+L.+Spaldingauthor=O.+Bergmannauthor=K.+Alkassauthor=S.+Bernardauthor=M.+Salehpourauthor=H.+B.+Huttnerauthor=E.+Bostr%C3%B6mauthor=I.+Westerlundauthor=C.+Vialauthor=B.+A.+Buchholzauthor=G.+Possnertauthor=D.+C.+Mashauthor=H.+Druidauthor=J.+Fris%C3%A9n&title=Dynamics+of+hippocampal+neurogenesis+in+adult+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpalding%26aufirst%3DK.%2BL.%26aulast%3DBergmann%26aufirst%3DO.%26aulast%3DAlkass%26aufirst%3DK.%26aulast%3DBernard%26aufirst%3DS.%26aulast%3DSalehpour%26aufirst%3DM.%26aulast%3DHuttner%26aufirst%3DH.%2BB.%26aulast%3DBostr%25C3%25B6m%26aufirst%3DE.%26aulast%3DWesterlund%26aufirst%3DI.%26aulast%3DVial%26aufirst%3DC.%26aulast%3DBuchholz%26aufirst%3DB.%2BA.%26aulast%3DPossnert%26aufirst%3DG.%26aulast%3DMash%26aufirst%3DD.%2BC.%26aulast%3DDruid%26aufirst%3DH.%26aulast%3DFris%25C3%25A9n%26aufirst%3DJ.%26atitle%3DDynamics%2520of%2520hippocampal%2520neurogenesis%2520in%2520adult%2520humans%26jtitle%3DCell%26date%3D2013%26volume%3D153%26spage%3D1219%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Abdipranoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stayte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissel, B.</span><span> </span><span class="NLM_article-title">The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F187152708784083858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=18537646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslCitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=187-210&author=A.+Abdipranotoauthor=S.+Wuauthor=S.+Stayteauthor=B.+Vissel&title=The+role+of+neurogenesis+in+neurodegenerative+diseases+and+its+implications+for+therapeutic+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development</span></div><div class="casAuthors">Abdipranoto, Andrea; Wu, Sara; Stayte, Sandy; Vissel, Bryce</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-210</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are characterized by a net loss of neurons from specific regions of the central nervous system (CNS).  Until recently, research has focused on identifying mechanisms that lead to neurodegeneration, while therapeutic approaches have been primarily targeted to prevent neuronal loss.  This has had limited success and marketed pharmaceuticals do not have dramatic benefits.  Here we suggest that the future success of therapeutic strategies will depend on consideration and understanding of the role of neurogenesis in the adult CNS.  We summarize evidence suggesting that neurogenesis is impaired in neurodegenerative diseases such as Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis, while it is enhanced in stroke.  We review studies where stimulation of neurogenesis is assocd. with restored function in animal models of these diseases, suggesting that neurogenesis is functionally important.  We show that many current therapeutics, developed to block degeneration or to provide symptomatic relief, serendipitously stimulate neurogenesis or, at least, do not interfere with it.  Importantly, many receptors, ion channels and ligand-gated channels implicated in neurodegeneration, such as NMDA, AMPA, GABA and nicotinic acetylcholine receptors, also play an important role in neurogenesis and regeneration.  Therefore, new therapeutics targeted to block degeneration by antagonizing these channels may have limited benefit as they may also block regeneration.  Our conclusion is that future drug development must consider neurogenesis.  It appears unlikely that drugs being developed to treat neurodegenerative diseases will be beneficial if they impair neurogenesis.  And, most tantalizing, therapeutic approaches that stimulate neurogenesis might stimulate repair and even recovery from these devastating diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeesGdW1nlzbVg90H21EOLACvtfcHk0liOHaKq-va44Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslCitLk%253D&md5=4df96eb6a7a0927db8f2e90fd3931fba</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F187152708784083858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708784083858%26sid%3Dliteratum%253Aachs%26aulast%3DAbdipranoto%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DStayte%26aufirst%3DS.%26aulast%3DVissel%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520neurogenesis%2520in%2520neurodegenerative%2520diseases%2520and%2520its%2520implications%2520for%2520therapeutic%2520development%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D187%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bubenik, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konturek, S. J.</span><span> </span><span class="NLM_article-title">Melatonin and aging: Prospects for human treatment</span> <span class="citation_source-journal">J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=21451205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFagsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2011&pages=13-19&author=G.+A.+Bubenikauthor=S.+J.+Konturek&title=Melatonin+and+aging%3A+Prospects+for+human+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin and aging: prospects for human treatment</span></div><div class="casAuthors">Bubenik, G. A.; Konturek, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-19</span>CODEN:
                <span class="NLM_cas:coden">JPHPEI</span>;
        ISSN:<span class="NLM_cas:issn">0867-5910</span>.
    
            (<span class="NLM_cas:orgname">Polish Physiological Society</span>)
        </div><div class="casAbstract">A review.  Human life span, with or without modern medicine is around 85-95 years.  All living creatures have their inner clock that measures their daily (circadian) and their seasonal (circannual) time.  These time changes are mediated by the alteration of levels of melatonin, an evolutionary ancient hormone, which is produced in many body tissues, including the pineal gland, retina and the gastrointestinal tract (GIT).  Light is blocking the prodn. of melatonin in the pineal gland, darkness is stimulating it.  So, the diurnal changes of light intensity of melatonin, provide a "daily clock" and the seasonal changes provide a "seasonal clock".  Finally, the redn. of melatonin obsd. with aging, may indicate the presence of an "age clock".  Melatonin is a strong antioxidant (often it is called scavenger of free radicals), which protects the body from the effects of noxious compds.  Therefore it was hypothesized that the redn. of melatonin levels with age contributes to the aging process.  So far, the only remedy to extend the life span was a 40% redn. in caloric intake, which prolonged the life in mice, rats, dogs and monkeys by 30-50%.  A large group of people imitate these expts. performed on animals, but the results of these expts. will not be known for several decades.  How is being hungry prolonging the life span.  There is a connection between caloric redn. and melatonin levels in GIT.  Several expts. indicate that fasting in animals substantially increased their prodn. of GIT melatonin.  Therefore, instead of being permanently hungry, a prolongation of human life could be achieved by a replacement melatonin therapy.  A daily intake of melatonin before bed time might achieve the same effect as fasting e.g. an increase of body melatonin levels, which will protect the individual from the ravages of old age.  That includes Parkinson's disease and Alzheimer's disease.  There is a large group of people taking melatonin daily who believe that melatonin is the "fountain of youth".  Those are the subjects which will one day provide an exptl. evidence of the efficacy of melatonin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWWOWhgyFmI7Vg90H21EOLACvtfcHk0ljYSERif2Z4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFagsrg%253D&md5=8d32e375f02180bdedf6f09540d9d91e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubenik%26aufirst%3DG.%2BA.%26aulast%3DKonturek%26aufirst%3DS.%2BJ.%26atitle%3DMelatonin%2520and%2520aging%253A%2520Prospects%2520for%2520human%2520treatment%26jtitle%3DJ.%2520Physiol.%2520Pharmacol.%26date%3D2011%26volume%3D62%26spage%3D13%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Reiter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchester, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D. X.</span><span> </span><span class="NLM_article-title">Neurotoxins: Free radical mechanisms and melatonin protection</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F157015910792246236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=21358970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=194-210&author=R.+J.+Reiterauthor=L.+C.+Manchesterauthor=D.+X.+Tan&title=Neurotoxins%3A+Free+radical+mechanisms+and+melatonin+protection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxins: free radical mechanisms and melatonin protection</span></div><div class="casAuthors">Reiter, Russel J.; Manchester, Lucien C.; Tan, Dun-Xian</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-210</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxins that pass through the blood-brain barrier put neurons and glia in peril.  The damage inflicted is usually a consequence of the ability of these toxic agents to induce free radical generation within cells but esp. at the level of the mitochondria.  The elevated prodn. of oxygen and nitrogen-based radicals and related non-radical products leads to the oxidn. of essential macromols. including lipids, proteins and DNA.  The resultant damage is referred to as oxidative and nitrosative stress and, when the mol. destruction is sufficiently severe, it causes apoptosis or necrosis of neurons and glia.  Loss of brain cells compromises the functions of the central nervous system expressed as motor, sensory and cognitive deficits and psychol. alterations.  In this survey we summarize the publications related to the following neurotoxins and the protective actions of melatonin: aminolevulinic acid, cyanide, domoic acid, kainic acid, metals, methamphetamine, polychlorinated biphenyls, rotenone, toluene and 6-hydroxydopamine.  Given the potent direct free radical scavenging activities of melatonin and its metabolites, their ability to indirectly stimulate antioxidative enzymes and their efficacy in reducing electron leakage from mitochondria, it would be expected that these mols. would protect the brain from oxidative and nitrosative mol. mutilation.  The studies summarized in this review indicate that this is indeed the case, an action that is obviously assisted by the fact that melatonin readily crosses the blood brain barrier.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcOwOv1M5VV7Vg90H21EOLACvtfcHk0ljYSERif2Z4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2mtrvI&md5=c18bc9fb326167358209cdd17b89ffd5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F157015910792246236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015910792246236%26sid%3Dliteratum%253Aachs%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26aulast%3DManchester%26aufirst%3DL.%2BC.%26aulast%3DTan%26aufirst%3DD.%2BX.%26atitle%3DNeurotoxins%253A%2520Free%2520radical%2520mechanisms%2520and%2520melatonin%2520protection%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2010%26volume%3D8%26spage%3D194%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Reiter, R. J.</span><span> </span><span class="NLM_article-title">Oxidative damage in the central nervous system: Protection by melatonin</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0301-0082%2898%2900052-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=9770244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaK1cXmtFKhtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=359-384&author=R.+J.+Reiter&title=Oxidative+damage+in+the+central+nervous+system%3A+Protection+by+melatonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative damage in the central nervous system: protection by melatonin</span></div><div class="casAuthors">Reiter, Russel J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-384</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with ∼275 refs.  Melatonin was recently reported to be an effective free radical scavenger and antioxidant.  Melatonin is believed to scavenge the highly toxic hydroxyl radical, the peroxynitrite anion, and possibly the peroxyl radical.  Also, secondarily, it reportedly scavenges the superoxide anion radical and it quenches singlet oxygen.  Addnl., it stimulates mRNA levels for superoxide dismutase and the activities of glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase (all of which are antioxidative enzymes), thereby increasing its antioxidative capacity.  Also, melatonin, at least at some sites, inhibits nitric oxide synthase, a pro-oxidative enzyme.  In both in vivo and in vitro expts. melatonin has been shown to reduce lipid peroxidn. and oxidative damage to nuclear DNA.  While these effects have been obsd. primarily using pharmacol. doses of melatonin, in a small no. of expts. melatonin has been found to be physiol. relevant as an antioxidant as well.  The efficacy of melatonin in inhibiting oxidative damage has been tested in a variety of neurol. disease models where free radicals have been implicated as being in part causative of the condition.  Thus, melatonin has been shown prophylactically to reduce amyloid β protein toxicity of Alzheimer's disease, to reduce oxidative damage in several models of Parkinson's disease (dopamine auto-oxidn., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine), to protect against glutamate excitotoxicity, to reduce ischemia-reperfusion injury, to lower neural damage due to δ-aminolevulinic acid (porphyria), hyperbaric hyperoxia and a variety of neural toxins.  Since endogenous melatonin levels fall markedly in advanced age, the implication of these findings is that the loss of this antioxidant may contribute to the incidence or severity of some age-assocd. neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbMBfTYQqFtLVg90H21EOLACvtfcHk0ljYSERif2Z4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtFKhtbc%253D&md5=2518032c1c106627bdef1151ab5d269f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2898%2900052-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252898%252900052-5%26sid%3Dliteratum%253Aachs%26aulast%3DReiter%26aufirst%3DR.%2BJ.%26atitle%3DOxidative%2520damage%2520in%2520the%2520central%2520nervous%2520system%253A%2520Protection%2520by%2520melatonin%26jtitle%3DProg.%2520Neurobiol.%26date%3D1998%26volume%3D56%26spage%3D359%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pandi-Perumal, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BaHammam, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharti, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardeland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardinali, D. P.</span><span> </span><span class="NLM_article-title">Melatonin antioxidative defense: Therapeutical implications for aging and neurodegenerative processes</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1007%2Fs12640-012-9337-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22739839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFOit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=267-300&author=S.+R.+Pandi-Perumalauthor=A.+S.+BaHammamauthor=G.+M.+Brownauthor=D.+W.+Spenceauthor=V.+K.+Bhartiauthor=C.+Kaurauthor=R.+Hardelandauthor=D.+P.+Cardinali&title=Melatonin+antioxidative+defense%3A+Therapeutical+implications+for+aging+and+neurodegenerative+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes</span></div><div class="casAuthors">Pandi-Perumal, Seithikurippu R.; BaHammam, Ahmed S.; Brown, Gregory M.; Spence, D. Warren; Bharti, Vijay K.; Kaur, Charanjit; Hardeland, Ruediger; Cardinali, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-300</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The pineal product melatonin has remarkable antioxidant properties.  It is secreted during darkness and plays a key role in various physiol. responses including regulation of circadian rhythms, sleep homeostasis, retinal neuromodulation, and vasomotor responses.  It scavenges hydroxyl, carbonate, and various org. radicals as well as a no. of reactive nitrogen species.  Melatonin also enhances the antioxidant potential of the cell by stimulating the synthesis of antioxidant enzymes including superoxide dismutase, glutathione peroxidase, and glutathione reductase, and by augmenting glutathione levels.  Melatonin preserves mitochondrial homeostasis, reduces free radical generation and protects mitochondrial ATP synthesis by stimulating Complexes I and IV activities.  The decline in melatonin prodn. in aged individuals has been suggested as one of the primary contributing factors for the development of age-assocd. neurodegenerative diseases.  The efficacy of melatonin in preventing oxidative damage in either cultured neuronal cells or in the brains of animals treated with various neurotoxic agents, suggests that melatonin has a potential therapeutic value as a neuroprotective drug in treatment of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), stroke, and brain trauma.  Therapeutic trials with melatonin indicate that it has a potential therapeutic value as a neuroprotective drug in treatment of AD, ALS, and HD.  In the case of other neurol. conditions, like PD, the evidence is less compelling.  Melatonin's efficacy in combating free radical damage in the brain suggests that it can be a valuable therapeutic agent in the treatment of cerebral edema following traumatic brain injury or stroke.  Clin. trials employing melatonin doses in the range of 50-100 mg/day are warranted before its relative merits as a neuroprotective agent is definitively established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKtx6fhXb13LVg90H21EOLACvtfcHk0lhOF788CZxCwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFOit7g%253D&md5=9a6620bc929220deaf0b046ca790fadd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs12640-012-9337-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12640-012-9337-4%26sid%3Dliteratum%253Aachs%26aulast%3DPandi-Perumal%26aufirst%3DS.%2BR.%26aulast%3DBaHammam%26aufirst%3DA.%2BS.%26aulast%3DBrown%26aufirst%3DG.%2BM.%26aulast%3DSpence%26aufirst%3DD.%2BW.%26aulast%3DBharti%26aufirst%3DV.%2BK.%26aulast%3DKaur%26aufirst%3DC.%26aulast%3DHardeland%26aufirst%3DR.%26aulast%3DCardinali%26aufirst%3DD.%2BP.%26atitle%3DMelatonin%2520antioxidative%2520defense%253A%2520Therapeutical%2520implications%2520for%2520aging%2520and%2520neurodegenerative%2520processes%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2013%26volume%3D23%26spage%3D267%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span> </span><span class="NLM_article-title">Melatonin in Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">14575</span><span class="NLM_x">–</span> <span class="NLM_lpage">14593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.3390%2Fijms140714575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=14575-14593&author=L.+Linauthor=Q.+X.+Huangauthor=S.+S.+Yangauthor=J.+Chuauthor=J.+Z.+Wangauthor=Q.+Tian&title=Melatonin+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin in Alzheimer's disease</span></div><div class="casAuthors">Lin, Li; Huang, Qiong-Xia; Yang, Shu-Sheng; Chu, Jiang; Wang, Jian-Zhi; Tian, Qing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">14575-14593, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), an age-related neurodegenerative disorder with progressive cognition deficit, is characterized by extracellular senile plaques (SP) of aggregated β-amyloid (Aβ) and intracellular neurofibrillary tangles, mainly contg. the hyperphosphorylated microtubule-assocd. protein tau.  Multiple factors contribute to the etiol. of AD in terms of initiation and progression.  Melatonin is an endogenously produced hormone in the brain and decreases during aging and in patients with AD.  Data from clin. trials indicate that melatonin supplementation improves sleep, ameliorates sundowning and slows down the progression of cognitive impairment in AD patients.  Melatonin efficiently protects neuronal cells from Aβ-mediated toxicity via antioxidant and anti-amyloid properties.  It not only inhibits Aβ generation, but also arrests the formation of amyloid fibrils by a structure-dependent interaction with Aβ.  Our studies have demonstrated that melatonin efficiently attenuates Alzheimer-like tau hyperphosphorylation.  Although the exact mechanism is still not fully understood, a direct regulatory influence of melatonin on the activities of protein kinases and protein phosphatases is proposed.  Addnl., melatonin also plays a role in protecting the cholinergic system and in anti-inflammation.  The aim of this review is to stimulate interest in melatonin as a potentially useful agent in the prevention and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr72I0hQZs34LVg90H21EOLACvtfcHk0lhOF788CZxCwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvK&md5=16d19b4085258e91cbcff16887a3903a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fijms140714575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140714575%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DQ.%2BX.%26aulast%3DYang%26aufirst%3DS.%2BS.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DTian%26aufirst%3DQ.%26atitle%3DMelatonin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D14575%26epage%3D14593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ramírez-Rodríguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klempin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benítez-King, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempermann, G.</span><span> </span><span class="NLM_article-title">Melatonin modulates cell survival of new neurons in the hippocampus of adult mice</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2180</span><span class="NLM_x">–</span> <span class="NLM_lpage">2191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=2180-2191&author=G.+Ram%C3%ADrez-Rodr%C3%ADguezauthor=F.+Klempinauthor=H.+Babuauthor=G.+Ben%C3%ADtez-Kingauthor=G.+Kempermann&title=Melatonin+modulates+cell+survival+of+new+neurons+in+the+hippocampus+of+adult+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez-Rodr%25C3%25ADguez%26aufirst%3DG.%26aulast%3DKlempin%26aufirst%3DF.%26aulast%3DBabu%26aufirst%3DH.%26aulast%3DBen%25C3%25ADtez-King%26aufirst%3DG.%26aulast%3DKempermann%26aufirst%3DG.%26atitle%3DMelatonin%2520modulates%2520cell%2520survival%2520of%2520new%2520neurons%2520in%2520the%2520hippocampus%2520of%2520adult%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D2180%26epage%3D2191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Domínguez-Alonso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez-Rodríguez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benítez-King, G.</span><span> </span><span class="NLM_article-title">Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures</span> <span class="citation_source-journal">J. Pineal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1111%2Fj.1600-079X.2011.00957.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22257024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=427-436&author=A.+Dom%C3%ADnguez-Alonsoauthor=G.+Ram%C3%ADrez-Rodr%C3%ADguezauthor=G.+Ben%C3%ADtez-King&title=Melatonin+increases+dendritogenesis+in+the+hilus+of+hippocampal+organotypic+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures</span></div><div class="casAuthors">Dominguez-Alonso, Aline; Ramirez-Rodriguez, Gerardo; Benitez-King, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">427-436</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Neuropsychiatric disorders are characterized by hippocampus decreased vol. and loss of dendrite arborizations in the subiculum and prefrontal cortex.  These structural changes are assocd. with diminished memory performance.  Hilar neurons of the hippocampus integrate spatial memory and are lost in dementia.  They receive information from dentate gyrus neurons through dendrites, while they send axonal tracts to the CA3 region.  Dendrites are complex structures of neurons that receive chem. information from presynaptic and postsynaptic terminals.  Melatonin, the main product of the pineal gland, has neuroprotective actions through its free radical-scavenging properties and decreases neuronal apoptosis.  Recently, we found that melatonin increases dendrite maturation and complexity in new neurons formed in the dentate gyrus of mice.  In addn., in N1E-115 cultured cells, the indole stimulates early stages of neurite formation, a process that is known to antecede dendrite formation and maturation.  Thus, in this study, we explored whether melatonin stimulates dendrite formation and complexity in the adult rat hippocampus in organotypic slice cultures, which is a model that preserves the hippocampal circuitry and their tridimensional organizations of connectivity.  The effects of melatonin were studied in nonpathol. conditions and in the absence of harmful agents.  The results showed that the indole at nocturnal concns. reached in the cerebrospinal fluid stimulates dendritogenesis at formation, growth, and maturation stages.  Also, data showed that dendrites formed became competent to form presynaptic specializations.  Evidence strongly suggests that melatonin may be useful in the treatment of neuropsychiatric diseases to repair the loss of dendrites and re-establish lost synaptic connections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE9u2zi62ygLVg90H21EOLACvtfcHk0lhUYzbgvcWVQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyluro%253D&md5=78e5986508795dc86a9ad8b8caa48b90</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-079X.2011.00957.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-079X.2011.00957.x%26sid%3Dliteratum%253Aachs%26aulast%3DDom%25C3%25ADnguez-Alonso%26aufirst%3DA.%26aulast%3DRam%25C3%25ADrez-Rodr%25C3%25ADguez%26aufirst%3DG.%26aulast%3DBen%25C3%25ADtez-King%26aufirst%3DG.%26atitle%3DMelatonin%2520increases%2520dendritogenesis%2520in%2520the%2520hilus%2520of%2520hippocampal%2520organotypic%2520cultures%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2012%26volume%3D52%26spage%3D427%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somera-Molina, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubocovich, M. L.</span><span> </span><span class="NLM_article-title">Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus</span> <span class="citation_source-journal">J. Pineal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1111%2Fjpi.12023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=23190173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=222-231&author=J.+Liuauthor=K.+C.+Somera-Molinaauthor=R.+L.+Hudsonauthor=M.+L.+Dubocovich&title=Melatonin+potentiates+running+wheel-induced+neurogenesis+in+the+dentate+gyrus+of+adult+C3H%2FHeN+mice+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus</span></div><div class="casAuthors">Liu, Jiabei; Somera-Molina, Kathleen C.; Hudson, Randall L.; Dubocovich, Margarita L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pineal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">JPRSE9</span>;
        ISSN:<span class="NLM_cas:issn">0742-3098</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This study assessed the role of melatonin in modulating running wheel(RW)-induced hippocampal neurogenesis in adult C3H/HeN mice.  Chronic melatonin (0.02 mg/mL, oral for 12 days) treatment did not affect cell proliferation or cell survival detd. by the no. of BrdU-pos. cells in dentate gyrus of mice with access to fixed wheel (FW).  RW activity significantly increased cell proliferation [RW (n = 8) vs. FW (n = 6): dorsal, 199 ± 18 vs. 125 ± 12, P < 0.01; ventral, 211 ± 15 vs. 123 ± 13, P < 0.01] and newborn cell survival [RW (n = 7) vs. FW (n = 8): dorsal, 45 ± 8.5 vs. 15 ± 1.8, P < 0.01; ventral, 48 ± 8.1 vs. 15 ± 1.4] in the dorsal and ventral dentate gyrus.  Oral melatonin treatment further potentiated RW activity-induced cell survival in both areas of the dentate gyrus [melatonin (n = 10) vs. vehicle (n = 7): dorsal, 63 ± 5.4 vs. 45 ± 8.5 P < 0.05; ventral, 75 ± 7.9 vs. 48 ± 8.1, P < 0.01] and neurogenesis [melatonin (n = 8) vs. vehicle (n = 8): dorsal, 46 ± 3.4, vs. 34 ± 4.5, P < 0.05; ventral, 41 ± 3.4 vs. 25 ± 2.4, P < 0.01].  We conclude that melatonin potentiates RW-induced hippocampal neurogenesis by enhancing neuronal survival suggesting that the combination of phys. exercise and melatonin may be an effective treatment for diseases affecting the hippocampus neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT3S8HMJJ8zLVg90H21EOLACvtfcHk0lhUYzbgvcWVQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCqsLc%253D&md5=ba198eef56e191f22d1700295d2c0986</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fjpi.12023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjpi.12023%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSomera-Molina%26aufirst%3DK.%2BC.%26aulast%3DHudson%26aufirst%3DR.%2BL.%26aulast%3DDubocovich%26aufirst%3DM.%2BL.%26atitle%3DMelatonin%2520potentiates%2520running%2520wheel-induced%2520neurogenesis%2520in%2520the%2520dentate%2520gyrus%2520of%2520adult%2520C3H%252FHeN%2520mice%2520hippocampus%26jtitle%3DJ.%2520Pineal%2520Res.%26date%3D2013%26volume%3D54%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0ljQ7uQq3E83lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljQ7uQq3E83lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">León, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garc%C3%ADaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0ljQ7uQq3E83lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A small molecule targeting the multifactorial nature of Alzheimer’s disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+small+molecule+targeting+the+multifactorial+nature+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520small%2520molecule%2520targeting%2520the%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Capurro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busquet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e56870-1</span><span class="NLM_x">–</span> <span class="NLM_lpage">e56870-8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e56870-1-e56870-8&author=V.+Capurroauthor=P.+Busquetauthor=J.+P.+Lopesauthor=R.+Bertorelliauthor=G.+Tarozzoauthor=M.+L.+Bolognesiauthor=D.+Piomelliauthor=A.+Reggianiauthor=A.+Cavalli&title=Pharmacological+characterization+of+memoquin%2C+a+multi-target+compound+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DLopes%26aufirst%3DJ.%2BP.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520memoquin%252C%2520a%2520multi-target%2520compound%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De56870-1%26epage%3De56870-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Ladostigil: A novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer’s disease treatment</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.2174%2F138945012799499794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22280345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38XkslCmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=483-494&author=O.+Weinrebauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+B.+Youdim&title=Ladostigil%3A+A+novel+multimodal+neuroprotective+drug+with+cholinesterase+and+brain-selective+monoamine+oxidase+inhibitory+activities+for+Alzheimer%E2%80%99s+disease+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment</span></div><div class="casAuthors">Weinreb, Orly; Amit, Tamar; Bar-Am, Orit; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">483-494</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ladostigil [(N-propargyl-(3R) aminoindan-5yl)-Et Me carbamate] is a dual acetylcholine-butyrylcholineesterase and brain selective monoamine oxidase (MAO)-A and -B inhibitor in vivo (with little or no MAO inhibitory effect in the liver and small intestine), intended for the treatment of dementia co-morbid with extrapyramidal disorders and depression (presently in a Phase IIb clin. study).  This suggests that the drug should not cause a significant potentiation of the cardiovascular response to tyramine, thereby making it a potentially safer antidepressant than other irreversible MAO-A inhibitors.  Ladostigil was shown to antagonize scopolamine-induced impairment in spatial memory, indicating that it can cause significant increases in rat brain cholinergic activity.  Furthermore, ladostigil prevented gliosis and oxidative-nitrative stress and reduced the deficits in episodic and spatial memory induced by intracerebroventricular injection of streptozotocin in rats.  Ladostigil was demonstrated to possess potent anti-apoptotic and neuroprotective activities in vitro and in various neurodegenerative rat models, (e.g. hippocampal damage induced by global ischemia in gerbils and cerebral edema induced in mice by closed head injury).  These neuroprotective activities involve regulation of amyloid precursor protein processing; activation of protein kinase C and mitogen-activated protein kinase signaling pathways; inhibition of neuronal death markers; prevention of the fall in mitochondrial membrane potential and upregulation of neurotrophic factors and antioxidative activity.  Recent findings demonstrated that the major metabolite of ladostigil, hydroxy-1-(R)-aminoindan has also a neuroprotective activity and thus, may contribute to the overt activity of its parent compd.  This review will discuss the scientific evidence for the therapeutic potential use of ladostigil in Alzheimer's and Lewy Body diseases and the mol. signaling pathways that are considered to be involved in the biol. activities of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSPLqLnccsGLVg90H21EOLACvtfcHk0ljOeKpSEafUHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkslCmurY%253D&md5=2272d945e6eaf132035b6dfc43d2e569</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138945012799499794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945012799499794%26sid%3Dliteratum%253Aachs%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DLadostigil%253A%2520A%2520novel%2520multimodal%2520neuroprotective%2520drug%2520with%2520cholinesterase%2520and%2520brain-selective%2520monoamine%2520oxidase%2520inhibitory%2520activities%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2012%26volume%3D13%26spage%3D483%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badía, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junyent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Novel huprine derivatives with inhibitory activity toward beta-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1855-1870&author=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=L.+Ram%C3%ADrezauthor=M.+Ratiaauthor=A.+Bad%C3%ADaauthor=M.+V.+Closauthor=E.+Verdaguerauthor=F.+Junyentauthor=A.+Caminsauthor=M.+Pallasauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+huprine+derivatives+with+inhibitory+activity+toward+beta-amyloid+aggregation+and+formation+as+disease-modifying+anti-Alzheimer+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBad%25C3%25ADa%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPallas%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520huprine%2520derivatives%2520with%2520inhibitory%2520activity%2520toward%2520beta-amyloid%2520aggregation%2520and%2520formation%2520as%2520disease-modifying%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DChemMedChem.%26date%3D2010%26volume%3D5%26spage%3D1855%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giménez-Llort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badía, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huprine, X.</span><span> </span><span class="NLM_article-title">and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer’s disease in triple transgenic mice (3xTg-AD)</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1159%2F000336427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=22626981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=129-140&author=M.+Ratiaauthor=L.+Gim%C3%A9nez-Llortauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torreroauthor=B.+P%C3%A9rezauthor=M.+V.+Closauthor=A.+Bad%C3%ADaauthor=X.+Huprine&title=and+huperzine+A+improve+cognition+and+regulate+some+neurochemical+processes+related+with+Alzheimer%E2%80%99s+disease+in+triple+transgenic+mice+%283xTg-AD%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine X and Huperzine A Improve Cognition and Regulate Some Neurochemical Processes Related with Alzheimer's Disease in Triple Transgenic Mice (3xTg-AD)</span></div><div class="casAuthors">Ratia, M.; Gimenez-Llort, L.; Camps, P.; Munoz-Torrero, D.; Perez, B.; Clos, M. V.; Badia, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">129-140</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Different studies have established that cholinergic neurodegeneration could be a major pathol. feature of Alzheimer's disease (AD).  Thus, enhancement of the central cholinergic neurotransmission has been regarded as one of the most promising strategies for the symptomatic treatment of AD, mainly by means of reversible acetylcholinesterase inhibitors (AChEIs).  The cognitive-enhancing properties of both huprine X, a new AChEI, and the structurally related huperzine A, as well as their effects on the regulation of several neurochem. processes related to AD have been studied in triple transgenic mice (3xTg-AD).  Methods: Seven-month-old homozygous 3xTg-AD male mice, which received chronic i.p. treatment with either saline, huprine X (0.12 μmol·kg-1) or huperzine A (0.8 μmol·kg-1) were subjected to a battery of behavioral tests after 3 wk of treatment and thereafter the brains were dissected to study the neurochem. effects induced by the two AChEIs.  Results: Treatments with huprine X and huperzine A improved learning and memory in the Morris water maze and some indicators of emotionality without inducing important adverse effects.  Moreover, huprine X and huperzine A activate protein kinase C/mitogen-activated protein kinase pathway signalling, α-secretases (ADAM 10 and TACE) and increase the fraction of phospho-glycogen synthase kinase 3-β.  Conclusion: Results obtained herein using a sample of 3xTg-AD animals strongly suggest that the treatment with the two AChEIs not only improves the cognitive performance of the animals but also induces some neurochem. changes that could contribute to the beneficial effects obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4hYSxNmqNQLVg90H21EOLACvtfcHk0ljNIeb3-mnPng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWitbg%253D&md5=9abfb99b4d64cfac36a38f10fcce5eb7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1159%2F000336427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000336427%26sid%3Dliteratum%253Aachs%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DGim%25C3%25A9nez-Llort%26aufirst%3DL.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBad%25C3%25ADa%26aufirst%3DA.%26aulast%3DHuprine%26aufirst%3DX.%26atitle%3Dand%2520huperzine%2520A%2520improve%2520cognition%2520and%2520regulate%2520some%2520neurochemical%2520processes%2520related%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520triple%2520transgenic%2520mice%2520%25283xTg-AD%2529%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2013%26volume%3D11%26spage%3D129%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">New tacrine–4-oxo-4<i>H</i>-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine%E2%80%934-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+beta-amyloid-reducing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine%25E2%2580%25934-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520beta-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100329q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4927-4937&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=S.+Condeauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Novel+tacrine-8-hydroxyquinoline+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+neuroprotective%2C+cholinergic%2C+antioxidant%2C+and+copper-complexing+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm100329q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100329q%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNovel%2520tacrine-8-hydroxyquinoline%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520neuroprotective%252C%2520cholinergic%252C%2520antioxidant%252C%2520and%2520copper-complexing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4927%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, S.</span><span> </span><span class="NLM_article-title">Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7249</span><span class="NLM_x">–</span> <span class="NLM_lpage">7257</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900628z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7249-7257&author=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=C.+P%C3%A9rezauthor=B.+L%C3%B3pezauthor=M.+Villarroyaauthor=M.+G.+L%C3%B3pezauthor=A.+G.+Garc%C3%ADaauthor=S.+Conde&title=Neuroprotective+and+cholinergic+properties+of+multifunctional+glutamic+acid+derivatives+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm900628z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900628z%26sid%3Dliteratum%253Aachs%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DL%25C3%25B3pez%26aufirst%3DB.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DConde%26aufirst%3DS.%26atitle%3DNeuroprotective%2520and%2520cholinergic%2520properties%2520of%2520multifunctional%2520glutamic%2520acid%2520derivatives%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7249%26epage%3D7257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández-Ledesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, B.</span><span> </span><span class="NLM_article-title">Novel tacrine–melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=B.+Hern%C3%A1ndez-Ledesmaauthor=B.+Bartolom%C3%A9&title=Novel+tacrine%E2%80%93melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DHern%25C3%25A1ndez-Ledesma%26aufirst%3DB.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DNovel%2520tacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Fernández-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campillo, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Páez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span> </span><span class="NLM_article-title">Tacrine–melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and neuroprotective properties</span> <span class="citation_source-journal">ChemMedChem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=828-841&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=N.+E.+Campilloauthor=J.+A.+P%C3%A1ezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=A.+Mart%C3%ADnezauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Tacrine%E2%80%93melatonin+hybrids+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+neuroprotective+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DTacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520neuroprotective%2520properties%26jtitle%3DChemMedChem.%26date%3D2009%26volume%3D4%26spage%3D828%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: A dual function lead for Alzheimer’s disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalliauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+Valentiauthor=M.+Recanatini&title=3-%284-%5B%5BBenzyl%28methyl%29amino%5Dmethyl%5Dphenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation%3A+A+dual+function+lead+for+Alzheimer%E2%80%99s+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3D3-%25284-%255B%255BBenzyl%2528methyl%2529amino%255Dmethyl%255Dphenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%253A%2520A%2520dual%2520function%2520lead%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4250</span><span class="NLM_x">–</span> <span class="NLM_lpage">4254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070100g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4250-4254&author=L.+Piazziauthor=A.+Cavalliauthor=F.+Bellutiauthor=A.+Bisiauthor=S.+Gobbiauthor=S.+Rizzoauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=M.+Recanatiniauthor=A.+Rampa&title=Extensive+SAR+and+computational+studies+of+3-%7B4-%5B%28benzylmethylamino%29methyl%5Dphenyl%7D-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm070100g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070100g%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DExtensive%2520SAR%2520and%2520computational%2520studies%2520of%25203-%257B4-%255B%2528benzylmethylamino%2529methyl%255Dphenyl%257D-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4250%26epage%3D4254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1749</span><span class="NLM_x">–</span> <span class="NLM_lpage">1760</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1749-1760&author=S.+Rizzoauthor=M.+Bartoliniauthor=L.+Ceccariniauthor=L.+Piazziauthor=S.+Gobbiauthor=A.+Cavalliauthor=M.+Recanatiniauthor=V.+Andrisanoauthor=A.+Rampa&title=Targeting+Alzheimer%E2%80%99s+disease%3A+Novel+indanone+hybrids+bearing+a+pharmacophoric+fragment+of+AP2238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCeccarini%26aufirst%3DL.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DTargeting%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Novel%2520indanone%2520hybrids%2520bearing%2520a%2520pharmacophoric%2520fragment%2520of%2520AP2238%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D1749%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gilman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailie, J. C.</span><span> </span><span class="NLM_article-title">Relative reactivities of organometallic compounds. XVII. The azo linkage</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1937</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01224a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1937&pages=84-94&author=H.+Gilmanauthor=J.+C.+Bailie&title=Relative+reactivities+of+organometallic+compounds.+XVII.+The+azo+linkage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo01224a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01224a010%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DH.%26aulast%3DBailie%26aufirst%3DJ.%2BC.%26atitle%3DRelative%2520reactivities%2520of%2520organometallic%2520compounds.%2520XVII.%2520The%2520azo%2520linkage%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1937%26volume%3D2%26spage%3D84%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0ljEQ6WkqwzzjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Brunhofer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallarero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopi Mohan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuorela, P.</span><span> </span><span class="NLM_article-title">Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6669</span><span class="NLM_x">–</span> <span class="NLM_lpage">6679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=6669-6679&author=G.+Brunhoferauthor=A.+Fallareroauthor=D.+Karlssonauthor=A.+Batista-Gonzalezauthor=P.+Shindeauthor=C.+Gopi+Mohanauthor=P.+Vuorela&title=Exploration+of+natural+compounds+as+sources+of+new+bifunctional+scaffolds+targeting+cholinesterases+and+beta+amyloid+aggregation%3A+The+case+of+chelerythrine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunhofer%26aufirst%3DG.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DD.%26aulast%3DBatista-Gonzalez%26aufirst%3DA.%26aulast%3DShinde%26aufirst%3DP.%26aulast%3DGopi%2BMohan%26aufirst%3DC.%26aulast%3DVuorela%26aufirst%3DP.%26atitle%3DExploration%2520of%2520natural%2520compounds%2520as%2520sources%2520of%2520new%2520bifunctional%2520scaffolds%2520targeting%2520cholinesterases%2520and%2520beta%2520amyloid%2520aggregation%253A%2520The%2520case%2520of%2520chelerythrine%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D6669%26epage%3D6679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-García, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramón, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: Synthesis, pharmacological evaluation and mechanistic studies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=141-152&author=O.+Di+Pietroauthor=E.+Viaynaauthor=E.+Vicente-Garc%C3%ADaauthor=M.+Bartoliniauthor=R.+Ram%C3%B3nauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=V.+Andrisanoauthor=F.+J.+Luqueauthor=R.+Lavillaauthor=D.+Mu%C3%B1oz-Torrero&title=1%2C2%2C3%2C4-Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridines+as+a+new+family+of+potent+peripheral-to-midgorge-site+inhibitors+of+acetylcholinesterase%3A+Synthesis%2C+pharmacological+evaluation+and+mechanistic+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DVicente-Garc%25C3%25ADa%26aufirst%3DE.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DRam%25C3%25B3n%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3D1%252C2%252C3%252C4-Tetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridines%2520as%2520a%2520new%2520family%2520of%2520potent%2520peripheral-to-midgorge-site%2520inhibitors%2520of%2520acetylcholinesterase%253A%2520Synthesis%252C%2520pharmacological%2520evaluation%2520and%2520mechanistic%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D73%26spage%3D141%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lappi, S.</span><span> </span><span class="NLM_article-title">Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1997</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00680a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1989-1997&author=P.+Taylorauthor=S.+Lappi&title=Interaction+of+fluorescence+probes+with+acetylcholinesterase.+The+site+and+specificity+of+propidium+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi00680a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00680a029%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLappi%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520fluorescence%2520probes%2520with%2520acetylcholinesterase.%2520The%2520site%2520and%2520specificity%2520of%2520propidium%2520binding%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D1989%26epage%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0ligeFlJYWrtkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Dávalos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Cordovés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé, B.</span><span> </span><span class="NLM_article-title">Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf0305231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2004&pages=48-54&author=A.+D%C3%A1valosauthor=C.+G%C3%B3mez-Cordov%C3%A9sauthor=B.+Bartolom%C3%A9&title=Extending+applicability+of+the+oxygen+radical+absorbance+capacity+%28ORAC-fluorescein%29+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjf0305231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf0305231%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A1valos%26aufirst%3DA.%26aulast%3DG%25C3%25B3mez-Cordov%25C3%25A9s%26aufirst%3DC.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DExtending%2520applicability%2520of%2520the%2520oxygen%2520radical%2520absorbance%2520capacity%2520%2528ORAC-fluorescein%2529%2520assay%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2004%26volume%3D52%26spage%3D48%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sofic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimpapa, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundurovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sapcanin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustembegovic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G.</span><span> </span><span class="NLM_article-title">Antioxidant capacity of the neurohormone melatonin</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2005&pages=349-358&author=E.+Soficauthor=Z.+Rimpapaauthor=Z.+Kundurovicauthor=A.+Sapcaninauthor=I.+Tahirovicauthor=A.+Rustembegovicauthor=G.+Cao&title=Antioxidant+capacity+of+the+neurohormone+melatonin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSofic%26aufirst%3DE.%26aulast%3DRimpapa%26aufirst%3DZ.%26aulast%3DKundurovic%26aufirst%3DZ.%26aulast%3DSapcanin%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DI.%26aulast%3DRustembegovic%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DG.%26atitle%3DAntioxidant%2520capacity%2520of%2520the%2520neurohormone%2520melatonin%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2005%26volume%3D112%26spage%3D349%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span> </span><span class="NLM_article-title">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1111%2Fj.1471-4159.2007.04665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=17540012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=1842-1852&author=J.+Egeaauthor=A.+O.+Rosaauthor=A.+Cuadradoauthor=A.+G.+Garc%C3%ADaauthor=M.+G.+L%C3%B3pez&title=Nicotinic+receptor+activation+by+epibatidine+induces+heme+oxygenase-1+and+protects+chromaffin+cells+against+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress</span></div><div class="casAuthors">Egea, Javier; Rosa, Angelo O.; Cuadrado, Antonio; Garcia, Antonio G.; Lopez, Manuela G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1842-1852</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Activation of neuronal nicotinic acetylcholine receptors (nAChR) provides neuroprotection against different toxic stimuli that often lead to overprodn. of reactive oxygen species (ROS) and cell death.  ROS prodn. has been related with disease progression in several neurodegenerative pathologies such as Alzheimer's or Parkinson's diseases.  In this context, we investigated here if the exposure of bovine chromaffin cells to the potent nAChR agonist epibatidine protected against rotenone (30 μmol/L) plus oligomycin (10 μmol/L) (rot/oligo) toxicity, an in vitro model of mitochondrial ROS prodn.  Epibatidine induced a concn.- and time-dependent protection, which was maximal at 3 μmol/L after 24 h.  Pre-incubation with dantrolene (100 μmol/L) (a blocker of the ryanodine receptor channel), chelerythrine (1 μmol/L) (a protein kinase C inhibitor), or PD98059 (50 μmol/L) (a MEK inhibitor), aborted epibatidine-elicited cytoprotection.  Mitochondrial depolarization, ROS, and caspase 3 active produced by rot/oligo were also prevented by epibatidine.  Epibatidine doubled the amt. of heme oxygenase-1 (HO-1), a crit. cell defense enzyme against oxidative stress.  Furthermore, the HO-1 inhibitor Sn(IV) protoporphyrin IX dichloride reversed the epibatidine protecting effects and HO-1 inducer Co (III) protoporphyrin IX dichloride exhibited neuroprotective effects by itself.  The results of this study point to HO-1 as the cytoprotective target of nAChR activation through the following pathway: endoplasmic reticulum Ca2+-induced Ca2+-release activates the protein kinase C/extracellular regulated kinase/HO-1 axis to mitigate mitochondrial depolarization and ROS prodn.  This study provides a mechanistic insight on how nAChR activation translates into an antioxidant and antiapoptotic signal through up-regulation of HO-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3XG5b3a4IOLVg90H21EOLACvtfcHk0ljxcMAVofpajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVyksLbF&md5=689683073dac18206961fec581367cd9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2007.04665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2007.04665.x%26sid%3Dliteratum%253Aachs%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRosa%26aufirst%3DA.%2BO.%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26atitle%3DNicotinic%2520receptor%2520activation%2520by%2520epibatidine%2520induces%2520heme%2520oxygenase-1%2520and%2520protects%2520chromaffin%2520cells%2520against%2520oxidative%2520stress%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D102%26spage%3D1842%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Maroto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Fuente, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artalejo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Sancho, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A. G.</span><span> </span><span class="NLM_article-title">Effects of Ca<sup>2+</sup> channel antagonists on chromaffin cell death and cytosolic Ca<sup>2+</sup> oscillations induced by veratridine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=7805782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADyaK2cXlsVyqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1994&pages=331-339&author=R.+Marotoauthor=M.+T.+De+la+Fuenteauthor=A.+R.+Artalejoauthor=F.+Abadauthor=M.+G.+L%C3%B3pezauthor=J.+Garc%C3%ADa-Sanchoauthor=A.+G.+Garc%C3%ADa&title=Effects+of+Ca2%2B+channel+antagonists+on+chromaffin+cell+death+and+cytosolic+Ca2%2B+oscillations+induced+by+veratridine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Ca2+ channel antagonists on chromaffin cell death and cytosolic Ca2+ oscillations induced by veratridine</span></div><div class="casAuthors">Maroto, Rosario; Fuente, Maria-Teresa De la; Artalejo, Antonio R.; Abad, Francisco; Lopez, Manuela G.; Garcia-Sancho, Javier; Garcia, Antonio G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology, Environmental Toxicology and Pharmacology Section</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">331-9</span>CODEN:
                <span class="NLM_cas:coden">EPEPEG</span>;
        ISSN:<span class="NLM_cas:issn">0926-6917</span>.
    </div><div class="casAbstract">Exposure of bovine chromaffin cells to 30 μM veratridine for 24 h led to 70-80% cell death as reflected by phase contrast microscopy, trypan blue exclusion, lactate dehydrogenase (LDH) release and cell catecholamine contents.  Na+ deprivation, Ca2+ deletion or tetrodotoxin (5 μM) prevented the veratridine-induced cell damage.  Nimodipine and verapamil, but not ω-conotoxin GVIA afforded 20-30% protection.  Flunarizine protected the cells by 80% and R56865 by 60%.  Stimulation of fura-2-loaded single bovine chromaffin cells with 30 μM of 1,1-dimethyl-4-phenylpiperazinium (DMPP) or 59 mM K+ caused fast increases in cytosolic Ca2+ concns., ([Ca2+]i).  The [Ca2+]i rose from 0.1 to peaks of 1.9 μM, which quickly declined to near basal levels with a t1/2 of around 30 s.  In spite of sustained stimulation with these two depolarizing agents, the [Ca2+]i remained low and did not undergo oscillations.  In contrast, veratridine (30 μM) caused large and frequent oscillatory changes in the [Ca2+]i which were long-lasting and did not disappear even 30 min after washing out the toxin.  The [Ca2+]i oscillations were reversibly suppressed by Na+ or Ca2+ removal and by 5 μM tetrodotoxin.  Selective L-type Ca2+ channel blockers (10 μM nimodipine or verapamil) or N-type Ca2+ channel blockers (1 μM ω-conotoxin GVIA) did not affect the [Ca2+]i oscillations.  In contrast, flunarizine or R56865 (10 μM each) suppressed the oscillations of [Ca2+]i.  The results demonstrate that bovine chromaffin cells have the necessary machinery to develop prolonged and repetitive [Ca2+]i oscillations in the presence of veratridine; however, 'physiol.' depolarizing stimuli did not cause oscillations.  These non-inactivating [Ca2+]i oscillations may induce Ca2+ overload, thus explaining the well known cytotoxic effects of veratridine in neuronal and chromaffin cell cultures.  Drugs such as flunarizine and the novel cytoprotective agent R56865, which prevent such oscillations, avoid Ca2+ overload and cell damage.  The results also suggest that external Ca2+ entry through N- or L-type Ca2+ channels can equally be assocd. with the veratridine-evoked cell damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCytoybk0wArVg90H21EOLACvtfcHk0ljxcMAVofpajQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsVyqsbY%253D&md5=210984ed13f3a5a92451bfa4c59c9ca2</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaroto%26aufirst%3DR.%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DM.%2BT.%26aulast%3DArtalejo%26aufirst%3DA.%2BR.%26aulast%3DAbad%26aufirst%3DF.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DGarc%25C3%25ADa-Sancho%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26atitle%3DEffects%2520of%2520Ca2%252B%2520channel%2520antagonists%2520on%2520chromaffin%2520cell%2520death%2520and%2520cytosolic%2520Ca2%252B%2520oscillations%2520induced%2520by%2520veratridine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D270%26spage%3D331%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ferrón, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreu-Agullo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marqués-Torrejón, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farinas, I.</span><span> </span><span class="NLM_article-title">A combined ex/in vivo assay to detect effects of exogenously added factors in neural stem cells</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=849-859&author=S.+R.+Ferr%C3%B3nauthor=C.+Andreu-Agulloauthor=H.+Miraauthor=P.+S%C3%A1nchezauthor=M.+A.+Marqu%C3%A9s-Torrej%C3%B3nauthor=I.+Farinas&title=A+combined+ex%2Fin+vivo+assay+to+detect+effects+of+exogenously+added+factors+in+neural+stem+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25B3n%26aufirst%3DS.%2BR.%26aulast%3DAndreu-Agullo%26aufirst%3DC.%26aulast%3DMira%26aufirst%3DH.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DP.%26aulast%3DMarqu%25C3%25A9s-Torrej%25C3%25B3n%26aufirst%3DM.%2BA.%26aulast%3DFarinas%26aufirst%3DI.%26atitle%3DA%2520combined%2520ex%252Fin%2520vivo%2520assay%2520to%2520detect%2520effects%2520of%2520exogenously%2520added%2520factors%2520in%2520neural%2520stem%2520cells%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D849%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Morales-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luna-Medina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfaro-Cervello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Canteli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Verdugo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, A.</span><span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=293-307&author=J.+A.+Morales-Garc%C3%ADaauthor=R.+Luna-Medinaauthor=C.+Alfaro-Cervelloauthor=M.+Cortes-Canteliauthor=A.+Santosauthor=J.+M.+Garc%C3%ADa-Verdugoauthor=A.+P%C3%A9rez-Castillo&title=Peroxisome+proliferator-activated+receptor+gamma+ligands+regulate+neural+stem+cell+proliferation+and+differentiation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DLuna-Medina%26aufirst%3DR.%26aulast%3DAlfaro-Cervello%26aufirst%3DC.%26aulast%3DCortes-Canteli%26aufirst%3DM.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DGarc%25C3%25ADa-Verdugo%26aufirst%3DJ.%2BM.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma%2520ligands%2520regulate%2520neural%2520stem%2520cell%2520proliferation%2520and%2520differentiation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DGlia%26date%3D2011%26volume%3D59%26spage%3D293%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Morales-García, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luna-Medina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso-Gil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Sancristóbal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Castillo, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300110c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=963-971&author=J.+A.+Morales-Garc%C3%ADaauthor=R.+Luna-Medinaauthor=S.+Alonso-Gilauthor=M.+Sanz-Sancrist%C3%B3balauthor=V.+Palomoauthor=C.+Gilauthor=A.+Santosauthor=A.+Mart%C3%ADnezauthor=A.+P%C3%A9rez-Castillo&title=Glycogen+synthase+kinase+3+inhibition+promotes+adult+hippocampal+neurogenesis+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo</span></div><div class="casAuthors">Morales-Garcia, Jose A.; Luna-Medina, Rosario; Alonso-Gil, Sandra; Sanz-SanCristobal, Marina; Palomo, Valle; Gil, Carmen; Santos, Angel; Martinez, Ana; Perez-Castillo, Ana</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">963-971</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase originally identified as a regulator of glycogen metab. but it also plays a pivotal role in numerous cellular functions, including differentiation, cell cycle regulation, and proliferation.  The dentate gyrus of the hippocampus, together with the subventricular zone of the lateral ventricles, is one of the regions in which neurogenesis takes place in the adult brain.  Here, using a chem. genetic approach that involves the use of several diverse inhibitors of GSK-3 as pharmacol. tools, we show that inhibition of GSK-3 induces proliferation, migration, and differentiation of neural stem cells toward a neuronal phenotype in in vitro studies.  Also, we demonstrate that inhibition of GSK-3 with the small mol. NP03112, called tideglusib, induces neurogenesis in the dentate gyrus of the hippocampus of adult rats.  Taken together, our results suggest that GSK-3 should be considered as a new target mol. for modulating the prodn. and integration of new neurons in the hippocampus as a treatment for neurodegenerative diseases or brain injury and, consequently, its inhibitors may represent new potential therapeutic drugs in neuroregenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZkY2VITeIN7Vg90H21EOLACvtfcHk0lgw39vU-MzTNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2nsLbM&md5=8ec3f8126b23b3a635ace8a11b0911b0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcn300110c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300110c%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Garc%25C3%25ADa%26aufirst%3DJ.%2BA.%26aulast%3DLuna-Medina%26aufirst%3DR.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DSanz-Sancrist%25C3%25B3bal%26aufirst%3DM.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520inhibition%2520promotes%2520adult%2520hippocampal%2520neurogenesis%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D963%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampsch-Woodill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prior, R. L.</span><span> </span><span class="NLM_article-title">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4619</span><span class="NLM_x">–</span> <span class="NLM_lpage">4626</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf010586o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=4619-4626&author=B.+Ouauthor=M.+Hampsch-Woodillauthor=R.+L.+Prior&title=Development+and+validation+of+an+improved+oxygen+radical+absorbance+capacity+assay+using+fluorescein+as+the+fluorescent+probe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</span></div><div class="casAuthors">Ou, Boxin; Hampsch-Woodill, Maureen; Prior, Ronald L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4619-4626</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An improved method of oxygen radical absorbance capacity (ORAC) assay has been developed and validated using fluorescein (3',6'-dihydroxyspiro[isobenzofuran-1[3H],9'[9H]-xanthen]-3-one) as the fluorescent probe.  Our results demonstrate that fluorescein (FL) is superior to B-phycoerythrin.  The oxidized FL products induced by peroxyl radical were identified by LC/MS, and the reaction mechanism was detd. to follow a classic hydrogen atom transfer mechanism.  In addn., methodol. and mechanistic comparison of ORACFL with other widely used methods was discussed.  It is concluded that, unlike other popular methods, the improved ORACFL assay provides a direct measure of hydrophilic chain-breaking antioxidant capacity against peroxyl radical.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApt11rCiMJbVg90H21EOLACvtfcHk0lgw39vU-MzTNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVSgtLo%253D&md5=b4c9da1f30dc271228a916025322dbd7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjf010586o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf010586o%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DB.%26aulast%3DHampsch-Woodill%26aufirst%3DM.%26aulast%3DPrior%26aufirst%3DR.%2BL.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520an%2520improved%2520oxygen%2520radical%2520absorbance%2520capacity%2520assay%2520using%2520fluorescein%2520as%2520the%2520fluorescent%2520probe%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2001%26volume%3D49%26spage%3D4619%26epage%3D4626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm5000613&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm5000613&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5000613&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+colorimetric+assay+for+cell+growth+and+survival.+Modifications+to+the+tetrazolium+dye+procedure+giving+improved+sensitivity+and+reliability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2eaiyEv060j0r7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cell%2520growth%2520and%2520survival.%2520Modifications%2520to%2520the%2520tetrazolium%2520dye%2520procedure%2520giving%2520improved%2520sensitivity%2520and%2520reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i58"><a href="/doi/suppl/10.1021/jm5000613">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02505"></div></div></div></div></div><hr /></hr><p class="last">Elemental analyses of new melatonin–<i>N</i>,<i>N</i>-dibenzyl(<i>N</i>-methyl)amine hybrids <b>1</b>–<b>14</b> and intermediates <b>16</b>–<b>24</b>; permeability in the PAMPA-BBB assay of 10 commercial drugs; neuroprotection of the human neuroblastoma cell line SH-SY5Y against the combination of rotenone and oligomycin by hybrids <b>1</b>–<b>14</b>; percentages of MTT reduction and LDH release in SH-SY5Y cells exposed to compounds <b>3</b>, <b>11</b>, and <b>14</b>; and molecular modelling overlay of AP2238 and <b>3</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5000613/suppl_file/jm5000613_si_001.pdf">jm5000613_si_001.pdf (368.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5000613&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm5000613%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5000613" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998c796dce195b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
